id	sid	tid	token	lemma	pos
chd-117	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-117	1	2	e1	e1	NOUN
chd-117	1	3	cancer	cancer	NOUN
chd-117	1	4	health	health	NOUN
chd-117	1	5	disparities	disparity	NOUN
chd-117	1	6	research	research	NOUN
chd-117	1	7	prevalence	prevalence	NOUN
chd-117	1	8	of	of	ADP
chd-117	1	9	the	the	DET
chd-117	1	10	ugt1a1	ugt1a1	ADJ
chd-117	1	11	*	*	ADJ
chd-117	1	12	28	28	NUM
chd-117	1	13	promoter	promoter	NOUN
chd-117	1	14	polymorphism	polymorphism	NOUN
chd-117	1	15	and	and	CCONJ
chd-117	1	16	breast	breast	NOUN
chd-117	1	17	cancer	cancer	NOUN
chd-117	1	18	risk	risk	NOUN
chd-117	1	19	among	among	ADP
chd-117	1	20	african	african	ADJ
chd-117	1	21	american	american	ADJ
chd-117	1	22	women	woman	NOUN
chd-117	1	23	in	in	ADP
chd-117	1	24	memphis	memphis	PROPN
chd-117	1	25	,	,	PUNCT
chd-117	1	26	tn	tn	PROPN
chd-117	1	27	alana	alana	PROPN
chd-117	1	28	smith1	smith1	PROPN
chd-117	1	29	,	,	PUNCT
chd-117	1	30	cheryl	cheryl	PROPN
chd-117	1	31	d.	d.	PROPN
chd-117	1	32	cropp2,3	cropp2,3	PROPN
chd-117	1	33	,	,	PUNCT
chd-117	1	34	gregory	gregory	PROPN
chd-117	1	35	vidal4,5	vidal4,5	PROPN
chd-117	1	36	,	,	PUNCT
chd-117	1	37	elizabeth	elizabeth	PROPN
chd-117	1	38	pritchard5	pritchard5	PROPN
chd-117	1	39	,	,	PUNCT
chd-117	1	40	jennifer	jennifer	PROPN
chd-117	1	41	cordero1	cordero1	PROPN
chd-117	1	42	,	,	PUNCT
chd-117	1	43	claire	claire	PROPN
chd-117	1	44	simpson1	simpson1	PROPN
chd-117	1	45	,	,	PUNCT
chd-117	1	46	and	and	CCONJ
chd-117	1	47	athena	athena	PROPN
chd-117	1	48	starlard	starlard	PROPN
chd-117	1	49	-	-	PUNCT
chd-117	1	50	davenport1	davenport1	NOUN
chd-117	2	1	*	*	PUNCT
chd-117	3	1	*	*	PROPN
chd-117	3	2	1department	1department	NUM
chd-117	3	3	of	of	ADP
chd-117	3	4	genetics	genetic	NOUN
chd-117	3	5	,	,	PUNCT
chd-117	3	6	genomics	genomic	NOUN
chd-117	3	7	and	and	CCONJ
chd-117	3	8	informatics	informatic	NOUN
chd-117	3	9	,	,	PUNCT
chd-117	3	10	university	university	PROPN
chd-117	3	11	of	of	ADP
chd-117	3	12	tennessee	tennessee	PROPN
chd-117	3	13	health	health	PROPN
chd-117	3	14	science	science	PROPN
chd-117	3	15	center	center	PROPN
chd-117	3	16	,	,	PUNCT
chd-117	3	17	memphis	memphis	PROPN
chd-117	3	18	,	,	PUNCT
chd-117	3	19	tn	tn	PROPN
chd-117	3	20	38163	38163	NUM
chd-117	3	21	,	,	PUNCT
chd-117	3	22	usa	usa	PROPN
chd-117	3	23	,	,	PUNCT
chd-117	3	24	2integrated	2integrated	NUM
chd-117	3	25	cancer	cancer	NOUN
chd-117	3	26	genomics	genomic	NOUN
chd-117	3	27	division	division	NOUN
chd-117	3	28	,	,	PUNCT
chd-117	3	29	translational	translational	ADJ
chd-117	3	30	genomics	genomics	PROPN
chd-117	3	31	research	research	PROPN
chd-117	3	32	institute	institute	PROPN
chd-117	3	33	(	(	PUNCT
chd-117	3	34	tgen	tgen	NOUN
chd-117	3	35	)	)	PUNCT
chd-117	3	36	,	,	PUNCT
chd-117	3	37	phoenix	phoenix	PROPN
chd-117	3	38	,	,	PUNCT
chd-117	3	39	az	az	PROPN
chd-117	3	40	,	,	PUNCT
chd-117	3	41	85004	85004	NUM
chd-117	3	42	,	,	PUNCT
chd-117	3	43	usa	usa	PROPN
chd-117	3	44	,	,	PUNCT
chd-117	3	45	3department	3department	NUM
chd-117	3	46	of	of	ADP
chd-117	3	47	pharmaceutical	pharmaceutical	NOUN
chd-117	3	48	,	,	PUNCT
chd-117	3	49	social	social	ADJ
chd-117	3	50	and	and	CCONJ
chd-117	3	51	administrative	administrative	ADJ
chd-117	3	52	sciences	sciences	PROPN
chd-117	3	53	,	,	PUNCT
chd-117	3	54	mcwhorter	mcwhorter	NOUN
chd-117	3	55	school	school	NOUN
chd-117	3	56	of	of	ADP
chd-117	3	57	pharmacy	pharmacy	NOUN
chd-117	3	58	,	,	PUNCT
chd-117	3	59	samford	samford	PROPN
chd-117	3	60	university	university	PROPN
chd-117	3	61	,	,	PUNCT
chd-117	3	62	birmingham	birmingham	PROPN
chd-117	3	63	,	,	PUNCT
chd-117	3	64	al	al	PROPN
chd-117	3	65	,	,	PUNCT
chd-117	3	66	35229	35229	NUM
chd-117	3	67	,	,	PUNCT
chd-117	3	68	usa	usa	PROPN
chd-117	3	69	,	,	PUNCT
chd-117	3	70	4division	4division	PROPN
chd-117	3	71	of	of	ADP
chd-117	3	72	hematology	hematology	NOUN
chd-117	3	73	/	/	SYM
chd-117	3	74	oncology	oncology	NOUN
chd-117	3	75	,	,	PUNCT
chd-117	3	76	department	department	NOUN
chd-117	3	77	of	of	ADP
chd-117	3	78	medicine	medicine	NOUN
chd-117	3	79	,	,	PUNCT
chd-117	3	80	university	university	PROPN
chd-117	3	81	of	of	ADP
chd-117	3	82	tennessee	tennessee	PROPN
chd-117	3	83	health	health	PROPN
chd-117	3	84	science	science	PROPN
chd-117	3	85	center	center	PROPN
chd-117	3	86	,	,	PUNCT
chd-117	3	87	memphis	memphis	PROPN
chd-117	3	88	,	,	PUNCT
chd-117	3	89	tn	tn	PROPN
chd-117	3	90	38163	38163	NUM
chd-117	3	91	,	,	PUNCT
chd-117	3	92	5the	5the	DET
chd-117	3	93	university	university	PROPN
chd-117	3	94	of	of	ADP
chd-117	3	95	tennessee	tennessee	PROPN
chd-117	3	96	west	west	PROPN
chd-117	3	97	cancer	cancer	PROPN
chd-117	3	98	center	center	NOUN
chd-117	3	99	;	;	PUNCT
chd-117	3	100	memphis	memphis	PROPN
chd-117	3	101	,	,	PUNCT
chd-117	3	102	tn	tn	PROPN
chd-117	3	103	38163	38163	NUM
chd-117	3	104	*	*	PUNCT
chd-117	3	105	corresponding	correspond	VERB
chd-117	3	106	author	author	NOUN
chd-117	3	107	’s	’s	PART
chd-117	3	108	e	e	NOUN
chd-117	3	109	-	-	NOUN
chd-117	3	110	mail	mail	NOUN
chd-117	3	111	:	:	PUNCT
chd-117	3	112	astarlar@uthsc.edu	astarlar@uthsc.edu	PROPN
chd-117	3	113	abstract	abstract	ADJ
chd-117	3	114	inherited	inherit	VERB
chd-117	3	115	variations	variation	NOUN
chd-117	3	116	in	in	ADP
chd-117	3	117	udp	udp	NOUN
chd-117	3	118	-	-	NOUN
chd-117	3	119	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	3	120	1a1	1a1	NUM
chd-117	3	121	(	(	PUNCT
chd-117	3	122	ugt1a1	ugt1a1	NOUN
chd-117	3	123	)	)	PUNCT
chd-117	3	124	are	be	AUX
chd-117	3	125	associated	associate	VERB
chd-117	3	126	with	with	ADP
chd-117	3	127	an	an	DET
chd-117	3	128	increased	increase	VERB
chd-117	3	129	breast	breast	NOUN
chd-117	3	130	cancer	cancer	NOUN
chd-117	3	131	risk	risk	NOUN
chd-117	3	132	in	in	ADP
chd-117	3	133	women	woman	NOUN
chd-117	3	134	of	of	ADP
chd-117	3	135	african	african	ADJ
chd-117	3	136	ancestry	ancestry	NOUN
chd-117	3	137	.	.	PUNCT
chd-117	4	1	the	the	DET
chd-117	4	2	ugt1a1	ugt1a1	PROPN
chd-117	4	3	*	*	ADJ
chd-117	4	4	28	28	NUM
chd-117	4	5	promoter	promoter	NOUN
chd-117	4	6	polymorphism	polymorphism	NOUN
chd-117	4	7	is	be	AUX
chd-117	4	8	characterized	characterize	VERB
chd-117	4	9	by	by	ADP
chd-117	4	10	the	the	DET
chd-117	4	11	presence	presence	NOUN
chd-117	4	12	of	of	ADP
chd-117	4	13	7	7	NUM
chd-117	4	14	ta	ta	NOUN
chd-117	4	15	repeats	repeat	NOUN
chd-117	4	16	in	in	ADP
chd-117	4	17	the	the	DET
chd-117	4	18	tata	tata	PROPN
chd-117	4	19	box	box	PROPN
chd-117	4	20	sequence	sequence	NOUN
chd-117	4	21	and	and	CCONJ
chd-117	4	22	results	result	NOUN
chd-117	4	23	in	in	ADP
chd-117	4	24	reduced	reduced	ADJ
chd-117	4	25	ugt1a1	ugt1a1	ADJ
chd-117	4	26	gene	gene	NOUN
chd-117	4	27	expression	expression	NOUN
chd-117	4	28	and	and	CCONJ
chd-117	4	29	enzymatic	enzymatic	ADJ
chd-117	4	30	activity	activity	NOUN
chd-117	4	31	.	.	PUNCT
chd-117	5	1	in	in	ADP
chd-117	5	2	this	this	DET
chd-117	5	3	study	study	NOUN
chd-117	5	4	,	,	PUNCT
chd-117	5	5	we	we	PRON
chd-117	5	6	investigated	investigate	VERB
chd-117	5	7	associations	association	NOUN
chd-117	5	8	between	between	ADP
chd-117	5	9	the	the	DET
chd-117	5	10	ugt1a1	ugt1a1	PROPN
chd-117	5	11	*	*	ADJ
chd-117	5	12	28	28	NUM
chd-117	5	13	polymorphism	polymorphism	NOUN
chd-117	5	14	and	and	CCONJ
chd-117	5	15	breast	breast	NOUN
chd-117	5	16	cancer	cancer	NOUN
chd-117	5	17	risk	risk	NOUN
chd-117	5	18	among	among	ADP
chd-117	5	19	african	african	ADJ
chd-117	5	20	american	american	PROPN
chd-117	5	21	(	(	PUNCT
chd-117	5	22	aa	aa	NOUN
chd-117	5	23	)	)	PUNCT
chd-117	5	24	women	woman	NOUN
chd-117	5	25	in	in	ADP
chd-117	5	26	memphis	memphis	PROPN
chd-117	5	27	,	,	PUNCT
chd-117	5	28	tennessee	tennessee	PROPN
chd-117	5	29	,	,	PUNCT
chd-117	5	30	a	a	DET
chd-117	5	31	city	city	NOUN
chd-117	5	32	with	with	ADP
chd-117	5	33	increased	increase	VERB
chd-117	5	34	breast	breast	NOUN
chd-117	5	35	cancer	cancer	NOUN
chd-117	5	36	mortality	mortality	NOUN
chd-117	5	37	rates	rate	NOUN
chd-117	5	38	among	among	ADP
chd-117	5	39	aa	aa	PROPN
chd-117	5	40	women	woman	NOUN
chd-117	5	41	.	.	PUNCT
chd-117	6	1	saliva	saliva	NOUN
chd-117	6	2	was	be	AUX
chd-117	6	3	collected	collect	VERB
chd-117	6	4	from	from	ADP
chd-117	6	5	352	352	NUM
chd-117	6	6	aa	aa	ADJ
chd-117	6	7	women	woman	NOUN
chd-117	6	8	,	,	PUNCT
chd-117	6	9	including	include	VERB
chd-117	6	10	breast	breast	NOUN
chd-117	6	11	cancer	cancer	NOUN
chd-117	6	12	cases	case	NOUN
chd-117	6	13	(	(	PUNCT
chd-117	6	14	n=82	n=82	NOUN
chd-117	6	15	)	)	PUNCT
chd-117	6	16	and	and	CCONJ
chd-117	6	17	controls	control	NOUN
chd-117	6	18	(	(	PUNCT
chd-117	6	19	n=270	n=270	INTJ
chd-117	6	20	)	)	PUNCT
chd-117	6	21	between	between	ADP
chd-117	6	22	june	june	PROPN
chd-117	6	23	2016	2016	NUM
chd-117	6	24	to	to	ADP
chd-117	6	25	june	june	PROPN
chd-117	6	26	2017	2017	NUM
chd-117	6	27	.	.	PUNCT
chd-117	7	1	dna	dna	PROPN
chd-117	7	2	was	be	AUX
chd-117	7	3	isolated	isolate	VERB
chd-117	7	4	and	and	CCONJ
chd-117	7	5	sequenced	sequence	VERB
chd-117	7	6	for	for	ADP
chd-117	7	7	the	the	DET
chd-117	7	8	ugt1a1	ugt1a1	ADJ
chd-117	7	9	*	*	ADJ
chd-117	7	10	28	28	NUM
chd-117	7	11	polymorphism	polymorphism	NOUN
chd-117	7	12	.	.	PUNCT
chd-117	8	1	the	the	DET
chd-117	8	2	odds	odd	NOUN
chd-117	8	3	ratio	ratio	NOUN
chd-117	8	4	for	for	ADP
chd-117	8	5	cases	case	NOUN
chd-117	8	6	with	with	ADP
chd-117	8	7	the	the	DET
chd-117	8	8	low	low	ADJ
chd-117	8	9	ugt1a1	ugt1a1	ADJ
chd-117	8	10	activity	activity	NOUN
chd-117	8	11	alleles	allele	NOUN
chd-117	8	12	(	(	PUNCT
chd-117	8	13	ta)7/8	ta)7/8	NOUN
chd-117	8	14	repeat	repeat	NOUN
chd-117	8	15	genotypes	genotype	NOUN
chd-117	8	16	versus	versus	ADP
chd-117	8	17	5/5	5/5	NUM
chd-117	8	18	,	,	PUNCT
chd-117	8	19	5/6	5/6	NUM
chd-117	8	20	,	,	PUNCT
chd-117	8	21	and	and	CCONJ
chd-117	8	22	6/6	6/6	NUM
chd-117	8	23	genotypes	genotype	NOUN
chd-117	8	24	was	be	AUX
chd-117	8	25	1.46	1.46	NUM
chd-117	8	26	[	[	SYM
chd-117	8	27	95	95	NUM
chd-117	8	28	%	%	NOUN
chd-117	8	29	ci	ci	NOUN
chd-117	8	30	,	,	PUNCT
chd-117	8	31	0.65	0.65	NUM
chd-117	8	32	-	-	SYM
chd-117	8	33	3.31	3.31	NUM
chd-117	8	34	;	;	PUNCT
chd-117	8	35	p	p	X
chd-117	8	36	=	=	NOUN
chd-117	8	37	0.36	0.36	NUM
chd-117	8	38	]	]	PUNCT
chd-117	8	39	in	in	ADP
chd-117	8	40	premenopausal	premenopausal	ADJ
chd-117	8	41	women	woman	NOUN
chd-117	8	42	and	and	CCONJ
chd-117	8	43	1.10	1.10	NUM
chd-117	8	44	(	(	PUNCT
chd-117	8	45	95	95	NUM
chd-117	8	46	%	%	NOUN
chd-117	8	47	ci	ci	NOUN
chd-117	8	48	,	,	PUNCT
chd-117	8	49	0.52	0.52	NUM
chd-117	8	50	-	-	SYM
chd-117	8	51	2.38	2.38	NUM
chd-117	8	52	;	;	PUNCT
chd-117	8	53	p	p	X
chd-117	8	54	=	=	NOUN
chd-117	8	55	0.79	0.79	NUM
chd-117	8	56	)	)	PUNCT
chd-117	8	57	in	in	ADP
chd-117	8	58	postmenopausal	postmenopausal	ADJ
chd-117	8	59	women	woman	NOUN
chd-117	8	60	.	.	PUNCT
chd-117	9	1	further	further	ADJ
chd-117	9	2	analysis	analysis	NOUN
chd-117	9	3	of	of	ADP
chd-117	9	4	tcga	tcga	ADJ
chd-117	9	5	rna	rna	PROPN
chd-117	9	6	-	-	PUNCT
chd-117	9	7	seq	seq	NOUN
chd-117	9	8	data	datum	NOUN
chd-117	9	9	showed	show	VERB
chd-117	9	10	that	that	SCONJ
chd-117	9	11	ugt1a1	ugt1a1	PROPN
chd-117	9	12	mrna	mrna	PROPN
chd-117	9	13	was	be	AUX
chd-117	9	14	significantly	significantly	ADV
chd-117	9	15	lower	low	ADJ
chd-117	9	16	among	among	ADP
chd-117	9	17	estrogen	estrogen	NOUN
chd-117	9	18	receptor	receptor	NOUN
chd-117	9	19	(	(	PUNCT
chd-117	9	20	er)-negative	er)-negative	ADJ
chd-117	9	21	breast	breast	NOUN
chd-117	9	22	cancers	cancer	NOUN
chd-117	9	23	from	from	ADP
chd-117	9	24	aa	aa	NOUN
chd-117	9	25	as	as	SCONJ
chd-117	9	26	compared	compare	VERB
chd-117	9	27	to	to	ADP
chd-117	9	28	non	non	ADJ
chd-117	9	29	-	-	ADJ
chd-117	9	30	hispanic	hispanic	ADJ
chd-117	9	31	white	white	ADJ
chd-117	9	32	women	woman	NOUN
chd-117	9	33	with	with	ADP
chd-117	9	34	er	er	INTJ
chd-117	9	35	-	-	PUNCT
chd-117	9	36	negative	negative	ADJ
chd-117	9	37	breast	breast	NOUN
chd-117	9	38	cancer	cancer	NOUN
chd-117	9	39	.	.	PUNCT
chd-117	10	1	larger	large	ADJ
chd-117	10	2	epidemiological	epidemiological	ADJ
chd-117	10	3	studies	study	NOUN
chd-117	10	4	are	be	AUX
chd-117	10	5	needed	need	VERB
chd-117	10	6	to	to	PART
chd-117	10	7	determine	determine	VERB
chd-117	10	8	the	the	DET
chd-117	10	9	functional	functional	ADJ
chd-117	10	10	consequence	consequence	NOUN
chd-117	10	11	of	of	ADP
chd-117	10	12	the	the	DET
chd-117	10	13	ugt1a1	ugt1a1	ADJ
chd-117	10	14	*	*	ADJ
chd-117	10	15	28	28	NUM
chd-117	10	16	polymorphism	polymorphism	NOUN
chd-117	10	17	on	on	ADP
chd-117	10	18	breast	breast	NOUN
chd-117	10	19	cancer	cancer	NOUN
chd-117	10	20	risk	risk	NOUN
chd-117	10	21	in	in	ADP
chd-117	10	22	aa	aa	PROPN
chd-117	10	23	women	woman	NOUN
chd-117	10	24	.	.	PUNCT
chd-117	11	1	keywords	keyword	NOUN
chd-117	11	2	:	:	PUNCT
chd-117	11	3	ugt1a1	ugt1a1	ADJ
chd-117	11	4	,	,	PUNCT
chd-117	11	5	ugt1a1	ugt1a1	NOUN
chd-117	11	6	*	*	ADJ
chd-117	11	7	28	28	NUM
chd-117	11	8	,	,	PUNCT
chd-117	11	9	breast	breast	NOUN
chd-117	11	10	cancer	cancer	NOUN
chd-117	11	11	disparities	disparity	NOUN
chd-117	11	12	,	,	PUNCT
chd-117	11	13	african	african	ADJ
chd-117	11	14	american	american	PROPN
chd-117	11	15	,	,	PUNCT
chd-117	11	16	memphis	memphis	PROPN
chd-117	11	17	,	,	PUNCT
chd-117	11	18	tn	tn	PROPN
chd-117	11	19	citation	citation	NOUN
chd-117	11	20	:	:	PUNCT
chd-117	11	21	smith	smith	PROPN
chd-117	12	1	a	a	DET
chd-117	12	2	et	et	NOUN
chd-117	12	3	al	al	PROPN
chd-117	12	4	(	(	PUNCT
chd-117	12	5	2019	2019	NUM
chd-117	12	6	)	)	PUNCT
chd-117	12	7	prevalence	prevalence	NOUN
chd-117	12	8	of	of	ADP
chd-117	12	9	the	the	DET
chd-117	12	10	ugt1a1	ugt1a1	ADJ
chd-117	12	11	*	*	ADJ
chd-117	12	12	28	28	NUM
chd-117	12	13	promoter	promoter	NOUN
chd-117	12	14	polymorphism	polymorphism	NOUN
chd-117	12	15	and	and	CCONJ
chd-117	12	16	breast	breast	NOUN
chd-117	12	17	cancer	cancer	NOUN
chd-117	12	18	risk	risk	NOUN
chd-117	12	19	among	among	ADP
chd-117	12	20	african	african	ADJ
chd-117	12	21	american	american	ADJ
chd-117	12	22	women	woman	NOUN
chd-117	12	23	in	in	ADP
chd-117	12	24	memphis	memphis	PROPN
chd-117	12	25	,	,	PUNCT
chd-117	12	26	tn	tn	PROPN
chd-117	12	27	.	.	PUNCT
chd-117	12	28	cancer	cancer	NOUN
chd-117	12	29	health	health	NOUN
chd-117	12	30	disparities	disparity	NOUN
chd-117	12	31	3	3	NUM
chd-117	12	32	:	:	PUNCT
chd-117	12	33	e1	e1	NOUN
chd-117	12	34	-	-	PUNCT
chd-117	12	35	e12	e12	NOUN
chd-117	12	36	.	.	PUNCT
chd-117	13	1	doi:10.9777	doi:10.9777	PROPN
chd-117	13	2	/	/	SYM
chd-117	13	3	chd.2019.1015	chd.2019.1015	PROPN
chd-117	13	4	.	.	PUNCT
chd-117	14	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-117	14	2	e2	e2	PROPN
chd-117	14	3	cancer	cancer	NOUN
chd-117	14	4	health	health	NOUN
chd-117	14	5	disparities	disparity	NOUN
chd-117	14	6	research	research	NOUN
chd-117	14	7	introduction	introduction	NOUN
chd-117	14	8	breast	breast	NOUN
chd-117	14	9	cancer	cancer	NOUN
chd-117	14	10	is	be	AUX
chd-117	14	11	a	a	DET
chd-117	14	12	leading	lead	VERB
chd-117	14	13	cause	cause	NOUN
chd-117	14	14	of	of	ADP
chd-117	14	15	cancer	cancer	NOUN
chd-117	14	16	death	death	NOUN
chd-117	14	17	among	among	ADP
chd-117	14	18	african	african	ADJ
chd-117	14	19	american	american	PROPN
chd-117	14	20	(	(	PUNCT
chd-117	14	21	aa	aa	NOUN
chd-117	14	22	)	)	PUNCT
chd-117	14	23	women	woman	NOUN
chd-117	14	24	(	(	PUNCT
chd-117	14	25	desantis	desantis	PROPN
chd-117	14	26	et	et	PROPN
chd-117	14	27	al	al	PROPN
chd-117	14	28	.	.	PROPN
chd-117	14	29	,	,	PUNCT
chd-117	14	30	2017	2017	NUM
chd-117	14	31	)	)	PUNCT
chd-117	14	32	.	.	PUNCT
chd-117	15	1	african	african	PROPN
chd-117	15	2	american	american	PROPN
chd-117	15	3	(	(	PUNCT
chd-117	15	4	aa	aa	NOUN
chd-117	15	5	)	)	PUNCT
chd-117	15	6	women	woman	NOUN
chd-117	15	7	under	under	ADP
chd-117	15	8	the	the	DET
chd-117	15	9	age	age	NOUN
chd-117	15	10	of	of	ADP
chd-117	15	11	45	45	NUM
chd-117	15	12	are	be	AUX
chd-117	15	13	most	most	ADV
chd-117	15	14	likely	likely	ADJ
chd-117	15	15	to	to	PART
chd-117	15	16	develop	develop	VERB
chd-117	15	17	breast	breast	NOUN
chd-117	15	18	cancer	cancer	NOUN
chd-117	15	19	,	,	PUNCT
chd-117	15	20	and	and	CCONJ
chd-117	15	21	aa	aa	ADJ
chd-117	15	22	women	woman	NOUN
chd-117	15	23	of	of	ADP
chd-117	15	24	all	all	DET
chd-117	15	25	ages	age	NOUN
chd-117	15	26	are	be	AUX
chd-117	15	27	most	most	ADV
chd-117	15	28	likely	likely	ADJ
chd-117	15	29	to	to	PART
chd-117	15	30	die	die	VERB
chd-117	15	31	from	from	ADP
chd-117	15	32	breast	breast	NOUN
chd-117	15	33	cancer	cancer	NOUN
chd-117	15	34	(	(	PUNCT
chd-117	15	35	desantis	desantis	PROPN
chd-117	15	36	et	et	PROPN
chd-117	15	37	al	al	PROPN
chd-117	15	38	.	.	PROPN
chd-117	15	39	,	,	PUNCT
chd-117	15	40	2017	2017	NUM
chd-117	15	41	)	)	PUNCT
chd-117	15	42	.	.	PUNCT
chd-117	16	1	recent	recent	ADJ
chd-117	16	2	data	datum	NOUN
chd-117	16	3	showed	show	VERB
chd-117	16	4	that	that	SCONJ
chd-117	16	5	aa	aa	PROPN
chd-117	16	6	women	woman	NOUN
chd-117	16	7	in	in	ADP
chd-117	16	8	memphis	memphis	PROPN
chd-117	16	9	,	,	PUNCT
chd-117	16	10	tennessee	tennessee	PROPN
chd-117	16	11	suffer	suffer	VERB
chd-117	16	12	disproportionately	disproportionately	ADV
chd-117	16	13	from	from	ADP
chd-117	16	14	higher	high	ADJ
chd-117	16	15	breast	breast	NOUN
chd-117	16	16	cancer	cancer	NOUN
chd-117	16	17	mortality	mortality	NOUN
chd-117	16	18	rates	rate	NOUN
chd-117	16	19	compared	compare	VERB
chd-117	16	20	to	to	ADP
chd-117	16	21	nonhispanic	nonhispanic	ADJ
chd-117	16	22	white	white	ADJ
chd-117	16	23	women	woman	NOUN
chd-117	16	24	(	(	PUNCT
chd-117	16	25	hunt	hunt	NOUN
chd-117	16	26	et	et	NOUN
chd-117	16	27	al	al	PROPN
chd-117	16	28	.	.	PROPN
chd-117	16	29	,	,	PUNCT
chd-117	16	30	2014	2014	NUM
chd-117	16	31	;	;	PUNCT
chd-117	16	32	vidal	vidal	PROPN
chd-117	16	33	et	et	PROPN
chd-117	16	34	al	al	PROPN
chd-117	16	35	.	.	PROPN
chd-117	16	36	,	,	PUNCT
chd-117	16	37	2017	2017	NUM
chd-117	16	38	;	;	PUNCT
chd-117	16	39	whitman	whitman	PROPN
chd-117	16	40	et	et	PROPN
chd-117	16	41	al	al	PROPN
chd-117	16	42	.	.	PROPN
chd-117	16	43	,	,	PUNCT
chd-117	16	44	2012	2012	NUM
chd-117	16	45	)	)	PUNCT
chd-117	16	46	.	.	PUNCT
chd-117	17	1	epidemiological	epidemiological	ADJ
chd-117	17	2	evidence	evidence	NOUN
chd-117	17	3	highlights	highlight	VERB
chd-117	17	4	the	the	DET
chd-117	17	5	influence	influence	NOUN
chd-117	17	6	of	of	ADP
chd-117	17	7	estrogen	estrogen	NOUN
chd-117	17	8	exposures	exposure	NOUN
chd-117	17	9	with	with	ADP
chd-117	17	10	breast	breast	NOUN
chd-117	17	11	cancer	cancer	NOUN
chd-117	17	12	development	development	NOUN
chd-117	17	13	in	in	ADP
chd-117	17	14	women	woman	NOUN
chd-117	17	15	of	of	ADP
chd-117	17	16	african	african	ADJ
chd-117	17	17	ancestry	ancestry	NOUN
chd-117	17	18	(	(	PUNCT
chd-117	17	19	ambrosone	ambrosone	NOUN
chd-117	17	20	et	et	PROPN
chd-117	17	21	al	al	PROPN
chd-117	17	22	.	.	PROPN
chd-117	17	23	,	,	PUNCT
chd-117	17	24	2015	2015	NUM
chd-117	17	25	;	;	PUNCT
chd-117	17	26	corsini	corsini	PROPN
chd-117	17	27	et	et	PROPN
chd-117	17	28	al	al	PROPN
chd-117	17	29	.	.	PROPN
chd-117	17	30	,	,	PUNCT
chd-117	17	31	2017	2017	NUM
chd-117	17	32	)	)	PUNCT
chd-117	17	33	.	.	PUNCT
chd-117	18	1	established	establish	VERB
chd-117	18	2	breast	breast	NOUN
chd-117	18	3	cancer	cancer	NOUN
chd-117	18	4	risk	risk	NOUN
chd-117	18	5	factors	factor	NOUN
chd-117	18	6	,	,	PUNCT
chd-117	18	7	e.g.	e.g.	ADV
chd-117	18	8	increased	increase	VERB
chd-117	18	9	body	body	NOUN
chd-117	18	10	mass	mass	NOUN
chd-117	18	11	index	index	NOUN
chd-117	18	12	(	(	PUNCT
chd-117	18	13	bmi	bmi	PROPN
chd-117	18	14	)	)	PUNCT
chd-117	18	15	,	,	PUNCT
chd-117	18	16	obesity	obesity	NOUN
chd-117	18	17	,	,	PUNCT
chd-117	18	18	and	and	CCONJ
chd-117	18	19	postmenopausal	postmenopausal	ADJ
chd-117	18	20	status	status	NOUN
chd-117	18	21	(	(	PUNCT
chd-117	18	22	dietze	dietze	PROPN
chd-117	18	23	et	et	PROPN
chd-117	18	24	al	al	PROPN
chd-117	18	25	.	.	PROPN
chd-117	18	26	,	,	PUNCT
chd-117	18	27	2018	2018	NUM
chd-117	18	28	;	;	PUNCT
chd-117	18	29	gerard	gerard	NOUN
chd-117	18	30	and	and	CCONJ
chd-117	18	31	brown	brown	ADJ
chd-117	18	32	,	,	PUNCT
chd-117	18	33	2018	2018	NUM
chd-117	18	34	)	)	PUNCT
chd-117	18	35	,	,	PUNCT
chd-117	18	36	are	be	AUX
chd-117	18	37	thought	think	VERB
chd-117	18	38	to	to	PART
chd-117	18	39	increase	increase	VERB
chd-117	18	40	breast	breast	NOUN
chd-117	18	41	cancer	cancer	NOUN
chd-117	18	42	risk	risk	NOUN
chd-117	18	43	in	in	ADP
chd-117	18	44	women	woman	NOUN
chd-117	18	45	through	through	ADP
chd-117	18	46	modulation	modulation	NOUN
chd-117	18	47	of	of	ADP
chd-117	18	48	estrogens	estrogen	NOUN
chd-117	18	49	.	.	PUNCT
chd-117	19	1	in	in	ADP
chd-117	19	2	support	support	NOUN
chd-117	19	3	of	of	ADP
chd-117	19	4	these	these	DET
chd-117	19	5	findings	finding	NOUN
chd-117	19	6	,	,	PUNCT
chd-117	19	7	aa	aa	PROPN
chd-117	19	8	women	woman	NOUN
chd-117	19	9	tend	tend	VERB
chd-117	19	10	to	to	PART
chd-117	19	11	have	have	VERB
chd-117	19	12	higher	high	ADJ
chd-117	19	13	bmi	bmi	NOUN
chd-117	19	14	and	and	CCONJ
chd-117	19	15	obesity	obesity	NOUN
chd-117	19	16	rates	rate	NOUN
chd-117	19	17	compared	compare	VERB
chd-117	19	18	to	to	ADP
chd-117	19	19	non	non	ADJ
chd-117	19	20	-	-	ADJ
chd-117	19	21	hispanic	hispanic	ADJ
chd-117	19	22	white	white	ADJ
chd-117	19	23	women	woman	NOUN
chd-117	19	24	(	(	PUNCT
chd-117	19	25	tan	tan	NOUN
chd-117	19	26	et	et	PROPN
chd-117	19	27	al	al	PROPN
chd-117	19	28	.	.	PROPN
chd-117	19	29	,	,	PUNCT
chd-117	19	30	2017	2017	NUM
chd-117	19	31	)	)	PUNCT
chd-117	19	32	.	.	PUNCT
chd-117	20	1	these	these	DET
chd-117	20	2	factors	factor	NOUN
chd-117	20	3	,	,	PUNCT
chd-117	20	4	along	along	ADP
chd-117	20	5	with	with	ADP
chd-117	20	6	genetic	genetic	ADJ
chd-117	20	7	variation	variation	NOUN
chd-117	20	8	in	in	ADP
chd-117	20	9	key	key	ADJ
chd-117	20	10	genes	gene	NOUN
chd-117	20	11	involved	involve	VERB
chd-117	20	12	in	in	ADP
chd-117	20	13	estrogen	estrogen	NOUN
chd-117	20	14	conjugation	conjugation	NOUN
chd-117	20	15	and	and	CCONJ
chd-117	20	16	metabolism	metabolism	NOUN
chd-117	20	17	,	,	PUNCT
chd-117	20	18	may	may	AUX
chd-117	20	19	contribute	contribute	VERB
chd-117	20	20	to	to	ADP
chd-117	20	21	increased	increase	VERB
chd-117	20	22	breast	breast	NOUN
chd-117	20	23	cancer	cancer	NOUN
chd-117	20	24	risk	risk	NOUN
chd-117	20	25	among	among	ADP
chd-117	20	26	aa	aa	PROPN
chd-117	20	27	women	woman	NOUN
chd-117	20	28	.	.	PUNCT
chd-117	21	1	a	a	DET
chd-117	21	2	major	major	ADJ
chd-117	21	3	pathway	pathway	NOUN
chd-117	21	4	involved	involve	VERB
chd-117	21	5	in	in	ADP
chd-117	21	6	estrogen	estrogen	NOUN
chd-117	21	7	conjugation	conjugation	NOUN
chd-117	21	8	and	and	CCONJ
chd-117	21	9	detoxification	detoxification	NOUN
chd-117	21	10	from	from	ADP
chd-117	21	11	circulation	circulation	NOUN
chd-117	21	12	is	be	AUX
chd-117	21	13	through	through	ADP
chd-117	21	14	the	the	DET
chd-117	21	15	process	process	NOUN
chd-117	21	16	of	of	ADP
chd-117	21	17	glucuronidation	glucuronidation	NOUN
chd-117	21	18	,	,	PUNCT
chd-117	21	19	catalyzed	catalyze	VERB
chd-117	21	20	by	by	ADP
chd-117	21	21	udpglucuronosyltransferases	udpglucuronosyltransferase	NOUN
chd-117	21	22	(	(	PUNCT
chd-117	21	23	ugts	ugts	PROPN
chd-117	21	24	)	)	PUNCT
chd-117	21	25	(	(	PUNCT
chd-117	21	26	bock	bock	NOUN
chd-117	21	27	et	et	PROPN
chd-117	21	28	al	al	PROPN
chd-117	21	29	.	.	PROPN
chd-117	21	30	,	,	PUNCT
chd-117	21	31	1987	1987	NUM
chd-117	21	32	;	;	PUNCT
chd-117	21	33	starlard	starlard	NOUN
chd-117	21	34	-	-	PUNCT
chd-117	21	35	davenport	davenport	NOUN
chd-117	21	36	et	et	PROPN
chd-117	21	37	al	al	PROPN
chd-117	21	38	.	.	PROPN
chd-117	21	39	,	,	PUNCT
chd-117	21	40	2007	2007	NUM
chd-117	21	41	)	)	PUNCT
chd-117	21	42	.	.	PUNCT
chd-117	22	1	human	human	ADJ
chd-117	22	2	ugt1a1	ugt1a1	NOUN
chd-117	22	3	is	be	AUX
chd-117	22	4	a	a	DET
chd-117	22	5	major	major	ADJ
chd-117	22	6	ugt	ugt	NOUN
chd-117	22	7	enzyme	enzyme	NOUN
chd-117	22	8	involved	involve	VERB
chd-117	22	9	in	in	ADP
chd-117	22	10	estrogen	estrogen	NOUN
chd-117	22	11	conjugation	conjugation	NOUN
chd-117	22	12	(	(	PUNCT
chd-117	22	13	lepine	lepine	NOUN
chd-117	22	14	et	et	PROPN
chd-117	22	15	al	al	PROPN
chd-117	22	16	.	.	PROPN
chd-117	22	17	,	,	PUNCT
chd-117	22	18	2004	2004	NUM
chd-117	22	19	)	)	PUNCT
chd-117	22	20	.	.	PUNCT
chd-117	23	1	variation	variation	NOUN
chd-117	23	2	in	in	ADP
chd-117	23	3	the	the	DET
chd-117	23	4	number	number	NOUN
chd-117	23	5	of	of	ADP
chd-117	23	6	thymine	thymine	NOUN
chd-117	23	7	-	-	PUNCT
chd-117	23	8	adenine	adenine	ADJ
chd-117	23	9	(	(	PUNCT
chd-117	23	10	ta	ta	NOUN
chd-117	23	11	)	)	PUNCT
chd-117	23	12	repeats	repeat	NOUN
chd-117	23	13	in	in	ADP
chd-117	23	14	the	the	DET
chd-117	23	15	tata	tata	NOUN
chd-117	23	16	-	-	PUNCT
chd-117	23	17	box	box	NOUN
chd-117	23	18	of	of	ADP
chd-117	23	19	the	the	DET
chd-117	23	20	ugt1a1	ugt1a1	ADJ
chd-117	23	21	promoter	promoter	NOUN
chd-117	23	22	(	(	PUNCT
chd-117	23	23	rs8175347	rs8175347	PROPN
chd-117	23	24	)	)	PUNCT
chd-117	23	25	significantly	significantly	ADV
chd-117	23	26	alters	alter	VERB
chd-117	23	27	ugt1a1	ugt1a1	ADJ
chd-117	23	28	expression	expression	NOUN
chd-117	23	29	and	and	CCONJ
chd-117	23	30	catalytic	catalytic	ADJ
chd-117	23	31	activity	activity	NOUN
chd-117	23	32	towards	towards	ADP
chd-117	23	33	estrogens	estrogen	NOUN
chd-117	23	34	and	and	CCONJ
chd-117	23	35	other	other	ADJ
chd-117	23	36	compounds	compound	NOUN
chd-117	23	37	(	(	PUNCT
chd-117	23	38	boyd	boyd	PROPN
chd-117	23	39	et	et	PROPN
chd-117	23	40	al	al	PROPN
chd-117	23	41	.	.	PROPN
chd-117	23	42	,	,	PUNCT
chd-117	23	43	2006	2006	NUM
chd-117	23	44	;	;	PUNCT
chd-117	23	45	iyer	iyer	PROPN
chd-117	23	46	et	et	PROPN
chd-117	23	47	al	al	PROPN
chd-117	23	48	.	.	PROPN
chd-117	23	49	,	,	PUNCT
chd-117	23	50	1999	1999	NUM
chd-117	23	51	)	)	PUNCT
chd-117	23	52	.	.	PUNCT
chd-117	24	1	the	the	DET
chd-117	24	2	number	number	NOUN
chd-117	24	3	of	of	ADP
chd-117	24	4	ta	ta	PROPN
chd-117	24	5	repeats	repeat	NOUN
chd-117	24	6	vary	vary	VERB
chd-117	24	7	from	from	ADP
chd-117	24	8	5	5	NUM
chd-117	24	9	to	to	PART
chd-117	24	10	8	8	NUM
chd-117	24	11	,	,	PUNCT
chd-117	24	12	with	with	ADP
chd-117	24	13	6	6	NUM
chd-117	24	14	ta	ta	PROPN
chd-117	24	15	repeats	repeat	NOUN
chd-117	24	16	representing	represent	VERB
chd-117	24	17	the	the	DET
chd-117	24	18	most	most	ADV
chd-117	24	19	common	common	ADJ
chd-117	24	20	(	(	PUNCT
chd-117	24	21	wild	wild	ADJ
chd-117	24	22	-	-	PUNCT
chd-117	24	23	type	type	NOUN
chd-117	24	24	)	)	PUNCT
chd-117	24	25	number	number	NOUN
chd-117	24	26	of	of	ADP
chd-117	24	27	repeats	repeat	NOUN
chd-117	24	28	(	(	PUNCT
chd-117	24	29	beutler	beutler	NOUN
chd-117	24	30	et	et	NOUN
chd-117	24	31	al	al	PROPN
chd-117	24	32	.	.	PROPN
chd-117	24	33	,	,	PUNCT
chd-117	24	34	1998	1998	NUM
chd-117	24	35	)	)	PUNCT
chd-117	24	36	.	.	PUNCT
chd-117	25	1	individuals	individual	NOUN
chd-117	25	2	with	with	ADP
chd-117	25	3	more	more	ADJ
chd-117	25	4	than	than	ADP
chd-117	25	5	6	6	NUM
chd-117	25	6	ta	ta	NOUN
chd-117	25	7	repeats	repeat	NOUN
chd-117	25	8	(	(	PUNCT
chd-117	25	9	i.e.	i.e.	X
chd-117	25	10	,	,	PUNCT
chd-117	25	11	7	7	NUM
chd-117	25	12	ta	ta	NOUN
chd-117	25	13	repeats	repeat	NOUN
chd-117	25	14	;	;	PUNCT
chd-117	25	15	ugt1a1	ugt1a1	NOUN
chd-117	25	16	*	*	NOUN
chd-117	25	17	28	28	NUM
chd-117	25	18	)	)	PUNCT
chd-117	25	19	have	have	AUX
chd-117	25	20	markedly	markedly	ADV
chd-117	25	21	reduced	reduce	VERB
chd-117	25	22	enzymatic	enzymatic	ADJ
chd-117	25	23	activity	activity	NOUN
chd-117	25	24	,	,	PUNCT
chd-117	25	25	resulting	result	VERB
chd-117	25	26	in	in	ADP
chd-117	25	27	increased	increase	VERB
chd-117	25	28	estrogen	estrogen	NOUN
chd-117	25	29	and	and	CCONJ
chd-117	25	30	bilirubin	bilirubin	NOUN
chd-117	25	31	levels	level	NOUN
chd-117	25	32	,	,	PUNCT
chd-117	25	33	and	and	CCONJ
chd-117	25	34	increased	increase	VERB
chd-117	25	35	risk	risk	NOUN
chd-117	25	36	for	for	ADP
chd-117	25	37	diseases	disease	NOUN
chd-117	25	38	,	,	PUNCT
chd-117	25	39	including	include	VERB
chd-117	25	40	breast	breast	NOUN
chd-117	25	41	cancer	cancer	NOUN
chd-117	25	42	development	development	NOUN
chd-117	25	43	(	(	PUNCT
chd-117	25	44	adegoke	adegoke	VERB
chd-117	25	45	et	et	PROPN
chd-117	25	46	al	al	PROPN
chd-117	25	47	.	.	PROPN
chd-117	25	48	,	,	PUNCT
chd-117	25	49	2004	2004	NUM
chd-117	25	50	;	;	PUNCT
chd-117	25	51	guillemette	guillemette	NOUN
chd-117	25	52	et	et	PROPN
chd-117	25	53	al	al	PROPN
chd-117	25	54	.	.	PROPN
chd-117	25	55	,	,	PUNCT
chd-117	25	56	2001	2001	NUM
chd-117	25	57	;	;	PUNCT
chd-117	25	58	huo	huo	PROPN
chd-117	25	59	et	et	NOUN
chd-117	25	60	al	al	PROPN
chd-117	25	61	.	.	PROPN
chd-117	25	62	,	,	PUNCT
chd-117	25	63	2008	2008	NUM
chd-117	25	64	)	)	PUNCT
chd-117	25	65	.	.	PUNCT
chd-117	26	1	studies	study	NOUN
chd-117	26	2	have	have	AUX
chd-117	26	3	shown	show	VERB
chd-117	26	4	that	that	SCONJ
chd-117	26	5	the	the	DET
chd-117	26	6	frequency	frequency	NOUN
chd-117	26	7	of	of	ADP
chd-117	26	8	the	the	DET
chd-117	26	9	low	low	ADJ
chd-117	26	10	activity	activity	NOUN
chd-117	26	11	ugt1a1	ugt1a1	NOUN
chd-117	26	12	*	*	SYM
chd-117	26	13	28	28	NUM
chd-117	26	14	promoter	promoter	NOUN
chd-117	26	15	polymorphism	polymorphism	NOUN
chd-117	26	16	varies	vary	VERB
chd-117	26	17	significantly	significantly	ADV
chd-117	26	18	between	between	ADP
chd-117	26	19	ethnic	ethnic	ADJ
chd-117	26	20	groups	group	NOUN
chd-117	26	21	,	,	PUNCT
chd-117	26	22	with	with	ADP
chd-117	26	23	prevalence	prevalence	NOUN
chd-117	26	24	being	be	AUX
chd-117	26	25	highest	high	ADJ
chd-117	26	26	among	among	ADP
chd-117	26	27	populations	population	NOUN
chd-117	26	28	of	of	ADP
chd-117	26	29	african	african	ADJ
chd-117	26	30	descent	descent	NOUN
chd-117	26	31	(	(	PUNCT
chd-117	26	32	beutler	beutler	NOUN
chd-117	26	33	et	et	NOUN
chd-117	26	34	al	al	PROPN
chd-117	26	35	.	.	PROPN
chd-117	26	36	,	,	PUNCT
chd-117	26	37	1998	1998	NUM
chd-117	26	38	;	;	PUNCT
chd-117	26	39	guillemette	guillemette	NOUN
chd-117	26	40	et	et	PROPN
chd-117	26	41	al	al	PROPN
chd-117	26	42	.	.	PROPN
chd-117	26	43	,	,	PUNCT
chd-117	26	44	2000	2000	NUM
chd-117	26	45	;	;	PUNCT
chd-117	26	46	huo	huo	PROPN
chd-117	26	47	et	et	NOUN
chd-117	26	48	al	al	PROPN
chd-117	26	49	.	.	PROPN
chd-117	26	50	,	,	PUNCT
chd-117	26	51	2008	2008	NUM
chd-117	26	52	)	)	PUNCT
chd-117	26	53	.	.	PUNCT
chd-117	27	1	considering	consider	VERB
chd-117	27	2	recent	recent	ADJ
chd-117	27	3	reports	report	NOUN
chd-117	27	4	of	of	ADP
chd-117	27	5	higher	high	ADJ
chd-117	27	6	breast	breast	NOUN
chd-117	27	7	cancer	cancer	NOUN
chd-117	27	8	mortality	mortality	NOUN
chd-117	27	9	rates	rate	NOUN
chd-117	27	10	among	among	ADP
chd-117	27	11	aa	aa	ADJ
chd-117	27	12	women	woman	NOUN
chd-117	27	13	in	in	ADP
chd-117	27	14	memphis	memphis	PROPN
chd-117	27	15	,	,	PUNCT
chd-117	27	16	tn	tn	PROPN
chd-117	27	17	as	as	SCONJ
chd-117	27	18	compared	compare	VERB
chd-117	27	19	to	to	ADP
chd-117	27	20	49	49	NUM
chd-117	27	21	of	of	ADP
chd-117	27	22	the	the	DET
chd-117	27	23	largest	large	ADJ
chd-117	27	24	us	us	PROPN
chd-117	27	25	cities	city	NOUN
chd-117	27	26	(	(	PUNCT
chd-117	27	27	hunt	hunt	NOUN
chd-117	27	28	et	et	NOUN
chd-117	27	29	al	al	PROPN
chd-117	27	30	.	.	PROPN
chd-117	27	31	,	,	PUNCT
chd-117	27	32	2014	2014	NUM
chd-117	27	33	;	;	PUNCT
chd-117	27	34	vidal	vidal	PROPN
chd-117	27	35	et	et	PROPN
chd-117	27	36	al	al	PROPN
chd-117	27	37	.	.	PROPN
chd-117	27	38	,	,	PUNCT
chd-117	27	39	2017	2017	NUM
chd-117	27	40	)	)	PUNCT
chd-117	27	41	,	,	PUNCT
chd-117	27	42	the	the	DET
chd-117	27	43	present	present	ADJ
chd-117	27	44	study	study	NOUN
chd-117	27	45	was	be	AUX
chd-117	27	46	conducted	conduct	VERB
chd-117	27	47	to	to	PART
chd-117	27	48	determine	determine	VERB
chd-117	27	49	the	the	DET
chd-117	27	50	possible	possible	ADJ
chd-117	27	51	association	association	NOUN
chd-117	27	52	between	between	ADP
chd-117	27	53	the	the	DET
chd-117	27	54	ugt1a1	ugt1a1	NOUN
chd-117	27	55	ta	ta	AUX
chd-117	27	56	repeat	repeat	VERB
chd-117	27	57	polymorphism	polymorphism	NOUN
chd-117	27	58	and	and	CCONJ
chd-117	27	59	breast	breast	NOUN
chd-117	27	60	cancer	cancer	NOUN
chd-117	27	61	risk	risk	NOUN
chd-117	27	62	in	in	ADP
chd-117	27	63	a	a	DET
chd-117	27	64	sample	sample	NOUN
chd-117	27	65	of	of	ADP
chd-117	27	66	aa	aa	ADJ
chd-117	27	67	women	woman	NOUN
chd-117	27	68	in	in	ADP
chd-117	27	69	memphis	memphis	PROPN
chd-117	27	70	,	,	PUNCT
chd-117	27	71	tn	tn	PROPN
chd-117	27	72	.	.	PUNCT
chd-117	28	1	we	we	PRON
chd-117	28	2	further	far	ADV
chd-117	28	3	explored	explore	VERB
chd-117	28	4	the	the	DET
chd-117	28	5	relationship	relationship	NOUN
chd-117	28	6	between	between	ADP
chd-117	28	7	ugt1a1	ugt1a1	ADJ
chd-117	28	8	expression	expression	NOUN
chd-117	28	9	and	and	CCONJ
chd-117	28	10	breast	breast	NOUN
chd-117	28	11	cancer	cancer	NOUN
chd-117	28	12	risk	risk	NOUN
chd-117	28	13	in	in	ADP
chd-117	28	14	aa	aa	NOUN
chd-117	28	15	and	and	CCONJ
chd-117	28	16	non	non	ADJ
chd-117	28	17	-	-	ADJ
chd-117	28	18	hispanic	hispanic	ADJ
chd-117	28	19	white	white	ADJ
chd-117	28	20	women	woman	NOUN
chd-117	28	21	using	use	VERB
chd-117	28	22	rna	rna	NOUN
chd-117	28	23	sequencing	sequencing	NOUN
chd-117	28	24	data	datum	NOUN
chd-117	28	25	from	from	ADP
chd-117	28	26	the	the	DET
chd-117	28	27	cancer	cancer	NOUN
chd-117	28	28	genome	genome	NOUN
chd-117	28	29	atlas	atlas	PROPN
chd-117	28	30	(	(	PUNCT
chd-117	28	31	tcga	tcga	PROPN
chd-117	28	32	)	)	PUNCT
chd-117	28	33	.	.	PUNCT
chd-117	29	1	materials	material	NOUN
chd-117	29	2	and	and	CCONJ
chd-117	29	3	methods	method	NOUN
chd-117	29	4	study	study	VERB
chd-117	29	5	population	population	NOUN
chd-117	29	6	a	a	DET
chd-117	29	7	total	total	NOUN
chd-117	29	8	of	of	ADP
chd-117	29	9	352	352	NUM
chd-117	29	10	aa	aa	ADJ
chd-117	29	11	women	woman	NOUN
chd-117	29	12	participants	participant	NOUN
chd-117	29	13	,	,	PUNCT
chd-117	29	14	comprising	comprise	VERB
chd-117	29	15	82	82	NUM
chd-117	29	16	breast	breast	NOUN
chd-117	29	17	cancer	cancer	NOUN
chd-117	29	18	cases	case	NOUN
chd-117	29	19	and	and	CCONJ
chd-117	29	20	270	270	NUM
chd-117	29	21	healthy	healthy	ADJ
chd-117	29	22	women	woman	NOUN
chd-117	29	23	controls	control	VERB
chd-117	29	24	age	age	NOUN
chd-117	29	25	18	18	NUM
chd-117	29	26	and	and	CCONJ
chd-117	29	27	older	old	ADJ
chd-117	29	28	were	be	AUX
chd-117	29	29	included	include	VERB
chd-117	29	30	in	in	ADP
chd-117	29	31	this	this	DET
chd-117	29	32	pilot	pilot	NOUN
chd-117	29	33	study	study	NOUN
chd-117	29	34	.	.	PUNCT
chd-117	30	1	breast	breast	NOUN
chd-117	30	2	cancer	cancer	NOUN
chd-117	30	3	patients	patient	NOUN
chd-117	30	4	treated	treat	VERB
chd-117	30	5	at	at	ADP
chd-117	30	6	the	the	DET
chd-117	30	7	west	west	PROPN
chd-117	30	8	cancer	cancer	NOUN
chd-117	30	9	center	center	PROPN
chd-117	30	10	(	(	PUNCT
chd-117	30	11	wcc	wcc	PROPN
chd-117	30	12	)	)	PUNCT
chd-117	30	13	in	in	ADP
chd-117	30	14	memphis	memphis	PROPN
chd-117	30	15	,	,	PUNCT
chd-117	30	16	tn	tn	PROPN
chd-117	30	17	were	be	AUX
chd-117	30	18	recruited	recruit	VERB
chd-117	30	19	.	.	PUNCT
chd-117	31	1	normal	normal	ADJ
chd-117	31	2	healthy	healthy	ADJ
chd-117	31	3	controls	control	NOUN
chd-117	31	4	and	and	CCONJ
chd-117	31	5	cancer	cancer	NOUN
chd-117	31	6	survivors	survivor	NOUN
chd-117	31	7	were	be	AUX
chd-117	31	8	also	also	ADV
chd-117	31	9	recruited	recruit	VERB
chd-117	31	10	at	at	ADP
chd-117	31	11	local	local	ADJ
chd-117	31	12	community	community	NOUN
chd-117	31	13	outreach	outreach	NOUN
chd-117	31	14	events	event	NOUN
chd-117	31	15	in	in	ADP
chd-117	31	16	memphis	memphis	PROPN
chd-117	31	17	,	,	PUNCT
chd-117	31	18	tn	tn	PROPN
chd-117	31	19	between	between	ADP
chd-117	31	20	june	june	PROPN
chd-117	31	21	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-117	31	22	e3	e3	NOUN
chd-117	31	23	cancer	cancer	NOUN
chd-117	31	24	health	health	NOUN
chd-117	31	25	disparities	disparity	NOUN
chd-117	31	26	research	research	VERB
chd-117	31	27	2016	2016	NUM
chd-117	31	28	and	and	CCONJ
chd-117	31	29	june	june	PROPN
chd-117	31	30	2017	2017	NUM
chd-117	31	31	.	.	PUNCT
chd-117	32	1	all	all	DET
chd-117	32	2	recruited	recruit	VERB
chd-117	32	3	breast	breast	NOUN
chd-117	32	4	cancer	cancer	NOUN
chd-117	32	5	patients	patient	NOUN
chd-117	32	6	in	in	ADP
chd-117	32	7	this	this	DET
chd-117	32	8	study	study	NOUN
chd-117	32	9	were	be	AUX
chd-117	32	10	either	either	ADV
chd-117	32	11	being	be	AUX
chd-117	32	12	treated	treat	VERB
chd-117	32	13	for	for	ADP
chd-117	32	14	breast	breast	NOUN
chd-117	32	15	cancer	cancer	NOUN
chd-117	32	16	or	or	CCONJ
chd-117	32	17	had	have	VERB
chd-117	32	18	a	a	DET
chd-117	32	19	prior	prior	ADJ
chd-117	32	20	diagnosis	diagnosis	NOUN
chd-117	32	21	of	of	ADP
chd-117	32	22	breast	breast	NOUN
chd-117	32	23	cancer	cancer	NOUN
chd-117	32	24	.	.	PUNCT
chd-117	33	1	the	the	DET
chd-117	33	2	control	control	PROPN
chd-117	33	3	group	group	NOUN
chd-117	33	4	included	include	VERB
chd-117	33	5	healthy	healthy	ADJ
chd-117	33	6	volunteers	volunteer	NOUN
chd-117	33	7	without	without	ADP
chd-117	33	8	a	a	DET
chd-117	33	9	prior	prior	ADJ
chd-117	33	10	diagnosis	diagnosis	NOUN
chd-117	33	11	of	of	ADP
chd-117	33	12	breast	breast	NOUN
chd-117	33	13	cancer	cancer	NOUN
chd-117	33	14	and	and	CCONJ
chd-117	33	15	who	who	PRON
chd-117	33	16	were	be	AUX
chd-117	33	17	recruited	recruit	VERB
chd-117	33	18	at	at	ADP
chd-117	33	19	community	community	NOUN
chd-117	33	20	outreach	outreach	NOUN
chd-117	33	21	events	event	NOUN
chd-117	33	22	.	.	PUNCT
chd-117	34	1	all	all	DET
chd-117	34	2	recruited	recruit	VERB
chd-117	34	3	participants	participant	NOUN
chd-117	34	4	completed	complete	VERB
chd-117	34	5	a	a	DET
chd-117	34	6	3	3	NUM
chd-117	34	7	-	-	PUNCT
chd-117	34	8	page	page	NOUN
chd-117	34	9	health	health	NOUN
chd-117	34	10	questionnaire	questionnaire	NOUN
chd-117	34	11	that	that	PRON
chd-117	34	12	included	include	VERB
chd-117	34	13	information	information	NOUN
chd-117	34	14	on	on	ADP
chd-117	34	15	participants	participant	NOUN
chd-117	34	16	’	'	PUNCT
chd-117	34	17	reproductive	reproductive	ADJ
chd-117	34	18	history	history	NOUN
chd-117	34	19	,	,	PUNCT
chd-117	34	20	diet	diet	NOUN
chd-117	34	21	and	and	CCONJ
chd-117	34	22	lifestyle	lifestyle	NOUN
chd-117	34	23	factors	factor	NOUN
chd-117	34	24	,	,	PUNCT
chd-117	34	25	and	and	CCONJ
chd-117	34	26	family	family	NOUN
chd-117	34	27	history	history	NOUN
chd-117	34	28	of	of	ADP
chd-117	34	29	cancer	cancer	NOUN
chd-117	34	30	.	.	PUNCT
chd-117	35	1	race	race	NOUN
chd-117	35	2	was	be	AUX
chd-117	35	3	classified	classify	VERB
chd-117	35	4	according	accord	VERB
chd-117	35	5	to	to	ADP
chd-117	35	6	selfreport	selfreport	NOUN
chd-117	35	7	.	.	PUNCT
chd-117	36	1	a	a	DET
chd-117	36	2	2	2	NUM
chd-117	36	3	ml	ml	NOUN
chd-117	36	4	saliva	saliva	NOUN
chd-117	36	5	sample	sample	NOUN
chd-117	36	6	was	be	AUX
chd-117	36	7	also	also	ADV
chd-117	36	8	collected	collect	VERB
chd-117	36	9	using	use	VERB
chd-117	36	10	oragene	oragene	ADJ
chd-117	36	11	®	®	NOUN
chd-117	36	12	og-500	og-500	PROPN
chd-117	36	13	dna	dna	NOUN
chd-117	36	14	self	self	NOUN
chd-117	36	15	-	-	PUNCT
chd-117	36	16	collection	collection	NOUN
chd-117	36	17	kit	kit	NOUN
chd-117	36	18	(	(	PUNCT
chd-117	36	19	ottawa	ottawa	PROPN
chd-117	36	20	,	,	PUNCT
chd-117	36	21	ontario	ontario	PROPN
chd-117	36	22	,	,	PUNCT
chd-117	36	23	canada	canada	PROPN
chd-117	36	24	)	)	PUNCT
chd-117	36	25	at	at	ADP
chd-117	36	26	the	the	DET
chd-117	36	27	same	same	ADJ
chd-117	36	28	time	time	NOUN
chd-117	36	29	the	the	DET
chd-117	36	30	participants	participant	NOUN
chd-117	36	31	completed	complete	VERB
chd-117	36	32	the	the	DET
chd-117	36	33	health	health	NOUN
chd-117	36	34	questionnaire	questionnaire	NOUN
chd-117	36	35	.	.	PUNCT
chd-117	37	1	ethics	ethic	NOUN
chd-117	37	2	written	write	VERB
chd-117	37	3	informed	informed	ADJ
chd-117	37	4	consent	consent	NOUN
chd-117	37	5	was	be	AUX
chd-117	37	6	obtained	obtain	VERB
chd-117	37	7	from	from	ADP
chd-117	37	8	each	each	DET
chd-117	37	9	study	study	NOUN
chd-117	37	10	participant	participant	NOUN
chd-117	37	11	and	and	CCONJ
chd-117	37	12	the	the	DET
chd-117	37	13	study	study	NOUN
chd-117	37	14	protocol	protocol	NOUN
chd-117	37	15	(	(	PUNCT
chd-117	37	16	protocol	protocol	NOUN
chd-117	37	17	#	#	NOUN
chd-117	37	18	16	16	NUM
chd-117	37	19	-	-	PUNCT
chd-117	37	20	04551	04551	NUM
chd-117	37	21	-	-	PUNCT
chd-117	37	22	xp	xp	NOUN
chd-117	37	23	and	and	CCONJ
chd-117	37	24	16	16	NUM
chd-117	37	25	-	-	PUNCT
chd-117	37	26	04502	04502	NUM
chd-117	37	27	-	-	PUNCT
chd-117	37	28	xp	xp	NOUN
chd-117	37	29	)	)	PUNCT
chd-117	37	30	was	be	AUX
chd-117	37	31	approved	approve	VERB
chd-117	37	32	by	by	ADP
chd-117	37	33	the	the	DET
chd-117	37	34	institutional	institutional	ADJ
chd-117	37	35	review	review	PROPN
chd-117	37	36	board	board	NOUN
chd-117	37	37	of	of	ADP
chd-117	37	38	the	the	DET
chd-117	37	39	university	university	PROPN
chd-117	37	40	of	of	ADP
chd-117	37	41	tennessee	tennessee	PROPN
chd-117	37	42	health	health	PROPN
chd-117	37	43	science	science	PROPN
chd-117	37	44	center	center	PROPN
chd-117	37	45	,	,	PUNCT
chd-117	37	46	memphis	memphis	PROPN
chd-117	37	47	,	,	PUNCT
chd-117	37	48	tn	tn	PROPN
chd-117	37	49	and	and	CCONJ
chd-117	37	50	was	be	AUX
chd-117	37	51	carried	carry	VERB
chd-117	37	52	out	out	ADP
chd-117	37	53	in	in	ADP
chd-117	37	54	accordance	accordance	NOUN
chd-117	37	55	with	with	ADP
chd-117	37	56	the	the	DET
chd-117	37	57	guidelines	guideline	NOUN
chd-117	37	58	of	of	ADP
chd-117	37	59	the	the	DET
chd-117	37	60	declaration	declaration	NOUN
chd-117	37	61	of	of	ADP
chd-117	37	62	helsinki	helsinki	PROPN
chd-117	37	63	.	.	PUNCT
chd-117	38	1	ugt1a1	ugt1a1	ADJ
chd-117	38	2	promoter	promoter	NOUN
chd-117	38	3	genotyping	genotyping	NOUN
chd-117	38	4	analysis	analysis	NOUN
chd-117	38	5	.	.	PUNCT
chd-117	39	1	dna	dna	PROPN
chd-117	39	2	was	be	AUX
chd-117	39	3	isolated	isolate	VERB
chd-117	39	4	from	from	ADP
chd-117	39	5	saliva	saliva	NOUN
chd-117	39	6	using	use	VERB
chd-117	39	7	dna	dna	PROPN
chd-117	39	8	genotek	genotek	PROPN
chd-117	39	9	’s	’s	PART
chd-117	39	10	prep	prep	NOUN
chd-117	39	11	-	-	PUNCT
chd-117	39	12	it	it	PRON
chd-117	39	13	l2p	l2p	PROPN
chd-117	39	14	dna	dna	PROPN
chd-117	39	15	isolation	isolation	NOUN
chd-117	39	16	kit	kit	NOUN
chd-117	39	17	(	(	PUNCT
chd-117	39	18	ottawa	ottawa	PROPN
chd-117	39	19	,	,	PUNCT
chd-117	39	20	ontario	ontario	PROPN
chd-117	39	21	,	,	PUNCT
chd-117	39	22	canada	canada	PROPN
chd-117	39	23	)	)	PUNCT
chd-117	39	24	.	.	PUNCT
chd-117	40	1	dna	dna	PROPN
chd-117	40	2	was	be	AUX
chd-117	40	3	purified	purify	VERB
chd-117	40	4	using	use	VERB
chd-117	40	5	a	a	DET
chd-117	40	6	zymoresearch	zymoresearch	NOUN
chd-117	40	7	dna	dna	PROPN
chd-117	40	8	clean	clean	ADJ
chd-117	40	9	and	and	CCONJ
chd-117	40	10	concentrator	concentrator	PROPN
chd-117	40	11	kit	kit	NOUN
chd-117	40	12	(	(	PUNCT
chd-117	40	13	irvine	irvine	PROPN
chd-117	40	14	,	,	PUNCT
chd-117	40	15	california	california	PROPN
chd-117	40	16	)	)	PUNCT
chd-117	40	17	.	.	PUNCT
chd-117	41	1	the	the	DET
chd-117	41	2	ugt1a1	ugt1a1	PROPN
chd-117	41	3	*	*	ADJ
chd-117	41	4	28	28	NUM
chd-117	41	5	polymorphism	polymorphism	NOUN
chd-117	41	6	was	be	AUX
chd-117	41	7	identified	identify	VERB
chd-117	41	8	from	from	ADP
chd-117	41	9	dna	dna	PROPN
chd-117	41	10	that	that	PRON
chd-117	41	11	was	be	AUX
chd-117	41	12	pcr	pcr	NOUN
chd-117	41	13	amplified	amplify	VERB
chd-117	41	14	as	as	ADP
chd-117	41	15	previously	previously	ADV
chd-117	41	16	described	describe	VERB
chd-117	41	17	(	(	PUNCT
chd-117	41	18	massacesi	massacesi	PROPN
chd-117	41	19	et	et	PROPN
chd-117	41	20	al	al	PROPN
chd-117	41	21	.	.	PROPN
chd-117	41	22	,	,	PUNCT
chd-117	41	23	2006	2006	NUM
chd-117	41	24	)	)	PUNCT
chd-117	41	25	.	.	PUNCT
chd-117	42	1	briefly	briefly	ADV
chd-117	42	2	,	,	PUNCT
chd-117	42	3	polymerase	polymerase	NOUN
chd-117	42	4	chain	chain	NOUN
chd-117	42	5	reactions	reaction	NOUN
chd-117	42	6	(	(	PUNCT
chd-117	42	7	pcr	pcr	PROPN
chd-117	42	8	)	)	PUNCT
chd-117	42	9	were	be	AUX
chd-117	42	10	conducted	conduct	VERB
chd-117	42	11	in	in	ADP
chd-117	42	12	a	a	DET
chd-117	42	13	total	total	ADJ
chd-117	42	14	volume	volume	NOUN
chd-117	42	15	of	of	ADP
chd-117	42	16	50	50	NUM
chd-117	42	17	μl	μl	ADV
chd-117	42	18	containing	contain	VERB
chd-117	42	19	100	100	NUM
chd-117	42	20	ng	ng	PROPN
chd-117	42	21	of	of	ADP
chd-117	42	22	genomic	genomic	PROPN
chd-117	42	23	dna	dna	NOUN
chd-117	42	24	,	,	PUNCT
chd-117	42	25	25	25	NUM
chd-117	42	26	pmoles	pmole	NOUN
chd-117	42	27	of	of	ADP
chd-117	42	28	the	the	DET
chd-117	42	29	ugt1a1	ugt1a1	ADJ
chd-117	42	30	primer	primer	NOUN
chd-117	42	31	(	(	PUNCT
chd-117	42	32	ugt1a1	ugt1a1	ADJ
chd-117	42	33	forward	forward	ADV
chd-117	42	34	:	:	PUNCT
chd-117	42	35	5’-gat	5’-gat	NUM
chd-117	42	36	ttg	ttg	NOUN
chd-117	42	37	agt	agt	PROPN
chd-117	42	38	atg	atg	PROPN
chd-117	42	39	aaa	aaa	PROPN
chd-117	42	40	ttc	ttc	PROPN
chd-117	42	41	cag	cag	PROPN
chd-117	42	42	cca	cca	PROPN
chd-117	42	43	g-3	g-3	PROPN
chd-117	42	44	’	'	PUNCT
chd-117	42	45	and	and	CCONJ
chd-117	42	46	ugt1a1	ugt1a1	ADJ
chd-117	42	47	reverse	reverse	NOUN
chd-117	42	48	:	:	PUNCT
chd-117	42	49	5′-cca	5′-cca	NUM
chd-117	42	50	gtg	gtg	PROPN
chd-117	42	51	gct	gct	PROPN
chd-117	42	52	gcc	gcc	PROPN
chd-117	42	53	atc	atc	PROPN
chd-117	42	54	cac	cac	PROPN
chd-117	42	55	t-3′	t-3′	PROPN
chd-117	42	56	)	)	PUNCT
chd-117	42	57	(	(	PUNCT
chd-117	42	58	massacesi	massacesi	PROPN
chd-117	42	59	et	et	PROPN
chd-117	42	60	al	al	PROPN
chd-117	42	61	.	.	PROPN
chd-117	42	62	,	,	PUNCT
chd-117	42	63	2006	2006	NUM
chd-117	42	64	)	)	PUNCT
chd-117	42	65	and	and	CCONJ
chd-117	42	66	the	the	DET
chd-117	42	67	following	follow	VERB
chd-117	42	68	reagents	reagent	NOUN
chd-117	42	69	(	(	PUNCT
chd-117	42	70	promega	promega	PROPN
chd-117	42	71	,	,	PUNCT
chd-117	42	72	madison	madison	PROPN
chd-117	42	73	,	,	PUNCT
chd-117	42	74	wi	wi	PROPN
chd-117	42	75	):	):	PUNCT
chd-117	42	76	0.1	0.1	NUM
chd-117	42	77	mm	mm	NOUN
chd-117	42	78	each	each	PRON
chd-117	42	79	of	of	ADP
chd-117	42	80	dctp	dctp	PROPN
chd-117	42	81	,	,	PUNCT
chd-117	42	82	dgtp	dgtp	NOUN
chd-117	42	83	,	,	PUNCT
chd-117	42	84	datp	datp	NOUN
chd-117	42	85	and	and	CCONJ
chd-117	42	86	dttp	dttp	ADJ
chd-117	42	87	;	;	PUNCT
chd-117	42	88	2.5	2.5	NUM
chd-117	42	89	mm	mm	NOUN
chd-117	42	90	of	of	ADP
chd-117	42	91	mgcl2	mgcl2	PROPN
chd-117	42	92	;	;	PUNCT
chd-117	42	93	50	50	NUM
chd-117	42	94	mm	mm	NOUN
chd-117	42	95	of	of	ADP
chd-117	42	96	potassium	potassium	NOUN
chd-117	42	97	chloride	chloride	NOUN
chd-117	42	98	;	;	PUNCT
chd-117	42	99	10	10	NUM
chd-117	42	100	mm	mm	NOUN
chd-117	42	101	of	of	ADP
chd-117	42	102	tris	tris	NOUN
chd-117	42	103	(	(	PUNCT
chd-117	42	104	ph	ph	NOUN
chd-117	42	105	9.0	9.0	NUM
chd-117	42	106	)	)	PUNCT
chd-117	42	107	;	;	PUNCT
chd-117	42	108	0.1	0.1	NUM
chd-117	42	109	%	%	NOUN
chd-117	42	110	triton	triton	PROPN
chd-117	42	111	-	-	PUNCT
chd-117	42	112	x	x	NOUN
chd-117	42	113	;	;	PUNCT
chd-117	42	114	and	and	CCONJ
chd-117	42	115	2.5	2.5	NUM
chd-117	42	116	u	u	NOUN
chd-117	42	117	of	of	ADP
chd-117	42	118	taq	taq	NOUN
chd-117	42	119	polymerase	polymerase	NOUN
chd-117	42	120	.	.	PUNCT
chd-117	43	1	after	after	ADP
chd-117	43	2	35	35	NUM
chd-117	43	3	cycles	cycle	NOUN
chd-117	43	4	of	of	ADP
chd-117	43	5	amplification	amplification	NOUN
chd-117	43	6	(	(	PUNCT
chd-117	43	7	denaturation	denaturation	NOUN
chd-117	43	8	at	at	ADP
chd-117	43	9	94	94	NUM
chd-117	43	10	°	°	ADP
chd-117	43	11	c	c	NOUN
chd-117	43	12	for	for	ADP
chd-117	43	13	30	30	NUM
chd-117	43	14	sec	sec	PROPN
chd-117	43	15	,	,	PUNCT
chd-117	43	16	annealing	anneal	VERB
chd-117	43	17	at	at	ADP
chd-117	43	18	60	60	NUM
chd-117	43	19	°	°	ADP
chd-117	43	20	c	c	NOUN
chd-117	43	21	for	for	ADP
chd-117	43	22	1	1	NUM
chd-117	43	23	min	min	NOUN
chd-117	43	24	,	,	PUNCT
chd-117	43	25	and	and	CCONJ
chd-117	43	26	extension	extension	NOUN
chd-117	43	27	at	at	ADP
chd-117	43	28	72	72	NUM
chd-117	43	29	°	°	ADP
chd-117	43	30	c	c	NOUN
chd-117	43	31	for	for	ADP
chd-117	43	32	1	1	NUM
chd-117	43	33	min	min	NOUN
chd-117	43	34	)	)	PUNCT
chd-117	43	35	,	,	PUNCT
chd-117	43	36	the	the	DET
chd-117	43	37	amplification	amplification	NOUN
chd-117	43	38	products	product	NOUN
chd-117	43	39	were	be	AUX
chd-117	43	40	electrophoresed	electrophorese	VERB
chd-117	43	41	in	in	ADP
chd-117	43	42	3	3	NUM
chd-117	43	43	%	%	NOUN
chd-117	43	44	agarose	agarose	NOUN
chd-117	43	45	gel	gel	NOUN
chd-117	43	46	and	and	CCONJ
chd-117	43	47	visualized	visualize	VERB
chd-117	43	48	after	after	ADP
chd-117	43	49	staining	stain	VERB
chd-117	43	50	with	with	ADP
chd-117	43	51	ethidium	ethidium	ADJ
chd-117	43	52	bromide	bromide	NOUN
chd-117	43	53	.	.	PUNCT
chd-117	44	1	genotypes	genotype	NOUN
chd-117	44	2	of	of	ADP
chd-117	44	3	the	the	DET
chd-117	44	4	a(ta)6	a(ta)6	PROPN
chd-117	44	5	-	-	PUNCT
chd-117	44	6	8taa	8taa	NUM
chd-117	44	7	polymorphism	polymorphism	NOUN
chd-117	44	8	were	be	AUX
chd-117	44	9	determined	determine	VERB
chd-117	44	10	by	by	ADP
chd-117	44	11	bidirectional	bidirectional	ADJ
chd-117	44	12	sequencing	sequencing	NOUN
chd-117	44	13	with	with	ADP
chd-117	44	14	forward	forward	ADV
chd-117	44	15	or	or	CCONJ
chd-117	44	16	reverse	reverse	ADJ
chd-117	44	17	primers	primer	NOUN
chd-117	44	18	.	.	PUNCT
chd-117	45	1	pcr	pcr	ADJ
chd-117	45	2	products	product	NOUN
chd-117	45	3	were	be	AUX
chd-117	45	4	purified	purify	VERB
chd-117	45	5	using	use	VERB
chd-117	45	6	the	the	DET
chd-117	45	7	qiagen	qiagen	NOUN
chd-117	45	8	dna	dna	PROPN
chd-117	45	9	purification	purification	NOUN
chd-117	45	10	kit	kit	NOUN
chd-117	45	11	(	(	PUNCT
chd-117	45	12	valencia	valencia	PROPN
chd-117	45	13	,	,	PUNCT
chd-117	45	14	ca	ca	NOUN
chd-117	45	15	)	)	PUNCT
chd-117	45	16	.	.	PUNCT
chd-117	46	1	dna	dna	PROPN
chd-117	46	2	sequencing	sequencing	NOUN
chd-117	46	3	of	of	ADP
chd-117	46	4	the	the	DET
chd-117	46	5	ugt1a1	ugt1a1	ADJ
chd-117	46	6	product	product	NOUN
chd-117	46	7	(	(	PUNCT
chd-117	46	8	351	351	NUM
chd-117	46	9	bp	bp	NOUN
chd-117	46	10	)	)	PUNCT
chd-117	46	11	containing	contain	VERB
chd-117	46	12	the	the	DET
chd-117	46	13	polymorphic	polymorphic	ADJ
chd-117	46	14	ta	ta	PROPN
chd-117	46	15	repeats	repeat	NOUN
chd-117	46	16	was	be	AUX
chd-117	46	17	performed	perform	VERB
chd-117	46	18	using	use	VERB
chd-117	46	19	the	the	DET
chd-117	46	20	sanger	sanger	PROPN
chd-117	46	21	method	method	NOUN
chd-117	46	22	employing	employ	VERB
chd-117	46	23	applied	apply	VERB
chd-117	46	24	biosystems	biosystem	NOUN
chd-117	46	25	big	big	ADJ
chd-117	46	26	dye	dye	NOUN
chd-117	46	27	v3.1	v3.1	ADP
chd-117	46	28	reaction	reaction	NOUN
chd-117	46	29	mix	mix	NOUN
chd-117	46	30	at	at	ADP
chd-117	46	31	1/10x	1/10x	NUM
chd-117	46	32	strength	strength	NOUN
chd-117	46	33	combined	combine	VERB
chd-117	46	34	with	with	ADP
chd-117	46	35	an	an	DET
chd-117	46	36	appropriate	appropriate	ADJ
chd-117	46	37	amount	amount	NOUN
chd-117	46	38	of	of	ADP
chd-117	46	39	pcr	pcr	ADJ
chd-117	46	40	product	product	NOUN
chd-117	46	41	and	and	CCONJ
chd-117	46	42	5	5	NUM
chd-117	46	43	pmol	pmol	NOUN
chd-117	46	44	of	of	ADP
chd-117	46	45	the	the	DET
chd-117	46	46	relevant	relevant	ADJ
chd-117	46	47	primer	primer	NOUN
chd-117	46	48	.	.	PUNCT
chd-117	47	1	all	all	DET
chd-117	47	2	sequencing	sequence	VERB
chd-117	47	3	data	datum	NOUN
chd-117	47	4	was	be	AUX
chd-117	47	5	generated	generate	VERB
chd-117	47	6	in	in	ADP
chd-117	47	7	the	the	DET
chd-117	47	8	molecular	molecular	ADJ
chd-117	47	9	resource	resource	NOUN
chd-117	47	10	center	center	NOUN
chd-117	47	11	(	(	PUNCT
chd-117	47	12	mrc	mrc	NOUN
chd-117	47	13	)	)	PUNCT
chd-117	47	14	of	of	ADP
chd-117	47	15	excellence	excellence	NOUN
chd-117	47	16	at	at	ADP
chd-117	47	17	the	the	DET
chd-117	47	18	university	university	PROPN
chd-117	47	19	of	of	ADP
chd-117	47	20	tennessee	tennessee	PROPN
chd-117	47	21	health	health	PROPN
chd-117	47	22	science	science	PROPN
chd-117	47	23	center	center	PROPN
chd-117	47	24	,	,	PUNCT
chd-117	47	25	memphis	memphis	PROPN
chd-117	47	26	,	,	PUNCT
chd-117	47	27	tn	tn	PROPN
chd-117	47	28	.	.	PUNCT
chd-117	48	1	all	all	DET
chd-117	48	2	pcr	pcr	ADJ
chd-117	48	3	protocols	protocol	NOUN
chd-117	48	4	and	and	CCONJ
chd-117	48	5	template	template	NOUN
chd-117	48	6	/	/	SYM
chd-117	48	7	primer	primer	NOUN
chd-117	48	8	ratios	ratio	NOUN
chd-117	48	9	were	be	AUX
chd-117	48	10	those	those	PRON
chd-117	48	11	suggested	suggest	VERB
chd-117	48	12	by	by	ADP
chd-117	48	13	the	the	DET
chd-117	48	14	manufacturer	manufacturer	NOUN
chd-117	48	15	.	.	PUNCT
chd-117	49	1	the	the	DET
chd-117	49	2	thermofisher	thermofisher	ADJ
chd-117	49	3	(	(	PUNCT
chd-117	49	4	applied	apply	VERB
chd-117	49	5	biosystems	biosystem	NOUN
chd-117	49	6	)	)	PUNCT
chd-117	49	7	bdxterminator	bdxterminator	NOUN
chd-117	49	8	system	system	NOUN
chd-117	49	9	was	be	AUX
chd-117	49	10	used	use	VERB
chd-117	49	11	to	to	PART
chd-117	49	12	remove	remove	VERB
chd-117	49	13	salts	salt	NOUN
chd-117	49	14	,	,	PUNCT
chd-117	49	15	primers	primer	NOUN
chd-117	49	16	and	and	CCONJ
chd-117	49	17	unincorporated	unincorporate	VERB
chd-117	49	18	nucleotides	nucleotide	NOUN
chd-117	49	19	from	from	ADP
chd-117	49	20	the	the	DET
chd-117	49	21	labeling	labeling	NOUN
chd-117	49	22	reaction	reaction	NOUN
chd-117	49	23	.	.	PUNCT
chd-117	50	1	labelled	label	VERB
chd-117	50	2	samples	sample	NOUN
chd-117	50	3	were	be	AUX
chd-117	50	4	analyzed	analyze	VERB
chd-117	50	5	with	with	ADP
chd-117	50	6	an	an	DET
chd-117	50	7	applied	apply	VERB
chd-117	50	8	biosystems	biosystem	NOUN
chd-117	50	9	3130xl	3130xl	VERB
chd-117	50	10	genetic	genetic	ADJ
chd-117	50	11	analyzer	analyzer	NOUN
chd-117	50	12	using	use	VERB
chd-117	50	13	sequencing	sequence	VERB
chd-117	50	14	analysis	analysis	NOUN
chd-117	50	15	v5.2.0	v5.2.0	PROPN
chd-117	50	16	software	software	NOUN
chd-117	50	17	employing	employ	VERB
chd-117	50	18	the	the	DET
chd-117	50	19	kb.bcp	kb.bcp	NOUN
chd-117	50	20	program	program	NOUN
chd-117	50	21	using	use	VERB
chd-117	50	22	the	the	DET
chd-117	50	23	kb_3130_pop7_bdtv3	kb_3130_pop7_bdtv3	NOUN
chd-117	50	24	mobility	mobility	NOUN
chd-117	50	25	file	file	NOUN
chd-117	50	26	.	.	PUNCT
chd-117	51	1	all	all	DET
chd-117	51	2	electropherograms	electropherogram	NOUN
chd-117	51	3	were	be	AUX
chd-117	51	4	visually	visually	ADV
chd-117	51	5	examined	examine	VERB
chd-117	51	6	in	in	ADP
chd-117	51	7	the	the	DET
chd-117	51	8	mrc	mrc	NOUN
chd-117	51	9	to	to	PART
chd-117	51	10	ensure	ensure	VERB
chd-117	51	11	the	the	DET
chd-117	51	12	highest	high	ADJ
chd-117	51	13	data	datum	NOUN
chd-117	51	14	quality	quality	NOUN
chd-117	51	15	.	.	PUNCT
chd-117	52	1	sample	sample	NOUN
chd-117	52	2	quality	quality	NOUN
chd-117	52	3	was	be	AUX
chd-117	52	4	determined	determine	VERB
chd-117	52	5	prior	prior	ADV
chd-117	52	6	to	to	ADP
chd-117	52	7	dntp	dntp	VERB
chd-117	52	8	incorporation	incorporation	NOUN
chd-117	52	9	by	by	ADP
chd-117	52	10	assaying	assay	VERB
chd-117	52	11	the	the	DET
chd-117	52	12	a260	a260	PROPN
chd-117	52	13	,	,	PUNCT
chd-117	52	14	a280	a280	PROPN
chd-117	52	15	and	and	CCONJ
chd-117	52	16	a230	a230	PROPN
chd-117	52	17	values	value	NOUN
chd-117	52	18	using	use	VERB
chd-117	52	19	a	a	DET
chd-117	52	20	nanodrop	nanodrop	NOUN
chd-117	52	21	spectrophotometer	spectrophotometer	NOUN
chd-117	52	22	:	:	PUNCT
chd-117	52	23	the	the	DET
chd-117	52	24	preferred	preferred	ADJ
chd-117	52	25	a260	a260	PROPN
chd-117	52	26	/	/	SYM
chd-117	52	27	a280	a280	PROPN
chd-117	52	28	and	and	CCONJ
chd-117	52	29	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-117	52	30	e4	e4	PROPN
chd-117	52	31	cancer	cancer	NOUN
chd-117	52	32	health	health	NOUN
chd-117	52	33	disparities	disparity	NOUN
chd-117	52	34	research	research	VERB
chd-117	52	35	a260	a260	PROPN
chd-117	52	36	/	/	SYM
chd-117	52	37	a230	a230	PROPN
chd-117	52	38	ratios	ratio	NOUN
chd-117	52	39	were	be	AUX
chd-117	52	40	1.7	1.7	NUM
chd-117	52	41	or	or	CCONJ
chd-117	52	42	better	well	ADJ
chd-117	52	43	.	.	PUNCT
chd-117	53	1	ugt1a1	ugt1a1	ADJ
chd-117	53	2	genotypes	genotype	NOUN
chd-117	53	3	were	be	AUX
chd-117	53	4	assigned	assign	VERB
chd-117	53	5	based	base	VERB
chd-117	53	6	on	on	ADP
chd-117	53	7	the	the	DET
chd-117	53	8	number	number	NOUN
chd-117	53	9	of	of	ADP
chd-117	53	10	ta	ta	PROPN
chd-117	53	11	repeats	repeat	NOUN
chd-117	53	12	for	for	ADP
chd-117	53	13	each	each	DET
chd-117	53	14	allele	allele	NOUN
chd-117	53	15	(	(	PUNCT
chd-117	53	16	i.e.	i.e.	X
chd-117	53	17	,	,	PUNCT
chd-117	53	18	6/6	6/6	NUM
chd-117	53	19	,	,	PUNCT
chd-117	53	20	6/7	6/7	NUM
chd-117	53	21	,	,	PUNCT
chd-117	53	22	7/7	7/7	NUM
chd-117	53	23	,	,	PUNCT
chd-117	53	24	or	or	CCONJ
chd-117	53	25	7/8	7/8	NUM
chd-117	53	26	)	)	PUNCT
chd-117	53	27	.	.	PUNCT
chd-117	54	1	the	the	DET
chd-117	54	2	percentage	percentage	NOUN
chd-117	54	3	of	of	ADP
chd-117	54	4	samples	sample	NOUN
chd-117	54	5	with	with	ADP
chd-117	54	6	successful	successful	ADJ
chd-117	54	7	calls	call	NOUN
chd-117	54	8	was	be	AUX
chd-117	54	9	≥98	≥98	NUM
chd-117	54	10	%	%	NOUN
chd-117	54	11	.	.	PUNCT
chd-117	55	1	rna	rna	NOUN
chd-117	55	2	sequencing	sequence	VERB
chd-117	55	3	analysis	analysis	NOUN
chd-117	55	4	.	.	PUNCT
chd-117	56	1	rna	rna	NOUN
chd-117	56	2	sequencing	sequence	VERB
chd-117	56	3	analysis	analysis	NOUN
chd-117	56	4	was	be	AUX
chd-117	56	5	done	do	VERB
chd-117	56	6	with	with	ADP
chd-117	56	7	cufflinks	cufflink	NOUN
chd-117	56	8	(	(	PUNCT
chd-117	56	9	trapnell	trapnell	NOUN
chd-117	56	10	et	et	NOUN
chd-117	56	11	al	al	PROPN
chd-117	56	12	.	.	PROPN
chd-117	56	13	,	,	PUNCT
chd-117	56	14	2013	2013	NUM
chd-117	56	15	)	)	PUNCT
chd-117	56	16	.	.	PUNCT
chd-117	57	1	this	this	DET
chd-117	57	2	algorithm	algorithm	NOUN
chd-117	57	3	reports	report	VERB
chd-117	57	4	changes	change	NOUN
chd-117	57	5	at	at	ADP
chd-117	57	6	the	the	DET
chd-117	57	7	transcript	transcript	NOUN
chd-117	57	8	and	and	CCONJ
chd-117	57	9	gene	gene	NOUN
chd-117	57	10	level	level	NOUN
chd-117	57	11	as	as	ADP
chd-117	57	12	fragment	fragment	ADJ
chd-117	57	13	reads	read	NOUN
chd-117	57	14	per	per	ADP
chd-117	57	15	kilobase	kilobase	NOUN
chd-117	57	16	of	of	ADP
chd-117	57	17	exon	exon	PROPN
chd-117	57	18	per	per	ADP
chd-117	57	19	million	million	NUM
chd-117	57	20	reads	read	NOUN
chd-117	57	21	mapped	map	VERB
chd-117	57	22	(	(	PUNCT
chd-117	57	23	fpkm	fpkm	NOUN
chd-117	57	24	)	)	PUNCT
chd-117	57	25	values	value	NOUN
chd-117	57	26	.	.	PUNCT
chd-117	58	1	breast	breast	NOUN
chd-117	58	2	carcinoma	carcinoma	PROPN
chd-117	58	3	rna	rna	NOUN
chd-117	58	4	-	-	PUNCT
chd-117	58	5	seq	seq	NOUN
chd-117	58	6	data	datum	NOUN
chd-117	58	7	,	,	PUNCT
chd-117	58	8	made	make	VERB
chd-117	58	9	available	available	ADJ
chd-117	58	10	by	by	ADP
chd-117	58	11	nationwide	nationwide	ADJ
chd-117	58	12	’s	’s	PART
chd-117	58	13	children	child	NOUN
chd-117	58	14	,	,	PUNCT
chd-117	58	15	was	be	AUX
chd-117	58	16	queried	query	VERB
chd-117	58	17	through	through	ADP
chd-117	58	18	the	the	DET
chd-117	58	19	national	national	PROPN
chd-117	58	20	cancer	cancer	PROPN
chd-117	58	21	institute	institute	PROPN
chd-117	58	22	gcd	gcd	PROPN
chd-117	58	23	data	datum	NOUN
chd-117	58	24	portal	portal	PROPN
chd-117	58	25	using	use	VERB
chd-117	58	26	the	the	DET
chd-117	58	27	following	follow	VERB
chd-117	58	28	criteria	criterion	NOUN
chd-117	58	29	:	:	PUNCT
chd-117	58	30	female	female	ADJ
chd-117	58	31	,	,	PUNCT
chd-117	58	32	18	18	NUM
chd-117	58	33	-	-	SYM
chd-117	58	34	90	90	NUM
chd-117	58	35	years	year	NOUN
chd-117	58	36	old	old	ADJ
chd-117	58	37	at	at	ADP
chd-117	58	38	age	age	NOUN
chd-117	58	39	of	of	ADP
chd-117	58	40	diagnosis	diagnosis	NOUN
chd-117	58	41	,	,	PUNCT
chd-117	58	42	alive	alive	ADJ
chd-117	58	43	or	or	CCONJ
chd-117	58	44	dead	dead	ADJ
chd-117	58	45	,	,	PUNCT
chd-117	58	46	african	african	ADJ
chd-117	58	47	american	american	ADJ
chd-117	58	48	or	or	CCONJ
chd-117	58	49	european	european	PROPN
chd-117	58	50	american	american	PROPN
chd-117	58	51	,	,	PUNCT
chd-117	58	52	and	and	CCONJ
chd-117	58	53	not	not	PART
chd-117	58	54	hispanic	hispanic	ADJ
chd-117	58	55	.	.	PUNCT
chd-117	59	1	the	the	DET
chd-117	59	2	raw	raw	ADJ
chd-117	59	3	fpkm	fpkm	NOUN
chd-117	59	4	values	value	NOUN
chd-117	59	5	from	from	ADP
chd-117	59	6	this	this	DET
chd-117	59	7	rna	rna	NOUN
chd-117	59	8	-	-	PUNCT
chd-117	59	9	seq	seq	NOUN
chd-117	59	10	data	datum	NOUN
chd-117	59	11	were	be	AUX
chd-117	59	12	used	use	VERB
chd-117	59	13	for	for	ADP
chd-117	59	14	the	the	DET
chd-117	59	15	analysis	analysis	NOUN
chd-117	59	16	.	.	PUNCT
chd-117	60	1	no	no	DET
chd-117	60	2	differential	differential	ADJ
chd-117	60	3	gene	gene	NOUN
chd-117	60	4	expression	expression	NOUN
chd-117	60	5	analysis	analysis	NOUN
chd-117	60	6	,	,	PUNCT
chd-117	60	7	cuffdiff	cuffdiff	NOUN
chd-117	60	8	,	,	PUNCT
chd-117	60	9	was	be	AUX
chd-117	60	10	performed	perform	VERB
chd-117	60	11	and	and	CCONJ
chd-117	60	12	thus	thus	ADV
chd-117	60	13	no	no	DET
chd-117	60	14	log2	log2	NOUN
chd-117	60	15	(	(	PUNCT
chd-117	60	16	fold	fold	NOUN
chd-117	60	17	change	change	NOUN
chd-117	60	18	)	)	PUNCT
chd-117	60	19	values	value	NOUN
chd-117	60	20	were	be	AUX
chd-117	60	21	obtained	obtain	VERB
chd-117	60	22	.	.	PUNCT
chd-117	61	1	the	the	DET
chd-117	61	2	raw	raw	ADJ
chd-117	61	3	fpkm	fpkm	PROPN
chd-117	61	4	values	value	NOUN
chd-117	61	5	from	from	ADP
chd-117	61	6	cufflinks	cufflink	NOUN
chd-117	61	7	were	be	AUX
chd-117	61	8	converted	convert	VERB
chd-117	61	9	to	to	PART
chd-117	61	10	log	log	VERB
chd-117	61	11	scale	scale	NOUN
chd-117	61	12	for	for	ADP
chd-117	61	13	graphing	graph	VERB
chd-117	61	14	purposes	purpose	NOUN
chd-117	61	15	.	.	PUNCT
chd-117	62	1	statistical	statistical	ADJ
chd-117	62	2	analysis	analysis	NOUN
chd-117	62	3	demographic	demographic	ADJ
chd-117	62	4	characteristics	characteristic	NOUN
chd-117	62	5	and	and	CCONJ
chd-117	62	6	selected	select	VERB
chd-117	62	7	risk	risk	NOUN
chd-117	62	8	factors	factor	NOUN
chd-117	62	9	for	for	ADP
chd-117	62	10	breast	breast	NOUN
chd-117	62	11	cancer	cancer	NOUN
chd-117	62	12	were	be	AUX
chd-117	62	13	compared	compare	VERB
chd-117	62	14	between	between	ADP
chd-117	62	15	cases	case	NOUN
chd-117	62	16	and	and	CCONJ
chd-117	62	17	controls	control	NOUN
chd-117	62	18	using	use	VERB
chd-117	62	19	t	t	NOUN
chd-117	62	20	-	-	PUNCT
chd-117	62	21	tests	test	NOUN
chd-117	62	22	for	for	ADP
chd-117	62	23	continuous	continuous	ADJ
chd-117	62	24	variables	variable	NOUN
chd-117	62	25	and	and	CCONJ
chd-117	62	26	chi	chi	ADJ
chd-117	62	27	-	-	PUNCT
chd-117	62	28	square	square	ADJ
chd-117	62	29	tests	test	NOUN
chd-117	62	30	for	for	ADP
chd-117	62	31	categorical	categorical	ADJ
chd-117	62	32	data	datum	NOUN
chd-117	62	33	.	.	PUNCT
chd-117	63	1	data	datum	NOUN
chd-117	63	2	were	be	AUX
chd-117	63	3	expressed	express	VERB
chd-117	63	4	as	as	ADP
chd-117	63	5	the	the	DET
chd-117	63	6	mean	mean	PROPN
chd-117	63	7	±	±	NUM
chd-117	63	8	standard	standard	ADJ
chd-117	63	9	deviation	deviation	NOUN
chd-117	63	10	.	.	PUNCT
chd-117	64	1	ors	or	NOUN
chd-117	64	2	and	and	CCONJ
chd-117	64	3	95	95	NUM
chd-117	64	4	%	%	NOUN
chd-117	64	5	cis	cis	NOUN
chd-117	64	6	for	for	ADP
chd-117	64	7	breast	breast	NOUN
chd-117	64	8	cancer	cancer	NOUN
chd-117	64	9	were	be	AUX
chd-117	64	10	calculated	calculate	VERB
chd-117	64	11	from	from	ADP
chd-117	64	12	unconditional	unconditional	ADJ
chd-117	64	13	logistic	logistic	ADJ
chd-117	64	14	regression	regression	NOUN
chd-117	64	15	models	model	NOUN
chd-117	64	16	and	and	CCONJ
chd-117	64	17	used	use	VERB
chd-117	64	18	to	to	PART
chd-117	64	19	estimate	estimate	VERB
chd-117	64	20	relative	relative	ADJ
chd-117	64	21	risk	risk	NOUN
chd-117	64	22	.	.	PUNCT
chd-117	65	1	to	to	PART
chd-117	65	2	estimate	estimate	VERB
chd-117	65	3	the	the	DET
chd-117	65	4	allele	allele	NOUN
chd-117	65	5	frequencies	frequency	NOUN
chd-117	65	6	,	,	PUNCT
chd-117	65	7	data	datum	NOUN
chd-117	65	8	were	be	AUX
chd-117	65	9	analyzed	analyze	VERB
chd-117	65	10	using	use	VERB
chd-117	65	11	χ2	χ2	ADJ
chd-117	65	12	analysis	analysis	NOUN
chd-117	65	13	and	and	CCONJ
chd-117	65	14	two	two	NUM
chd-117	65	15	-	-	PUNCT
chd-117	65	16	tailed	tail	VERB
chd-117	65	17	fisher	fisher	NOUN
chd-117	65	18	’s	’s	PART
chd-117	65	19	exact	exact	ADJ
chd-117	65	20	test	test	NOUN
chd-117	65	21	.	.	PUNCT
chd-117	66	1	the	the	DET
chd-117	66	2	observed	observe	VERB
chd-117	66	3	genotype	genotype	NOUN
chd-117	66	4	frequencies	frequency	NOUN
chd-117	66	5	of	of	ADP
chd-117	66	6	ugt1a1	ugt1a1	NOUN
chd-117	66	7	were	be	AUX
chd-117	66	8	compared	compare	VERB
chd-117	66	9	with	with	ADP
chd-117	66	10	the	the	DET
chd-117	66	11	expected	expect	VERB
chd-117	66	12	frequencies	frequency	NOUN
chd-117	66	13	,	,	PUNCT
chd-117	66	14	according	accord	VERB
chd-117	66	15	to	to	ADP
chd-117	66	16	the	the	DET
chd-117	66	17	hardy	hardy	ADJ
chd-117	66	18	-	-	PUNCT
chd-117	66	19	weinberg	weinberg	NOUN
chd-117	66	20	equation	equation	NOUN
chd-117	66	21	.	.	PUNCT
chd-117	67	1	a	a	DET
chd-117	67	2	pvalue	pvalue	NOUN
chd-117	67	3	of	of	ADP
chd-117	67	4	<	<	NOUN
chd-117	67	5	0.05	0.05	NUM
chd-117	67	6	was	be	AUX
chd-117	67	7	considered	consider	VERB
chd-117	67	8	statistically	statistically	ADV
chd-117	67	9	significant	significant	ADJ
chd-117	67	10	.	.	PUNCT
chd-117	68	1	all	all	DET
chd-117	68	2	statistical	statistical	ADJ
chd-117	68	3	analyses	analysis	NOUN
chd-117	68	4	were	be	AUX
chd-117	68	5	performed	perform	VERB
chd-117	68	6	using	use	VERB
chd-117	68	7	graphpad	graphpad	NOUN
chd-117	68	8	prism	prism	NOUN
chd-117	68	9	,	,	PUNCT
chd-117	68	10	version	version	NOUN
chd-117	68	11	7	7	NUM
chd-117	68	12	software	software	NOUN
chd-117	68	13	(	(	PUNCT
chd-117	68	14	la	la	PROPN
chd-117	68	15	jolla	jolla	PROPN
chd-117	68	16	,	,	PUNCT
chd-117	68	17	ca	ca	NOUN
chd-117	68	18	)	)	PUNCT
chd-117	68	19	.	.	PUNCT
chd-117	69	1	results	result	NOUN
chd-117	69	2	participant	participant	ADJ
chd-117	69	3	characteristics	characteristic	NOUN
chd-117	69	4	this	this	DET
chd-117	69	5	study	study	NOUN
chd-117	69	6	was	be	AUX
chd-117	69	7	conducted	conduct	VERB
chd-117	69	8	on	on	ADP
chd-117	69	9	a	a	DET
chd-117	69	10	total	total	NOUN
chd-117	69	11	of	of	ADP
chd-117	69	12	352	352	NUM
chd-117	69	13	aa	aa	ADJ
chd-117	69	14	women	woman	NOUN
chd-117	69	15	participants	participant	NOUN
chd-117	69	16	,	,	PUNCT
chd-117	69	17	consisting	consist	VERB
chd-117	69	18	of	of	ADP
chd-117	69	19	82	82	NUM
chd-117	69	20	breast	breast	NOUN
chd-117	69	21	cancer	cancer	NOUN
chd-117	69	22	cases	case	NOUN
chd-117	69	23	and	and	CCONJ
chd-117	69	24	270	270	NUM
chd-117	69	25	healthy	healthy	ADJ
chd-117	69	26	women	woman	NOUN
chd-117	69	27	volunteers	volunteer	NOUN
chd-117	69	28	(	(	PUNCT
chd-117	69	29	table	table	NOUN
chd-117	69	30	1	1	NUM
chd-117	69	31	)	)	PUNCT
chd-117	69	32	.	.	PUNCT
chd-117	70	1	the	the	DET
chd-117	70	2	mean	mean	ADJ
chd-117	70	3	±	±	NOUN
chd-117	70	4	sd	sd	ADP
chd-117	70	5	age	age	NOUN
chd-117	70	6	of	of	ADP
chd-117	70	7	the	the	DET
chd-117	70	8	breast	breast	NOUN
chd-117	70	9	cancer	cancer	NOUN
chd-117	70	10	cases	case	NOUN
chd-117	70	11	and	and	CCONJ
chd-117	70	12	the	the	DET
chd-117	70	13	comparison	comparison	NOUN
chd-117	70	14	group	group	NOUN
chd-117	70	15	was	be	AUX
chd-117	70	16	54.5	54.5	NUM
chd-117	70	17	±	±	NUM
chd-117	70	18	13.8	13.8	NUM
chd-117	70	19	and	and	CCONJ
chd-117	70	20	48.2	48.2	NUM
chd-117	70	21	±	±	NUM
chd-117	70	22	13.8	13.8	NUM
chd-117	70	23	years	year	NOUN
chd-117	70	24	,	,	PUNCT
chd-117	70	25	respectively	respectively	ADV
chd-117	70	26	.	.	PUNCT
chd-117	71	1	the	the	DET
chd-117	71	2	minimum	minimum	ADJ
chd-117	71	3	and	and	CCONJ
chd-117	71	4	maximum	maximum	ADJ
chd-117	71	5	age	age	NOUN
chd-117	71	6	among	among	ADP
chd-117	71	7	breast	breast	NOUN
chd-117	71	8	cancer	cancer	NOUN
chd-117	71	9	cases	case	NOUN
chd-117	71	10	was	be	AUX
chd-117	71	11	20	20	NUM
chd-117	71	12	and	and	CCONJ
chd-117	71	13	88	88	NUM
chd-117	71	14	years	year	NOUN
chd-117	71	15	.	.	PUNCT
chd-117	72	1	the	the	DET
chd-117	72	2	minimum	minimum	ADJ
chd-117	72	3	and	and	CCONJ
chd-117	72	4	maximum	maximum	ADJ
chd-117	72	5	age	age	NOUN
chd-117	72	6	among	among	ADP
chd-117	72	7	healthy	healthy	ADJ
chd-117	72	8	volunteers	volunteer	NOUN
chd-117	72	9	was	be	AUX
chd-117	72	10	18	18	NUM
chd-117	72	11	and	and	CCONJ
chd-117	72	12	79	79	NUM
chd-117	72	13	years	year	NOUN
chd-117	72	14	.	.	PUNCT
chd-117	73	1	as	as	SCONJ
chd-117	73	2	can	can	AUX
chd-117	73	3	be	be	AUX
chd-117	73	4	seen	see	VERB
chd-117	73	5	from	from	ADP
chd-117	73	6	table	table	NOUN
chd-117	73	7	1	1	NUM
chd-117	73	8	,	,	PUNCT
chd-117	73	9	the	the	DET
chd-117	73	10	group	group	NOUN
chd-117	73	11	of	of	ADP
chd-117	73	12	breast	breast	NOUN
chd-117	73	13	cancer	cancer	NOUN
chd-117	73	14	patients	patient	NOUN
chd-117	73	15	was	be	AUX
chd-117	73	16	matched	match	VERB
chd-117	73	17	to	to	ADP
chd-117	73	18	the	the	DET
chd-117	73	19	control	control	NOUN
chd-117	73	20	group	group	NOUN
chd-117	73	21	on	on	ADP
chd-117	73	22	age	age	NOUN
chd-117	73	23	(	(	PUNCT
chd-117	73	24	p	p	X
chd-117	73	25	>	>	X
chd-117	73	26	0.05	0.05	NUM
chd-117	73	27	)	)	PUNCT
chd-117	73	28	.	.	PUNCT
chd-117	74	1	there	there	PRON
chd-117	74	2	was	be	VERB
chd-117	74	3	no	no	DET
chd-117	74	4	significant	significant	ADJ
chd-117	74	5	difference	difference	NOUN
chd-117	74	6	between	between	ADP
chd-117	74	7	cases	case	NOUN
chd-117	74	8	and	and	CCONJ
chd-117	74	9	controls	control	NOUN
chd-117	74	10	for	for	ADP
chd-117	74	11	body	body	NOUN
chd-117	74	12	mass	mass	NOUN
chd-117	74	13	index	index	NOUN
chd-117	74	14	(	(	PUNCT
chd-117	74	15	bmi	bmi	PROPN
chd-117	74	16	)	)	PUNCT
chd-117	74	17	,	,	PUNCT
chd-117	74	18	smoking	smoking	NOUN
chd-117	74	19	status	status	NOUN
chd-117	74	20	,	,	PUNCT
chd-117	74	21	alcohol	alcohol	NOUN
chd-117	74	22	consumption	consumption	NOUN
chd-117	74	23	,	,	PUNCT
chd-117	74	24	family	family	NOUN
chd-117	74	25	history	history	NOUN
chd-117	74	26	of	of	ADP
chd-117	74	27	cancer	cancer	NOUN
chd-117	74	28	or	or	CCONJ
chd-117	74	29	menopausal	menopausal	ADJ
chd-117	74	30	status	status	NOUN
chd-117	74	31	.	.	PUNCT
chd-117	75	1	the	the	DET
chd-117	75	2	majority	majority	NOUN
chd-117	75	3	of	of	ADP
chd-117	75	4	participants	participant	NOUN
chd-117	75	5	,	,	PUNCT
chd-117	75	6	both	both	DET
chd-117	75	7	cases	case	NOUN
chd-117	75	8	and	and	CCONJ
chd-117	75	9	controls	control	NOUN
chd-117	75	10	,	,	PUNCT
chd-117	75	11	in	in	ADP
chd-117	75	12	the	the	DET
chd-117	75	13	cohort	cohort	NOUN
chd-117	75	14	had	have	VERB
chd-117	75	15	a	a	DET
chd-117	75	16	bmi	bmi	NOUN
chd-117	75	17	greater	great	ADJ
chd-117	75	18	than	than	ADP
chd-117	75	19	30	30	NUM
chd-117	75	20	,	,	PUNCT
chd-117	75	21	did	do	AUX
chd-117	75	22	not	not	PART
chd-117	75	23	smoke	smoke	VERB
chd-117	75	24	,	,	PUNCT
chd-117	75	25	had	have	VERB
chd-117	75	26	a	a	DET
chd-117	75	27	family	family	NOUN
chd-117	75	28	history	history	NOUN
chd-117	75	29	of	of	ADP
chd-117	75	30	breast	breast	NOUN
chd-117	75	31	cancer	cancer	NOUN
chd-117	75	32	,	,	PUNCT
chd-117	75	33	or	or	CCONJ
chd-117	75	34	were	be	AUX
chd-117	75	35	postmenopausal	postmenopausal	ADJ
chd-117	75	36	.	.	PUNCT
chd-117	76	1	specifically	specifically	ADV
chd-117	76	2	,	,	PUNCT
chd-117	76	3	more	more	ADJ
chd-117	76	4	than	than	ADP
chd-117	76	5	90	90	NUM
chd-117	76	6	%	%	NOUN
chd-117	76	7	of	of	ADP
chd-117	76	8	cases	case	NOUN
chd-117	76	9	and	and	CCONJ
chd-117	76	10	89	89	NUM
chd-117	76	11	%	%	NOUN
chd-117	76	12	of	of	ADP
chd-117	76	13	controls	control	NOUN
chd-117	76	14	reported	report	VERB
chd-117	76	15	that	that	SCONJ
chd-117	76	16	they	they	PRON
chd-117	76	17	do	do	AUX
chd-117	76	18	not	not	PART
chd-117	76	19	smoke	smoke	VERB
chd-117	76	20	.	.	PUNCT
chd-117	77	1	however	however	ADV
chd-117	77	2	,	,	PUNCT
chd-117	77	3	more	more	ADJ
chd-117	77	4	than	than	ADP
chd-117	77	5	73	73	NUM
chd-117	77	6	%	%	NOUN
chd-117	77	7	of	of	ADP
chd-117	77	8	breast	breast	NOUN
chd-117	77	9	cancer	cancer	NOUN
chd-117	77	10	cases	case	NOUN
chd-117	77	11	reported	report	VERB
chd-117	77	12	that	that	SCONJ
chd-117	77	13	they	they	PRON
chd-117	77	14	do	do	AUX
chd-117	77	15	not	not	PART
chd-117	77	16	consume	consume	VERB
chd-117	77	17	alcoholic	alcoholic	ADJ
chd-117	77	18	beverages	beverage	NOUN
chd-117	77	19	while	while	SCONJ
chd-117	77	20	greater	great	ADJ
chd-117	77	21	than	than	ADP
chd-117	77	22	52	52	NUM
chd-117	77	23	%	%	NOUN
chd-117	77	24	of	of	ADP
chd-117	77	25	healthy	healthy	ADJ
chd-117	77	26	volunteers	volunteer	NOUN
chd-117	77	27	reported	report	VERB
chd-117	77	28	that	that	SCONJ
chd-117	77	29	they	they	PRON
chd-117	77	30	do	do	AUX
chd-117	77	31	consume	consume	VERB
chd-117	77	32	alcohol	alcohol	NOUN
chd-117	77	33	.	.	PUNCT
chd-117	78	1	overall	overall	ADJ
chd-117	78	2	,	,	PUNCT
chd-117	78	3	no	no	DET
chd-117	78	4	differences	difference	NOUN
chd-117	78	5	were	be	AUX
chd-117	78	6	found	find	VERB
chd-117	78	7	between	between	ADP
chd-117	78	8	the	the	DET
chd-117	78	9	groups	group	NOUN
chd-117	78	10	regarding	regard	VERB
chd-117	78	11	the	the	DET
chd-117	78	12	characteristics	characteristic	NOUN
chd-117	78	13	shown	show	VERB
chd-117	78	14	in	in	ADP
chd-117	78	15	table	table	NOUN
chd-117	78	16	1	1	NUM
chd-117	78	17	.	.	PUNCT
chd-117	78	18	table	table	NOUN
chd-117	78	19	1	1	NUM
chd-117	78	20	.	.	PUNCT
chd-117	79	1	characteristics	characteristic	NOUN
chd-117	79	2	of	of	ADP
chd-117	79	3	study	study	NOUN
chd-117	79	4	participants	participant	NOUN
chd-117	79	5	.	.	PUNCT
chd-117	80	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-117	80	2	e5	e5	PROPN
chd-117	80	3	cancer	cancer	NOUN
chd-117	80	4	health	health	NOUN
chd-117	80	5	disparities	disparity	NOUN
chd-117	80	6	research	research	VERB
chd-117	80	7	characteristic	characteristic	ADJ
chd-117	80	8	cases	case	NOUN
chd-117	80	9	(	(	PUNCT
chd-117	80	10	n	n	NOUN
chd-117	80	11	=	=	SYM
chd-117	80	12	82	82	NUM
chd-117	80	13	)	)	PUNCT
chd-117	80	14	a	a	DET
chd-117	80	15	controls	control	NOUN
chd-117	80	16	(	(	PUNCT
chd-117	80	17	n	n	NOUN
chd-117	80	18	=	=	SYM
chd-117	80	19	270	270	NUM
chd-117	80	20	)	)	PUNCT
chd-117	80	21	p	p	X
chd-117	80	22	-	-	PUNCT
chd-117	80	23	value	value	NOUN
chd-117	80	24	age	age	NOUN
chd-117	80	25	in	in	ADP
chd-117	80	26	years	year	NOUN
chd-117	80	27	,	,	PUNCT
chd-117	80	28	mean	mean	VERB
chd-117	80	29			PROPN
chd-117	80	30	sd	sd	ADP
chd-117	80	31	54.5	54.5	NUM
chd-117	80	32			PROPN
chd-117	80	33	13.8	13.8	NUM
chd-117	80	34	48.2	48.2	NUM
chd-117	81	1			PROPN
chd-117	81	2	13.8	13.8	NUM
chd-117	81	3	0.170	0.170	NUM
chd-117	81	4	minimum	minimum	NOUN
chd-117	81	5	20.0	20.0	NUM
chd-117	81	6	18.0	18.0	NUM
chd-117	81	7	25	25	NUM
chd-117	81	8	%	%	NOUN
chd-117	81	9	percentile	percentile	NOUN
chd-117	81	10	44.0	44.0	NUM
chd-117	81	11	38.0	38.0	NUM
chd-117	81	12	median	median	NOUN
chd-117	81	13	52.5	52.5	NUM
chd-117	81	14	50.0	50.0	NUM
chd-117	81	15	75	75	NUM
chd-117	81	16	%	%	NOUN
chd-117	81	17	percentile	percentile	VERB
chd-117	81	18	64.3	64.3	NUM
chd-117	81	19	58.0	58.0	NUM
chd-117	81	20	maximum	maximum	ADJ
chd-117	81	21	88.0	88.0	NUM
chd-117	81	22	79.0	79.0	NUM
chd-117	81	23	body	body	NOUN
chd-117	81	24	mass	mass	NOUN
chd-117	81	25	index	index	NOUN
chd-117	81	26	(	(	PUNCT
chd-117	81	27	bmi	bmi	PROPN
chd-117	81	28	)	)	PUNCT
chd-117	81	29	,	,	PUNCT
chd-117	81	30	n	n	PROPN
chd-117	81	31	(	(	PUNCT
chd-117	81	32	%	%	INTJ
chd-117	81	33	)	)	PUNCT
chd-117	81	34	0.920	0.920	NUM
chd-117	81	35	optimal	optimal	ADJ
chd-117	81	36	,	,	PUNCT
chd-117	81	37	bmi	bmi	PROPN
chd-117	81	38	18.5	18.5	NUM
chd-117	81	39	–	–	PUNCT
chd-117	81	40	25	25	NUM
chd-117	81	41	17	17	NUM
chd-117	81	42	(	(	PUNCT
chd-117	81	43	20.7	20.7	NUM
chd-117	81	44	)	)	PUNCT
chd-117	81	45	47	47	NUM
chd-117	81	46	(	(	PUNCT
chd-117	81	47	17.4	17.4	NUM
chd-117	81	48	)	)	PUNCT
chd-117	81	49	overweight	overweight	NOUN
chd-117	81	50	,	,	PUNCT
chd-117	81	51	bmi	bmi	VERB
chd-117	81	52	25	25	NUM
chd-117	81	53	-	-	SYM
chd-117	81	54	30	30	NUM
chd-117	81	55	21	21	NUM
chd-117	81	56	(	(	PUNCT
chd-117	81	57	25.6	25.6	NUM
chd-117	81	58	)	)	PUNCT
chd-117	81	59	75	75	NUM
chd-117	81	60	(	(	PUNCT
chd-117	81	61	27.8	27.8	NUM
chd-117	81	62	)	)	PUNCT
chd-117	81	63	obese	obese	NOUN
chd-117	81	64	,	,	PUNCT
chd-117	81	65	bmi	bmi	X
chd-117	81	66	>	>	X
chd-117	81	67	30	30	NUM
chd-117	81	68	43	43	NUM
chd-117	81	69	(	(	PUNCT
chd-117	81	70	52.4	52.4	NUM
chd-117	81	71	)	)	PUNCT
chd-117	81	72	146	146	NUM
chd-117	81	73	(	(	PUNCT
chd-117	81	74	54.1	54.1	NUM
chd-117	81	75	)	)	PUNCT
chd-117	81	76	missing	miss	VERB
chd-117	81	77	1	1	NUM
chd-117	81	78	2	2	NUM
chd-117	81	79	smoking	smoking	NOUN
chd-117	81	80	status	status	NOUN
chd-117	81	81	,	,	PUNCT
chd-117	81	82	n	n	PROPN
chd-117	81	83	(	(	PUNCT
chd-117	81	84	%	%	INTJ
chd-117	81	85	)	)	PUNCT
chd-117	81	86	0.886	0.886	NUM
chd-117	82	1	yes	yes	NOUN
chd-117	82	2	3	3	NUM
chd-117	82	3	(	(	PUNCT
chd-117	82	4	3.66	3.66	NUM
chd-117	82	5	)	)	PUNCT
chd-117	82	6	23	23	NUM
chd-117	82	7	(	(	PUNCT
chd-117	82	8	8.52	8.52	NUM
chd-117	82	9	)	)	PUNCT
chd-117	82	10	no	no	DET
chd-117	82	11	79	79	NUM
chd-117	82	12	(	(	PUNCT
chd-117	82	13	96.3	96.3	NUM
chd-117	82	14	)	)	PUNCT
chd-117	82	15	241	241	NUM
chd-117	82	16	(	(	PUNCT
chd-117	82	17	89.3	89.3	NUM
chd-117	82	18	)	)	PUNCT
chd-117	82	19	missing	miss	VERB
chd-117	82	20	0	0	NUM
chd-117	82	21	6	6	NUM
chd-117	82	22	alcohol	alcohol	NOUN
chd-117	82	23	consumption	consumption	NOUN
chd-117	82	24	,	,	PUNCT
chd-117	82	25	n	n	CCONJ
chd-117	82	26	(	(	PUNCT
chd-117	82	27	%	%	INTJ
chd-117	82	28	)	)	PUNCT
chd-117	82	29	0.965	0.965	NUM
chd-117	83	1	yes	yes	INTJ
chd-117	83	2	22	22	NUM
chd-117	83	3	(	(	PUNCT
chd-117	83	4	26.8	26.8	NUM
chd-117	83	5	)	)	SYM
chd-117	83	6	141	141	NUM
chd-117	83	7	(	(	PUNCT
chd-117	83	8	52.2	52.2	NUM
chd-117	83	9	)	)	PUNCT
chd-117	83	10	no	no	DET
chd-117	83	11	60	60	NUM
chd-117	83	12	(	(	PUNCT
chd-117	83	13	73.2	73.2	NUM
chd-117	83	14	)	)	PUNCT
chd-117	83	15	121	121	NUM
chd-117	83	16	(	(	PUNCT
chd-117	83	17	44.8	44.8	NUM
chd-117	83	18	)	)	PUNCT
chd-117	83	19	missing	miss	VERB
chd-117	83	20	0	0	NUM
chd-117	83	21	8	8	NUM
chd-117	83	22	family	family	NOUN
chd-117	83	23	history	history	NOUN
chd-117	83	24	of	of	ADP
chd-117	83	25	cancer	cancer	NOUN
chd-117	83	26	,	,	PUNCT
chd-117	83	27	n	n	PROPN
chd-117	83	28	(	(	PUNCT
chd-117	83	29	%	%	INTJ
chd-117	83	30	)	)	PUNCT
chd-117	83	31	0.958	0.958	NUM
chd-117	84	1	yes	yes	NOUN
chd-117	84	2	52	52	NUM
chd-117	84	3	(	(	PUNCT
chd-117	84	4	63.4	63.4	NUM
chd-117	84	5	)	)	SYM
chd-117	84	6	141	141	NUM
chd-117	84	7	(	(	PUNCT
chd-117	84	8	52.2	52.2	NUM
chd-117	84	9	)	)	PUNCT
chd-117	84	10	no	no	DET
chd-117	84	11	29	29	NUM
chd-117	84	12	(	(	PUNCT
chd-117	84	13	35.4	35.4	NUM
chd-117	84	14	)	)	PUNCT
chd-117	84	15	122	122	NUM
chd-117	84	16	(	(	PUNCT
chd-117	84	17	45.2	45.2	NUM
chd-117	84	18	)	)	PUNCT
chd-117	84	19	missing	miss	VERB
chd-117	84	20	1	1	NUM
chd-117	84	21	5	5	NUM
chd-117	84	22	menopause	menopause	NOUN
chd-117	84	23	status	status	NOUN
chd-117	84	24	,	,	PUNCT
chd-117	84	25	n	n	PROPN
chd-117	84	26	(	(	PUNCT
chd-117	84	27	%	%	INTJ
chd-117	84	28	)	)	PUNCT
chd-117	84	29	>	>	PUNCT
chd-117	84	30	0.999	0.999	NUM
chd-117	84	31	pre	pre	ADJ
chd-117	84	32	-	-	ADJ
chd-117	84	33	menopausal	menopausal	ADJ
chd-117	84	34	36	36	NUM
chd-117	84	35	(	(	PUNCT
chd-117	84	36	43.9	43.9	NUM
chd-117	84	37	)	)	PUNCT
chd-117	84	38	132	132	NUM
chd-117	84	39	(	(	PUNCT
chd-117	84	40	48.9	48.9	NUM
chd-117	84	41	)	)	PUNCT
chd-117	84	42	post	post	ADJ
chd-117	84	43	-	-	ADJ
chd-117	84	44	menopausal	menopausal	ADJ
chd-117	84	45	46	46	NUM
chd-117	84	46	(	(	PUNCT
chd-117	84	47	56.1	56.1	NUM
chd-117	84	48	)	)	PUNCT
chd-117	84	49	138	138	NUM
chd-117	84	50	(	(	PUNCT
chd-117	84	51	51.1	51.1	NUM
chd-117	84	52	)	)	PUNCT
chd-117	84	53	distribution	distribution	NOUN
chd-117	84	54	of	of	ADP
chd-117	84	55	ugt1a1	ugt1a1	ADJ
chd-117	84	56	allele	allele	NOUN
chd-117	84	57	and	and	CCONJ
chd-117	84	58	genotype	genotype	NOUN
chd-117	84	59	frequencies	frequency	NOUN
chd-117	84	60	in	in	ADP
chd-117	84	61	our	our	PRON
chd-117	84	62	study	study	NOUN
chd-117	84	63	population	population	NOUN
chd-117	84	64	results	result	NOUN
chd-117	84	65	of	of	ADP
chd-117	84	66	genotyping	genotype	VERB
chd-117	84	67	analysis	analysis	NOUN
chd-117	84	68	for	for	ADP
chd-117	84	69	the	the	DET
chd-117	84	70	ugt1a1	ugt1a1	ADJ
chd-117	84	71	promoter	promoter	PROPN
chd-117	84	72	tata	tata	PROPN
chd-117	84	73	box	box	PROPN
chd-117	84	74	variants	variant	NOUN
chd-117	84	75	among	among	ADP
chd-117	84	76	breast	breast	NOUN
chd-117	84	77	cancer	cancer	NOUN
chd-117	84	78	cases	case	NOUN
chd-117	84	79	and	and	CCONJ
chd-117	84	80	controls	control	NOUN
chd-117	84	81	in	in	ADP
chd-117	84	82	our	our	PRON
chd-117	84	83	study	study	NOUN
chd-117	84	84	population	population	NOUN
chd-117	84	85	are	be	AUX
chd-117	84	86	presented	present	VERB
chd-117	84	87	in	in	ADP
chd-117	84	88	table	table	NOUN
chd-117	84	89	2	2	NUM
chd-117	84	90	.	.	PUNCT
chd-117	85	1	the	the	DET
chd-117	85	2	number	number	NOUN
chd-117	85	3	of	of	ADP
chd-117	85	4	(	(	PUNCT
chd-117	85	5	ta	ta	NOUN
chd-117	85	6	)	)	PUNCT
chd-117	85	7	repeats	repeat	NOUN
chd-117	85	8	in	in	ADP
chd-117	85	9	the	the	DET
chd-117	85	10	ugt1a1	ugt1a1	ADJ
chd-117	85	11	promoter	promoter	PROPN
chd-117	85	12	tata	tata	PROPN
chd-117	85	13	box	box	PROPN
chd-117	85	14	included	include	VERB
chd-117	85	15	5ta	5ta	NOUN
chd-117	85	16	,	,	PUNCT
chd-117	85	17	6ta	6ta	ADJ
chd-117	85	18	,	,	PUNCT
chd-117	85	19	7ta	7ta	ADJ
chd-117	85	20	and	and	CCONJ
chd-117	85	21	8ta	8ta	ADV
chd-117	85	22	.	.	PUNCT
chd-117	86	1	the	the	DET
chd-117	86	2	normal	normal	ADJ
chd-117	86	3	or	or	CCONJ
chd-117	86	4	wild	wild	ADJ
chd-117	86	5	-	-	PUNCT
chd-117	86	6	type	type	NOUN
chd-117	86	7	allele	allele	NOUN
chd-117	86	8	is	be	AUX
chd-117	86	9	characterized	characterize	VERB
chd-117	86	10	by	by	ADP
chd-117	86	11	6	6	NUM
chd-117	86	12	ta	ta	NOUN
chd-117	86	13	repeats	repeat	NOUN
chd-117	86	14	,	,	PUNCT
chd-117	86	15	while	while	SCONJ
chd-117	86	16	5ta	5ta	ADJ
chd-117	86	17	,	,	PUNCT
chd-117	86	18	7ta	7ta	ADJ
chd-117	86	19	,	,	PUNCT
chd-117	86	20	and	and	CCONJ
chd-117	86	21	8ta	8ta	ADJ
chd-117	86	22	repeats	repeat	NOUN
chd-117	86	23	are	be	AUX
chd-117	86	24	variants	variant	NOUN
chd-117	86	25	.	.	PUNCT
chd-117	87	1	the	the	DET
chd-117	87	2	polymorphism	polymorphism	NOUN
chd-117	87	3	with	with	ADP
chd-117	87	4	the	the	DET
chd-117	87	5	highest	high	ADJ
chd-117	87	6	allele	allele	NOUN
chd-117	87	7	frequency	frequency	NOUN
chd-117	87	8	among	among	ADP
chd-117	87	9	breast	breast	NOUN
chd-117	87	10	cancer	cancer	NOUN
chd-117	87	11	cases	case	NOUN
chd-117	87	12	was	be	AUX
chd-117	87	13	7ta	7ta	ADJ
chd-117	87	14	(	(	PUNCT
chd-117	87	15	ugt1a1	ugt1a1	NOUN
chd-117	87	16	*	*	NOUN
chd-117	87	17	28	28	NUM
chd-117	87	18	)	)	PUNCT
chd-117	87	19	at	at	ADP
chd-117	87	20	43	43	NUM
chd-117	87	21	%	%	NOUN
chd-117	87	22	.	.	PUNCT
chd-117	88	1	however	however	ADV
chd-117	88	2	,	,	PUNCT
chd-117	88	3	among	among	ADP
chd-117	88	4	controls	control	NOUN
chd-117	88	5	the	the	DET
chd-117	88	6	normal	normal	ADJ
chd-117	88	7	or	or	CCONJ
chd-117	88	8	wild	wild	ADJ
chd-117	88	9	-	-	PUNCT
chd-117	88	10	type	type	NOUN
chd-117	88	11	allele	allele	NOUN
chd-117	88	12	,	,	PUNCT
chd-117	88	13	consisting	consist	VERB
chd-117	88	14	of	of	ADP
chd-117	88	15	6ta	6ta	NOUN
chd-117	88	16	,	,	PUNCT
chd-117	88	17	was	be	AUX
chd-117	88	18	most	most	ADV
chd-117	88	19	common	common	ADJ
chd-117	88	20	at	at	ADP
chd-117	88	21	47	47	NUM
chd-117	88	22	%	%	NOUN
chd-117	88	23	.	.	PUNCT
chd-117	89	1	the	the	DET
chd-117	89	2	allele	allele	NOUN
chd-117	89	3	frequency	frequency	NOUN
chd-117	89	4	of	of	ADP
chd-117	89	5	the	the	DET
chd-117	89	6	ugt1a1	ugt1a1	NOUN
chd-117	89	7	*	*	NUM
chd-117	89	8	36	36	NUM
chd-117	89	9	(	(	PUNCT
chd-117	89	10	5ta	5ta	ADJ
chd-117	89	11	)	)	PUNCT
chd-117	89	12	and	and	CCONJ
chd-117	89	13	ugt1a1	ugt1a1	NOUN
chd-117	89	14	*	*	PROPN
chd-117	89	15	37	37	NUM
chd-117	89	16	(	(	PUNCT
chd-117	89	17	8ta	8ta	ADV
chd-117	89	18	)	)	PUNCT
chd-117	89	19	was	be	AUX
chd-117	89	20	least	least	ADV
chd-117	89	21	common	common	ADJ
chd-117	89	22	among	among	ADP
chd-117	89	23	both	both	DET
chd-117	89	24	breast	breast	NOUN
chd-117	89	25	cancer	cancer	NOUN
chd-117	89	26	cases	case	NOUN
chd-117	89	27	and	and	CCONJ
chd-117	89	28	controls	control	NOUN
chd-117	89	29	.	.	PUNCT
chd-117	90	1	table	table	NOUN
chd-117	90	2	2	2	NUM
chd-117	90	3	also	also	ADV
chd-117	90	4	shows	show	VERB
chd-117	90	5	the	the	DET
chd-117	90	6	ugt1a1	ugt1a1	NOUN
chd-117	90	7	(	(	PUNCT
chd-117	90	8	ta	ta	NOUN
chd-117	90	9	)	)	PUNCT
chd-117	90	10	genotype	genotype	NOUN
chd-117	90	11	frequencies	frequency	NOUN
chd-117	90	12	.	.	PUNCT
chd-117	91	1	the	the	DET
chd-117	91	2	7/7	7/7	NUM
chd-117	91	3	homozygous	homozygous	ADJ
chd-117	91	4	genotype	genotype	NOUN
chd-117	91	5	of	of	ADP
chd-117	91	6	the	the	DET
chd-117	91	7	ugt1a1	ugt1a1	ADJ
chd-117	91	8	gene	gene	NOUN
chd-117	91	9	(	(	PUNCT
chd-117	91	10	ugt1a1	ugt1a1	NOUN
chd-117	91	11	*	*	ADJ
chd-117	91	12	28	28	NUM
chd-117	91	13	)	)	PUNCT
chd-117	91	14	was	be	AUX
chd-117	91	15	identified	identify	VERB
chd-117	91	16	in	in	ADP
chd-117	91	17	17.8	17.8	NUM
chd-117	91	18	%	%	NOUN
chd-117	91	19	of	of	ADP
chd-117	91	20	breast	breast	NOUN
chd-117	91	21	cancer	cancer	NOUN
chd-117	91	22	cases	case	NOUN
chd-117	91	23	and	and	CCONJ
chd-117	91	24	17.1	17.1	NUM
chd-117	91	25	%	%	NOUN
chd-117	91	26	of	of	ADP
chd-117	91	27	controls	control	NOUN
chd-117	91	28	.	.	PUNCT
chd-117	92	1	the	the	DET
chd-117	92	2	6/7	6/7	NUM
chd-117	92	3	heterozygous	heterozygous	ADJ
chd-117	92	4	genotype	genotype	NOUN
chd-117	92	5	was	be	AUX
chd-117	92	6	the	the	DET
chd-117	92	7	most	most	ADV
chd-117	92	8	prevalent	prevalent	ADJ
chd-117	92	9	in	in	ADP
chd-117	92	10	both	both	DET
chd-117	92	11	breast	breast	NOUN
chd-117	92	12	cancer	cancer	NOUN
chd-117	92	13	cases	case	NOUN
chd-117	92	14	(	(	PUNCT
chd-117	92	15	35.6	35.6	NUM
chd-117	92	16	%	%	NOUN
chd-117	92	17	)	)	PUNCT
chd-117	92	18	and	and	CCONJ
chd-117	92	19	controls	control	NOUN
chd-117	92	20	(	(	PUNCT
chd-117	92	21	34.1	34.1	NUM
chd-117	92	22	%	%	NOUN
chd-117	92	23	)	)	PUNCT
chd-117	92	24	.	.	PUNCT
chd-117	93	1	there	there	PRON
chd-117	93	2	was	be	VERB
chd-117	93	3	no	no	DET
chd-117	93	4	departure	departure	NOUN
chd-117	93	5	from	from	ADP
chd-117	93	6	hardy	hardy	ADJ
chd-117	93	7	-	-	PUNCT
chd-117	93	8	weinberg	weinberg	NOUN
chd-117	93	9	equilibrium	equilibrium	NOUN
chd-117	93	10	and	and	CCONJ
chd-117	93	11	no	no	DET
chd-117	93	12	significant	significant	ADJ
chd-117	93	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-117	93	14	e6	e6	VERB
chd-117	93	15	cancer	cancer	NOUN
chd-117	93	16	health	health	NOUN
chd-117	93	17	disparities	disparity	NOUN
chd-117	93	18	research	research	NOUN
chd-117	93	19	association	association	NOUN
chd-117	93	20	in	in	ADP
chd-117	93	21	allele	allele	NOUN
chd-117	93	22	and	and	CCONJ
chd-117	93	23	genotype	genotype	NOUN
chd-117	93	24	frequencies	frequency	NOUN
chd-117	93	25	between	between	ADP
chd-117	93	26	cases	case	NOUN
chd-117	93	27	and	and	CCONJ
chd-117	93	28	controls	control	NOUN
chd-117	93	29	(	(	PUNCT
chd-117	93	30	χ2	χ2	NOUN
chd-117	93	31	test	test	NOUN
chd-117	93	32	,	,	PUNCT
chd-117	93	33	p>0.05	p>0.05	PROPN
chd-117	93	34	)	)	PUNCT
chd-117	93	35	.	.	PUNCT
chd-117	94	1	the	the	DET
chd-117	94	2	frequency	frequency	NOUN
chd-117	94	3	distribution	distribution	NOUN
chd-117	94	4	of	of	ADP
chd-117	94	5	the	the	DET
chd-117	94	6	ugt1a1	ugt1a1	ADJ
chd-117	94	7	promoter	promoter	NOUN
chd-117	94	8	variants	variant	NOUN
chd-117	94	9	in	in	ADP
chd-117	94	10	our	our	PRON
chd-117	94	11	population	population	NOUN
chd-117	94	12	and	and	CCONJ
chd-117	94	13	the	the	DET
chd-117	94	14	dna	dna	PROPN
chd-117	94	15	sequence	sequence	NOUN
chd-117	94	16	lengths	length	NOUN
chd-117	94	17	of	of	ADP
chd-117	94	18	the	the	DET
chd-117	94	19	promoter	promoter	NOUN
chd-117	94	20	variants	variant	NOUN
chd-117	94	21	are	be	AUX
chd-117	94	22	shown	show	VERB
chd-117	94	23	in	in	ADP
chd-117	94	24	supplementary	supplementary	ADJ
chd-117	94	25	figure	figure	NOUN
chd-117	94	26	1	1	NUM
chd-117	94	27	.	.	PUNCT
chd-117	94	28	table	table	NOUN
chd-117	94	29	2	2	NUM
chd-117	94	30	.	.	PUNCT
chd-117	94	31	ugt1a1	ugt1a1	ADJ
chd-117	94	32	promoter	promoter	NOUN
chd-117	94	33	allele	allele	NOUN
chd-117	94	34	and	and	CCONJ
chd-117	94	35	genotype	genotype	NOUN
chd-117	94	36	frequencies	frequency	NOUN
chd-117	94	37	of	of	ADP
chd-117	94	38	study	study	NOUN
chd-117	94	39	population	population	NOUN
chd-117	94	40	.	.	PUNCT
chd-117	95	1	allele	allele	NOUN
chd-117	95	2	a	a	DET
chd-117	95	3	cases	case	NOUN
chd-117	95	4	b	b	NOUN
chd-117	95	5	controls	control	NOUN
chd-117	95	6	b	b	PROPN
chd-117	95	7	p	p	NOUN
chd-117	95	8	-	-	PUNCT
chd-117	95	9	value	value	NOUN
chd-117	95	10	5	5	NUM
chd-117	95	11	0.07	0.07	NUM
chd-117	95	12	0.10	0.10	NUM
chd-117	95	13	0.33	0.33	NUM
chd-117	95	14	6	6	NUM
chd-117	95	15	0.42	0.42	NUM
chd-117	95	16	0.47	0.47	NUM
chd-117	95	17	7	7	NUM
chd-117	95	18	0.43	0.43	NUM
chd-117	95	19	0.40	0.40	NUM
chd-117	95	20	8	8	NUM
chd-117	95	21	0.08	0.08	NUM
chd-117	95	22	0.03	0.03	NUM
chd-117	95	23	genotype	genotype	NOUN
chd-117	95	24	c	c	NOUN
chd-117	95	25	cases	case	NOUN
chd-117	95	26	,	,	PUNCT
chd-117	95	27	n	n	CCONJ
chd-117	95	28	(	(	PUNCT
chd-117	95	29	%	%	INTJ
chd-117	95	30	)	)	PUNCT
chd-117	96	1	d	d	NOUN
chd-117	96	2	controls	control	NOUN
chd-117	96	3	,	,	PUNCT
chd-117	96	4	n	n	CCONJ
chd-117	96	5	(	(	PUNCT
chd-117	96	6	%	%	INTJ
chd-117	96	7	)	)	PUNCT
chd-117	97	1	d	d	NOUN
chd-117	97	2	5/5	5/5	NUM
chd-117	97	3	4	4	NUM
chd-117	97	4	(	(	PUNCT
chd-117	97	5	5.48	5.48	NUM
chd-117	97	6	)	)	PUNCT
chd-117	97	7	7	7	NUM
chd-117	97	8	(	(	PUNCT
chd-117	97	9	2.78	2.78	NUM
chd-117	97	10	)	)	PUNCT
chd-117	97	11	0.63	0.63	NUM
chd-117	97	12	5/6	5/6	NUM
chd-117	97	13	2	2	NUM
chd-117	97	14	(	(	PUNCT
chd-117	97	15	2.74	2.74	NUM
chd-117	97	16	)	)	PUNCT
chd-117	97	17	17	17	NUM
chd-117	97	18	(	(	PUNCT
chd-117	97	19	6.75	6.75	NUM
chd-117	97	20	)	)	PUNCT
chd-117	97	21	6/6	6/6	NUM
chd-117	97	22	17	17	NUM
chd-117	97	23	(	(	PUNCT
chd-117	97	24	23.3	23.3	NUM
chd-117	97	25	)	)	PUNCT
chd-117	97	26	68	68	NUM
chd-117	97	27	(	(	PUNCT
chd-117	97	28	27.0	27.0	NUM
chd-117	97	29	)	)	PUNCT
chd-117	97	30	6/7	6/7	NUM
chd-117	97	31	26	26	NUM
chd-117	97	32	(	(	PUNCT
chd-117	97	33	35.6	35.6	NUM
chd-117	97	34	)	)	PUNCT
chd-117	97	35	86	86	NUM
chd-117	97	36	(	(	PUNCT
chd-117	97	37	34.1	34.1	NUM
chd-117	97	38	)	)	PUNCT
chd-117	97	39	7/7	7/7	NUM
chd-117	97	40	13	13	NUM
chd-117	97	41	(	(	PUNCT
chd-117	97	42	17.8	17.8	NUM
chd-117	97	43	)	)	PUNCT
chd-117	97	44	43	43	NUM
chd-117	97	45	(	(	PUNCT
chd-117	97	46	17.1	17.1	NUM
chd-117	97	47	)	)	PUNCT
chd-117	97	48	7/8	7/8	NUM
chd-117	97	49	7	7	NUM
chd-117	97	50	(	(	PUNCT
chd-117	97	51	15.1	15.1	NUM
chd-117	97	52	)	)	PUNCT
chd-117	97	53	31	31	NUM
chd-117	97	54	(	(	PUNCT
chd-117	97	55	12.3	12.3	NUM
chd-117	97	56	)	)	PUNCT
chd-117	97	57	8/8	8/8	NUM
chd-117	97	58	0	0	NUM
chd-117	97	59	(	(	PUNCT
chd-117	97	60	0	0	NUM
chd-117	97	61	)	)	PUNCT
chd-117	97	62	0	0	NUM
chd-117	97	63	(	(	PUNCT
chd-117	97	64	0	0	NUM
chd-117	97	65	)	)	PUNCT
chd-117	97	66	adapted	adapt	VERB
chd-117	97	67	from	from	ADP
chd-117	97	68	guillemette	guillemette	PROPN
chd-117	97	69	et	et	PROPN
chd-117	97	70	al	al	PROPN
chd-117	97	71	,	,	PUNCT
chd-117	97	72	2000	2000	NUM
chd-117	97	73	(	(	PUNCT
chd-117	97	74	guillemette	guillemette	NOUN
chd-117	97	75	et	et	PROPN
chd-117	97	76	al	al	PROPN
chd-117	97	77	.	.	PROPN
chd-117	97	78	,	,	PUNCT
chd-117	97	79	2001	2001	NUM
chd-117	97	80	)	)	PUNCT
chd-117	97	81	a	a	DET
chd-117	97	82	2	2	PROPN
chd-117	97	83	test	test	NOUN
chd-117	97	84	comparing	compare	VERB
chd-117	97	85	distribution	distribution	NOUN
chd-117	97	86	in	in	ADP
chd-117	97	87	cases	case	NOUN
chd-117	97	88	versus	versus	ADP
chd-117	97	89	controls	control	NOUN
chd-117	97	90	for	for	ADP
chd-117	97	91	trend	trend	NOUN
chd-117	97	92	:	:	PUNCT
chd-117	97	93	p	p	X
chd-117	97	94	=	=	NOUN
chd-117	97	95	0.33	0.33	NUM
chd-117	97	96	b	b	NOUN
chd-117	97	97	number	number	NOUN
chd-117	97	98	of	of	ADP
chd-117	97	99	alleles	allele	NOUN
chd-117	97	100	/	/	SYM
chd-117	97	101	number	number	NOUN
chd-117	97	102	of	of	ADP
chd-117	97	103	chromosomes	chromosome	NOUN
chd-117	97	104	(	(	PUNCT
chd-117	97	105	unweighted	unweighted	ADJ
chd-117	97	106	)	)	PUNCT
chd-117	97	107	c	c	NOUN
chd-117	98	1	2	2	NOUN
chd-117	98	2	test	test	NOUN
chd-117	98	3	comparing	compare	VERB
chd-117	98	4	distribution	distribution	NOUN
chd-117	98	5	in	in	ADP
chd-117	98	6	cases	case	NOUN
chd-117	98	7	versus	versus	ADP
chd-117	98	8	controls	control	NOUN
chd-117	98	9	for	for	ADP
chd-117	98	10	trend	trend	NOUN
chd-117	98	11	:	:	PUNCT
chd-117	98	12	p	p	X
chd-117	98	13	=	=	PUNCT
chd-117	99	1	0.63	0.63	NUM
chd-117	99	2	d	d	NOUN
chd-117	99	3	number	number	NOUN
chd-117	99	4	of	of	ADP
chd-117	99	5	participants	participant	NOUN
chd-117	99	6	with	with	ADP
chd-117	99	7	genotype	genotype	NOUN
chd-117	99	8	/	/	SYM
chd-117	99	9	total	total	ADJ
chd-117	99	10	participants	participant	NOUN
chd-117	99	11	(	(	PUNCT
chd-117	99	12	unweighted	unweighted	ADJ
chd-117	99	13	)	)	PUNCT
chd-117	99	14	association	association	NOUN
chd-117	99	15	between	between	ADP
chd-117	99	16	ugt1a1	ugt1a1	ADJ
chd-117	99	17	genotypes	genotype	NOUN
chd-117	99	18	and	and	CCONJ
chd-117	99	19	obesity	obesity	NOUN
chd-117	99	20	and	and	CCONJ
chd-117	99	21	menopausal	menopausal	ADJ
chd-117	99	22	status	status	NOUN
chd-117	99	23	we	we	PRON
chd-117	99	24	further	far	ADV
chd-117	99	25	determined	determine	VERB
chd-117	99	26	the	the	DET
chd-117	99	27	effect	effect	NOUN
chd-117	99	28	of	of	ADP
chd-117	99	29	ugt1a1	ugt1a1	ADJ
chd-117	99	30	genotypes	genotype	NOUN
chd-117	99	31	on	on	ADP
chd-117	99	32	menopausal	menopausal	ADJ
chd-117	99	33	status	status	NOUN
chd-117	99	34	and	and	CCONJ
chd-117	99	35	obesity	obesity	NOUN
chd-117	99	36	status	status	NOUN
chd-117	99	37	using	use	VERB
chd-117	99	38	odds	odd	NOUN
chd-117	99	39	ratios	ratio	NOUN
chd-117	99	40	(	(	PUNCT
chd-117	99	41	ors	or	NOUN
chd-117	99	42	)	)	PUNCT
chd-117	99	43	(	(	PUNCT
chd-117	99	44	table	table	NOUN
chd-117	99	45	3	3	NUM
chd-117	99	46	)	)	PUNCT
chd-117	99	47	.	.	PUNCT
chd-117	100	1	participants	participant	NOUN
chd-117	100	2	were	be	AUX
chd-117	100	3	divided	divide	VERB
chd-117	100	4	into	into	ADP
chd-117	100	5	two	two	NUM
chd-117	100	6	categories	category	NOUN
chd-117	100	7	based	base	VERB
chd-117	100	8	on	on	ADP
chd-117	100	9	ugt1a1	ugt1a1	ADJ
chd-117	100	10	promoter	promoter	NOUN
chd-117	100	11	activity	activity	NOUN
chd-117	100	12	.	.	PUNCT
chd-117	101	1	participants	participant	NOUN
chd-117	101	2	with	with	ADP
chd-117	101	3	high	high	ADJ
chd-117	101	4	ugt1a1	ugt1a1	NOUN
chd-117	101	5	(	(	PUNCT
chd-117	101	6	ta	ta	NOUN
chd-117	101	7	)	)	PUNCT
chd-117	101	8	activity	activity	NOUN
chd-117	101	9	alleles	allele	NOUN
chd-117	101	10	carried	carry	VERB
chd-117	101	11	5/5	5/5	NUM
chd-117	101	12	,	,	PUNCT
chd-117	101	13	5/6	5/6	NUM
chd-117	101	14	,	,	PUNCT
chd-117	101	15	and	and	CCONJ
chd-117	101	16	6/6	6/6	NUM
chd-117	101	17	ta	ta	ADP
chd-117	101	18	repeats	repeat	NOUN
chd-117	101	19	and	and	CCONJ
chd-117	101	20	those	those	PRON
chd-117	101	21	considered	consider	VERB
chd-117	101	22	to	to	PART
chd-117	101	23	have	have	VERB
chd-117	101	24	low	low	ADJ
chd-117	101	25	activity	activity	NOUN
chd-117	101	26	alleles	allele	NOUN
chd-117	101	27	had	have	VERB
chd-117	101	28	the	the	DET
chd-117	101	29	presence	presence	NOUN
chd-117	101	30	of	of	ADP
chd-117	101	31	6/7	6/7	NUM
chd-117	101	32	,	,	PUNCT
chd-117	101	33	7/7	7/7	NUM
chd-117	101	34	or	or	CCONJ
chd-117	101	35	7/8	7/8	NUM
chd-117	101	36	ta	ta	NOUN
chd-117	101	37	repeats	repeat	NOUN
chd-117	101	38	.	.	PUNCT
chd-117	102	1	all	all	DET
chd-117	102	2	comparisons	comparison	NOUN
chd-117	102	3	were	be	AUX
chd-117	102	4	achieved	achieve	VERB
chd-117	102	5	with	with	ADP
chd-117	102	6	the	the	DET
chd-117	102	7	reference	reference	NOUN
chd-117	102	8	group	group	NOUN
chd-117	102	9	including	include	VERB
chd-117	102	10	5	5	NUM
chd-117	102	11	or	or	CCONJ
chd-117	102	12	6	6	NUM
chd-117	102	13	allele	allele	NOUN
chd-117	102	14	-	-	PUNCT
chd-117	102	15	containing	contain	VERB
chd-117	102	16	genotypes	genotype	NOUN
chd-117	102	17	(	(	PUNCT
chd-117	102	18	5/5	5/5	NUM
chd-117	102	19	,	,	PUNCT
chd-117	102	20	5/6	5/6	NUM
chd-117	102	21	,	,	PUNCT
chd-117	102	22	and	and	CCONJ
chd-117	102	23	6/6	6/6	NUM
chd-117	102	24	)	)	PUNCT
chd-117	102	25	.	.	PUNCT
chd-117	103	1	on	on	ADP
chd-117	103	2	stratification	stratification	NOUN
chd-117	103	3	by	by	ADP
chd-117	103	4	menopausal	menopausal	ADJ
chd-117	103	5	status	status	NOUN
chd-117	103	6	,	,	PUNCT
chd-117	103	7	association	association	NOUN
chd-117	103	8	between	between	ADP
chd-117	103	9	ugt1a1	ugt1a1	ADJ
chd-117	103	10	high	high	ADJ
chd-117	103	11	-	-	PUNCT
chd-117	103	12	risk	risk	NOUN
chd-117	103	13	genotypes	genotype	NOUN
chd-117	103	14	and	and	CCONJ
chd-117	103	15	risk	risk	NOUN
chd-117	103	16	of	of	ADP
chd-117	103	17	breast	breast	NOUN
chd-117	103	18	cancer	cancer	NOUN
chd-117	103	19	showed	show	VERB
chd-117	103	20	an	an	DET
chd-117	103	21	or	or	CCONJ
chd-117	103	22	of	of	ADP
chd-117	103	23	1.46	1.46	NUM
chd-117	103	24	in	in	ADP
chd-117	103	25	premenopausal	premenopausal	NOUN
chd-117	103	26	women	woman	NOUN
chd-117	103	27	(	(	PUNCT
chd-117	103	28	95	95	NUM
chd-117	103	29	%	%	NOUN
chd-117	103	30	ci	ci	NOUN
chd-117	103	31	,	,	PUNCT
chd-117	103	32	0.65	0.65	NUM
chd-117	103	33	-	-	SYM
chd-117	103	34	3.31	3.31	NUM
chd-117	103	35	;	;	PUNCT
chd-117	103	36	p	p	X
chd-117	103	37	=	=	NOUN
chd-117	103	38	0.361	0.361	NUM
chd-117	103	39	)	)	PUNCT
chd-117	103	40	and	and	CCONJ
chd-117	103	41	an	an	DET
chd-117	103	42	or	or	CCONJ
chd-117	103	43	of	of	ADP
chd-117	103	44	1.10	1.10	NUM
chd-117	103	45	in	in	ADP
chd-117	103	46	postmenopausal	postmenopausal	ADJ
chd-117	103	47	women	woman	NOUN
chd-117	103	48	(	(	PUNCT
chd-117	103	49	95	95	NUM
chd-117	103	50	%	%	NOUN
chd-117	103	51	ci	ci	NOUN
chd-117	103	52	,	,	PUNCT
chd-117	103	53	0.52	0.52	NUM
chd-117	103	54	-	-	SYM
chd-117	103	55	2.38	2.38	NUM
chd-117	103	56	;	;	PUNCT
chd-117	103	57	p	p	X
chd-117	103	58	=	=	NOUN
chd-117	103	59	0.793	0.793	NUM
chd-117	103	60	)	)	PUNCT
chd-117	103	61	.	.	PUNCT
chd-117	104	1	although	although	SCONJ
chd-117	104	2	not	not	PART
chd-117	104	3	significant	significant	ADJ
chd-117	104	4	,	,	PUNCT
chd-117	104	5	overweight	overweight	ADJ
chd-117	104	6	and	and	CCONJ
chd-117	104	7	obese	obese	ADJ
chd-117	104	8	status	status	NOUN
chd-117	104	9	among	among	ADP
chd-117	104	10	women	woman	NOUN
chd-117	104	11	with	with	ADP
chd-117	104	12	the	the	DET
chd-117	104	13	low	low	ADJ
chd-117	104	14	activity	activity	NOUN
chd-117	104	15	7/8	7/8	NUM
chd-117	104	16	ta	ta	PART
chd-117	104	17	repeat	repeat	NOUN
chd-117	104	18	alleles	allele	NOUN
chd-117	104	19	had	have	VERB
chd-117	104	20	a	a	DET
chd-117	104	21	92	92	NUM
chd-117	104	22	%	%	NOUN
chd-117	104	23	increased	increase	VERB
chd-117	104	24	risk	risk	NOUN
chd-117	104	25	of	of	ADP
chd-117	104	26	breast	breast	NOUN
chd-117	104	27	cancer	cancer	NOUN
chd-117	104	28	compared	compare	VERB
chd-117	104	29	to	to	ADP
chd-117	104	30	wild	wild	ADJ
chd-117	104	31	-	-	PUNCT
chd-117	104	32	type	type	NOUN
chd-117	104	33	(	(	PUNCT
chd-117	104	34	5ta	5ta	ADJ
chd-117	104	35	)	)	PUNCT
chd-117	104	36	and	and	CCONJ
chd-117	104	37	high	high	ADJ
chd-117	104	38	activity	activity	NOUN
chd-117	104	39	(	(	PUNCT
chd-117	104	40	6ta	6ta	ADJ
chd-117	104	41	)	)	PUNCT
chd-117	104	42	alleles	allele	NOUN
chd-117	104	43	.	.	PUNCT
chd-117	105	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-117	105	2	e7	e7	PROPN
chd-117	105	3	cancer	cancer	NOUN
chd-117	105	4	health	health	NOUN
chd-117	105	5	disparities	disparity	NOUN
chd-117	105	6	research	research	NOUN
chd-117	105	7	table	table	NOUN
chd-117	105	8	3	3	NUM
chd-117	105	9	.	.	PUNCT
chd-117	105	10	ugt1a1	ugt1a1	ADJ
chd-117	105	11	genotypes	genotype	NOUN
chd-117	105	12	and	and	CCONJ
chd-117	105	13	risk	risk	NOUN
chd-117	105	14	of	of	ADP
chd-117	105	15	breast	breast	NOUN
chd-117	105	16	cancer	cancer	NOUN
chd-117	105	17	by	by	ADP
chd-117	105	18	menopause	menopause	NOUN
chd-117	105	19	and	and	CCONJ
chd-117	105	20	obesity	obesity	NOUN
chd-117	105	21	status	status	NOUN
chd-117	105	22	.	.	PUNCT
chd-117	106	1	genotypes	genotype	NOUN
chd-117	106	2	cases	case	NOUN
chd-117	106	3	,	,	PUNCT
chd-117	106	4	n	n	CCONJ
chd-117	106	5	(	(	PUNCT
chd-117	106	6	%	%	INTJ
chd-117	106	7	)	)	PUNCT
chd-117	106	8	controls	control	NOUN
chd-117	106	9	,	,	PUNCT
chd-117	106	10	n	n	CCONJ
chd-117	106	11	(	(	PUNCT
chd-117	106	12	%	%	INTJ
chd-117	106	13	)	)	PUNCT
chd-117	106	14	or	or	CCONJ
chd-117	106	15	(	(	PUNCT
chd-117	106	16	95	95	NUM
chd-117	106	17	%	%	NOUN
chd-117	106	18	ci	ci	NOUN
chd-117	106	19	)	)	PUNCT
chd-117	106	20	p	p	ADJ
chd-117	106	21	-	-	PUNCT
chd-117	106	22	value	value	NOUN
chd-117	106	23	premenopausal	premenopausal	NOUN
chd-117	106	24	women	woman	NOUN
chd-117	106	25	5/5	5/5	NUM
chd-117	106	26	,	,	PUNCT
chd-117	106	27	5/6	5/6	NUM
chd-117	106	28	,	,	PUNCT
chd-117	106	29	6/6	6/6	NUM
chd-117	106	30	10	10	NUM
chd-117	106	31	(	(	PUNCT
chd-117	106	32	27.8	27.8	NUM
chd-117	106	33	)	)	PUNCT
chd-117	106	34	45	45	NUM
chd-117	106	35	(	(	PUNCT
chd-117	106	36	36.0	36.0	NUM
chd-117	106	37	)	)	PUNCT
chd-117	106	38	1.46	1.46	NUM
chd-117	106	39	(	(	PUNCT
chd-117	106	40	0.65	0.65	NUM
chd-117	106	41	-	-	SYM
chd-117	106	42	3.31	3.31	NUM
chd-117	106	43	)	)	PUNCT
chd-117	106	44	0.361	0.361	NUM
chd-117	106	45	6/7	6/7	NUM
chd-117	106	46	,	,	PUNCT
chd-117	106	47	7/7	7/7	NUM
chd-117	106	48	,	,	PUNCT
chd-117	106	49	7/8	7/8	NUM
chd-117	106	50	26	26	NUM
chd-117	106	51	(	(	PUNCT
chd-117	106	52	72.2	72.2	NUM
chd-117	106	53	)	)	PUNCT
chd-117	106	54	80	80	NUM
chd-117	106	55	(	(	PUNCT
chd-117	106	56	64.0	64.0	NUM
chd-117	106	57	)	)	PUNCT
chd-117	106	58	postmenopausal	postmenopausal	NOUN
chd-117	106	59	women	woman	NOUN
chd-117	106	60	5/5	5/5	NUM
chd-117	106	61	,	,	PUNCT
chd-117	106	62	5/6	5/6	NUM
chd-117	106	63	,	,	PUNCT
chd-117	106	64	6/6	6/6	NUM
chd-117	106	65	13	13	NUM
chd-117	106	66	(	(	PUNCT
chd-117	106	67	35.1	35.1	NUM
chd-117	106	68	)	)	PUNCT
chd-117	106	69	48	48	NUM
chd-117	106	70	(	(	PUNCT
chd-117	106	71	37.5	37.5	NUM
chd-117	106	72	)	)	PUNCT
chd-117	106	73	1.10	1.10	NUM
chd-117	106	74	(	(	PUNCT
chd-117	106	75	0.52	0.52	NUM
chd-117	106	76	-	-	SYM
chd-117	106	77	2.38	2.38	NUM
chd-117	106	78	)	)	PUNCT
chd-117	106	79	0.793	0.793	NUM
chd-117	106	80	6/7	6/7	NUM
chd-117	106	81	,	,	PUNCT
chd-117	106	82	7/7	7/7	NUM
chd-117	106	83	,	,	PUNCT
chd-117	106	84	7/8	7/8	NUM
chd-117	106	85	24	24	NUM
chd-117	106	86	(	(	PUNCT
chd-117	106	87	64.9	64.9	NUM
chd-117	106	88	)	)	PUNCT
chd-117	106	89	80	80	NUM
chd-117	106	90	(	(	PUNCT
chd-117	106	91	62.5	62.5	NUM
chd-117	106	92	)	)	PUNCT
chd-117	106	93	optimal	optimal	ADJ
chd-117	106	94	weight	weight	NOUN
chd-117	106	95	5/5	5/5	NUM
chd-117	106	96	,	,	PUNCT
chd-117	106	97	5/6	5/6	NUM
chd-117	106	98	,	,	PUNCT
chd-117	106	99	6/6	6/6	NUM
chd-117	106	100	6	6	NUM
chd-117	106	101	(	(	PUNCT
chd-117	106	102	40.0	40.0	NUM
chd-117	106	103	)	)	PUNCT
chd-117	106	104	14	14	NUM
chd-117	106	105	(	(	PUNCT
chd-117	106	106	34.1	34.1	NUM
chd-117	106	107	)	)	PUNCT
chd-117	106	108	0.78	0.78	NUM
chd-117	106	109	(	(	PUNCT
chd-117	106	110	0.23	0.23	NUM
chd-117	106	111	-	-	SYM
chd-117	106	112	2.63	2.63	NUM
chd-117	106	113	)	)	PUNCT
chd-117	106	114	0.686	0.686	NUM
chd-117	106	115	6/7	6/7	NUM
chd-117	106	116	,	,	PUNCT
chd-117	106	117	7/7	7/7	NUM
chd-117	106	118	,	,	PUNCT
chd-117	106	119	7/8	7/8	NUM
chd-117	106	120	27	27	NUM
chd-117	106	121	(	(	PUNCT
chd-117	106	122	65.9	65.9	NUM
chd-117	106	123	)	)	PUNCT
chd-117	106	124	overweight	overweight	NOUN
chd-117	106	125	/	/	SYM
chd-117	106	126	obese	obese	NOUN
chd-117	106	127	5/5	5/5	NUM
chd-117	106	128	,	,	PUNCT
chd-117	106	129	5/6	5/6	NUM
chd-117	106	130	,	,	PUNCT
chd-117	106	131	6/6	6/6	NUM
chd-117	106	132	12	12	NUM
chd-117	106	133	(	(	PUNCT
chd-117	106	134	24.0	24.0	NUM
chd-117	106	135	)	)	PUNCT
chd-117	106	136	75	75	NUM
chd-117	106	137	(	(	PUNCT
chd-117	106	138	37.7	37.7	NUM
chd-117	106	139	)	)	PUNCT
chd-117	106	140	1.92	1.92	NUM
chd-117	106	141	(	(	PUNCT
chd-117	106	142	0.94	0.94	NUM
chd-117	106	143	-	-	SYM
chd-117	106	144	3.89	3.89	NUM
chd-117	106	145	)	)	PUNCT
chd-117	106	146	0.073	0.073	NUM
chd-117	106	147	6/7	6/7	NUM
chd-117	106	148	,	,	PUNCT
chd-117	106	149	7/7	7/7	NUM
chd-117	106	150	,	,	PUNCT
chd-117	106	151	7/8	7/8	NUM
chd-117	106	152	38	38	NUM
chd-117	106	153	(	(	PUNCT
chd-117	106	154	76.0	76.0	NUM
chd-117	106	155	)	)	SYM
chd-117	106	156	124	124	NUM
chd-117	106	157	(	(	PUNCT
chd-117	106	158	62.3	62.3	NUM
chd-117	106	159	)	)	PUNCT
chd-117	106	160	investigation	investigation	NOUN
chd-117	106	161	of	of	ADP
chd-117	106	162	ugt1a1	ugt1a1	ADJ
chd-117	106	163	mrna	mrna	PROPN
chd-117	106	164	expression	expression	NOUN
chd-117	106	165	in	in	ADP
chd-117	106	166	breast	breast	NOUN
chd-117	106	167	tumor	tumor	NOUN
chd-117	106	168	tissues	tissue	NOUN
chd-117	106	169	from	from	ADP
chd-117	106	170	aa	aa	NOUN
chd-117	106	171	and	and	CCONJ
chd-117	106	172	non	non	ADJ
chd-117	106	173	-	-	ADJ
chd-117	106	174	hispanic	hispanic	ADJ
chd-117	106	175	white	white	ADJ
chd-117	106	176	women	woman	NOUN
chd-117	106	177	in	in	ADP
chd-117	106	178	the	the	DET
chd-117	106	179	tcga	tcga	NOUN
chd-117	106	180	we	we	PRON
chd-117	106	181	previously	previously	ADV
chd-117	106	182	showed	show	VERB
chd-117	106	183	that	that	SCONJ
chd-117	106	184	ugt1a1	ugt1a1	PROPN
chd-117	106	185	mrna	mrna	PROPN
chd-117	106	186	levels	level	NOUN
chd-117	106	187	was	be	AUX
chd-117	106	188	significantly	significantly	ADV
chd-117	106	189	lower	low	ADJ
chd-117	106	190	in	in	ADP
chd-117	106	191	breast	breast	NOUN
chd-117	106	192	tumors	tumor	NOUN
chd-117	106	193	as	as	SCONJ
chd-117	106	194	compared	compare	VERB
chd-117	106	195	to	to	ADP
chd-117	106	196	normal	normal	ADJ
chd-117	106	197	breast	breast	NOUN
chd-117	106	198	tissues	tissue	NOUN
chd-117	106	199	from	from	ADP
chd-117	106	200	aa	aa	NOUN
chd-117	106	201	and	and	CCONJ
chd-117	106	202	non	non	ADJ
chd-117	106	203	-	-	ADJ
chd-117	106	204	hispanic	hispanic	ADJ
chd-117	106	205	white	white	ADJ
chd-117	106	206	women	woman	NOUN
chd-117	106	207	(	(	PUNCT
chd-117	106	208	starlard	starlard	NOUN
chd-117	106	209	-	-	PUNCT
chd-117	106	210	davenport	davenport	NOUN
chd-117	106	211	et	et	PROPN
chd-117	106	212	al	al	PROPN
chd-117	106	213	.	.	PROPN
chd-117	106	214	,	,	PUNCT
chd-117	106	215	2012	2012	NUM
chd-117	106	216	)	)	PUNCT
chd-117	106	217	.	.	PUNCT
chd-117	107	1	we	we	PRON
chd-117	107	2	demonstrated	demonstrate	VERB
chd-117	107	3	that	that	SCONJ
chd-117	107	4	low	low	ADJ
chd-117	107	5	ugt1a1	ugt1a1	ADJ
chd-117	107	6	mrna	mrna	NOUN
chd-117	107	7	expression	expression	NOUN
chd-117	107	8	in	in	ADP
chd-117	107	9	breast	breast	NOUN
chd-117	107	10	tumors	tumor	NOUN
chd-117	107	11	correlated	correlate	VERB
chd-117	107	12	with	with	ADP
chd-117	107	13	ugt1a1	ugt1a1	NOUN
chd-117	107	14	*	*	ADJ
chd-117	107	15	28	28	NUM
chd-117	107	16	low	low	ADJ
chd-117	107	17	activity	activity	NOUN
chd-117	107	18	alleles	allele	NOUN
chd-117	107	19	.	.	PUNCT
chd-117	108	1	guillemette	guillemette	NOUN
chd-117	108	2	et	et	PROPN
chd-117	108	3	al	al	PROPN
chd-117	108	4	also	also	ADV
chd-117	108	5	showed	show	VERB
chd-117	108	6	that	that	SCONJ
chd-117	108	7	the	the	DET
chd-117	108	8	ugt1a1	ugt1a1	NOUN
chd-117	108	9	*	*	ADJ
chd-117	108	10	28	28	NUM
chd-117	108	11	was	be	AUX
chd-117	108	12	associated	associate	VERB
chd-117	108	13	with	with	ADP
chd-117	108	14	estrogen	estrogen	NOUN
chd-117	108	15	receptor	receptor	NOUN
chd-117	108	16	(	(	PUNCT
chd-117	108	17	er)-breast	er)-breast	VERB
chd-117	108	18	cancers	cancer	NOUN
chd-117	108	19	in	in	ADP
chd-117	108	20	premenopausal	premenopausal	NOUN
chd-117	108	21	aa	aa	NOUN
chd-117	108	22	women	woman	NOUN
chd-117	108	23	(	(	PUNCT
chd-117	108	24	guillemette	guillemette	NOUN
chd-117	108	25	et	et	PROPN
chd-117	108	26	al	al	PROPN
chd-117	108	27	.	.	PROPN
chd-117	108	28	,	,	PUNCT
chd-117	108	29	2000	2000	NUM
chd-117	108	30	)	)	PUNCT
chd-117	108	31	.	.	PUNCT
chd-117	109	1	therefore	therefore	ADV
chd-117	109	2	,	,	PUNCT
chd-117	109	3	we	we	PRON
chd-117	109	4	explored	explore	VERB
chd-117	109	5	the	the	DET
chd-117	109	6	cancer	cancer	NOUN
chd-117	109	7	genome	genome	NOUN
chd-117	109	8	atlas	atlas	PROPN
chd-117	109	9	(	(	PUNCT
chd-117	109	10	tcga	tcga	PROPN
chd-117	109	11	)	)	PUNCT
chd-117	109	12	,	,	PUNCT
chd-117	109	13	a	a	DET
chd-117	109	14	comprehensive	comprehensive	ADJ
chd-117	109	15	database	database	NOUN
chd-117	109	16	that	that	PRON
chd-117	109	17	catalogues	catalogue	VERB
chd-117	109	18	genomic	genomic	NOUN
chd-117	109	19	alterations	alteration	NOUN
chd-117	109	20	responsible	responsible	ADJ
chd-117	109	21	for	for	ADP
chd-117	109	22	cancer	cancer	NOUN
chd-117	109	23	from	from	ADP
chd-117	109	24	500	500	NUM
chd-117	109	25	patients	patient	NOUN
chd-117	109	26	,	,	PUNCT
chd-117	109	27	to	to	PART
chd-117	109	28	determine	determine	VERB
chd-117	109	29	whether	whether	SCONJ
chd-117	109	30	ugt1a1	ugt1a1	ADJ
chd-117	109	31	rna	rna	NOUN
chd-117	109	32	expression	expression	NOUN
chd-117	109	33	was	be	AUX
chd-117	109	34	altered	alter	VERB
chd-117	109	35	in	in	ADP
chd-117	109	36	a	a	DET
chd-117	109	37	group	group	NOUN
chd-117	109	38	of	of	ADP
chd-117	109	39	human	human	ADJ
chd-117	109	40	breast	breast	NOUN
chd-117	109	41	cancer	cancer	NOUN
chd-117	109	42	samples	sample	NOUN
chd-117	109	43	from	from	ADP
chd-117	109	44	aa	aa	PROPN
chd-117	109	45	(	(	PUNCT
chd-117	109	46	n	n	NOUN
chd-117	109	47	=	=	SYM
chd-117	109	48	94	94	NUM
chd-117	109	49	)	)	PUNCT
chd-117	109	50	and	and	CCONJ
chd-117	109	51	non	non	ADJ
chd-117	109	52	-	-	ADJ
chd-117	109	53	hispanic	hispanic	ADJ
chd-117	109	54	white	white	ADJ
chd-117	109	55	(	(	PUNCT
chd-117	109	56	n	n	NOUN
chd-117	109	57	=	=	SYM
chd-117	109	58	244	244	NUM
chd-117	109	59	)	)	PUNCT
chd-117	109	60	women	woman	NOUN
chd-117	109	61	by	by	ADP
chd-117	109	62	estrogen	estrogen	NOUN
chd-117	109	63	receptor	receptor	NOUN
chd-117	109	64	(	(	PUNCT
chd-117	109	65	er	er	INTJ
chd-117	109	66	)	)	PUNCT
chd-117	109	67	status	status	NOUN
chd-117	109	68	.	.	PUNCT
chd-117	110	1	tcga	tcga	PROPN
chd-117	110	2	rnasequencing	rnasequencing	NOUN
chd-117	110	3	data	datum	NOUN
chd-117	110	4	and	and	CCONJ
chd-117	110	5	the	the	DET
chd-117	110	6	log2	log2	PROPN
chd-117	110	7	(	(	PUNCT
chd-117	110	8	average	average	ADJ
chd-117	110	9	raw	raw	ADJ
chd-117	110	10	fpkm	fpkm	NOUN
chd-117	110	11	)	)	PUNCT
chd-117	110	12	value	value	NOUN
chd-117	110	13	was	be	AUX
chd-117	110	14	plotted	plot	VERB
chd-117	110	15	per	per	ADP
chd-117	110	16	ugt1a1	ugt1a1	ADJ
chd-117	110	17	gene	gene	NOUN
chd-117	110	18	for	for	ADP
chd-117	110	19	aa	aa	PROPN
chd-117	110	20	tumor	tumor	PROPN
chd-117	110	21	and	and	CCONJ
chd-117	110	22	non	non	ADJ
chd-117	110	23	-	-	ADJ
chd-117	110	24	hispanic	hispanic	ADJ
chd-117	110	25	white	white	ADJ
chd-117	110	26	tumor	tumor	NOUN
chd-117	110	27	samples	sample	NOUN
chd-117	110	28	by	by	ADP
chd-117	110	29	er	er	INTJ
chd-117	110	30	status	status	NOUN
chd-117	110	31	(	(	PUNCT
chd-117	110	32	figure	figure	NOUN
chd-117	110	33	1	1	NUM
chd-117	110	34	)	)	PUNCT
chd-117	110	35	.	.	PUNCT
chd-117	111	1	we	we	PRON
chd-117	111	2	observed	observe	VERB
chd-117	111	3	that	that	SCONJ
chd-117	111	4	ugt1a1	ugt1a1	ADJ
chd-117	111	5	mrna	mrna	PROPN
chd-117	111	6	expression	expression	NOUN
chd-117	111	7	was	be	AUX
chd-117	111	8	lower	low	ADJ
chd-117	111	9	in	in	ADP
chd-117	111	10	breast	breast	NOUN
chd-117	111	11	tumors	tumor	NOUN
chd-117	111	12	from	from	ADP
chd-117	111	13	aa	aa	NOUN
chd-117	111	14	as	as	SCONJ
chd-117	111	15	compared	compare	VERB
chd-117	111	16	to	to	ADP
chd-117	111	17	non	non	ADJ
chd-117	111	18	-	-	ADJ
chd-117	111	19	hispanic	hispanic	ADJ
chd-117	111	20	white	white	ADJ
chd-117	111	21	women	woman	NOUN
chd-117	111	22	although	although	SCONJ
chd-117	111	23	not	not	PART
chd-117	111	24	significant	significant	ADJ
chd-117	111	25	(	(	PUNCT
chd-117	111	26	figure	figure	NOUN
chd-117	111	27	1	1	NUM
chd-117	111	28	)	)	PUNCT
chd-117	111	29	.	.	PUNCT
chd-117	112	1	we	we	PRON
chd-117	112	2	further	far	ADV
chd-117	112	3	showed	show	VERB
chd-117	112	4	that	that	SCONJ
chd-117	112	5	ugt1a1	ugt1a1	ADJ
chd-117	112	6	gene	gene	NOUN
chd-117	112	7	expression	expression	NOUN
chd-117	112	8	was	be	AUX
chd-117	112	9	significantly	significantly	ADV
chd-117	112	10	higher	high	ADJ
chd-117	112	11	in	in	ADP
chd-117	112	12	er	er	INTJ
chd-117	112	13	negative	negative	ADJ
chd-117	112	14	breast	breast	NOUN
chd-117	112	15	tumors	tumor	NOUN
chd-117	112	16	from	from	ADP
chd-117	112	17	non	non	ADJ
chd-117	112	18	-	-	ADJ
chd-117	112	19	hispanic	hispanic	ADJ
chd-117	112	20	white	white	ADJ
chd-117	112	21	women	woman	NOUN
chd-117	112	22	as	as	SCONJ
chd-117	112	23	compared	compare	VERB
chd-117	112	24	to	to	ADP
chd-117	112	25	aa	aa	ADJ
chd-117	112	26	women	woman	NOUN
chd-117	112	27	with	with	ADP
chd-117	112	28	er	er	INTJ
chd-117	112	29	negative	negative	ADJ
chd-117	112	30	and	and	CCONJ
chd-117	112	31	er	er	INTJ
chd-117	112	32	positive	positive	ADJ
chd-117	112	33	breast	breast	NOUN
chd-117	112	34	tumors	tumor	NOUN
chd-117	112	35	.	.	PUNCT
chd-117	113	1	figure	figure	VERB
chd-117	113	2	1	1	NUM
chd-117	113	3	.	.	PUNCT
chd-117	114	1	ugt1a1	ugt1a1	ADJ
chd-117	114	2	rna	rna	NOUN
chd-117	114	3	expression	expression	NOUN
chd-117	114	4	from	from	ADP
chd-117	114	5	tcga	tcga	PROPN
chd-117	114	6	database	database	NOUN
chd-117	114	7	.	.	PUNCT
chd-117	115	1	the	the	DET
chd-117	115	2	log2(average	log2(average	NOUN
chd-117	115	3	raw	raw	PROPN
chd-117	115	4	fpkm	fpkm	PROPN
chd-117	115	5	)	)	PUNCT
chd-117	115	6	value	value	NOUN
chd-117	115	7	is	be	AUX
chd-117	115	8	plotted	plot	VERB
chd-117	115	9	per	per	ADP
chd-117	115	10	ugt1a1	ugt1a1	ADJ
chd-117	115	11	gene	gene	NOUN
chd-117	115	12	expression	expression	NOUN
chd-117	115	13	for	for	ADP
chd-117	115	14	aa	aa	PROPN
chd-117	115	15	tumor	tumor	PROPN
chd-117	115	16	and	and	CCONJ
chd-117	115	17	non	non	ADJ
chd-117	115	18	-	-	ADJ
chd-117	115	19	hispanic	hispanic	ADJ
chd-117	115	20	white	white	ADJ
chd-117	115	21	tumor	tumor	NOUN
chd-117	115	22	samples	sample	NOUN
chd-117	115	23	by	by	ADP
chd-117	115	24	estrogen	estrogen	NOUN
chd-117	115	25	receptor	receptor	NOUN
chd-117	115	26	(	(	PUNCT
chd-117	115	27	er	er	INTJ
chd-117	115	28	)	)	PUNCT
chd-117	115	29	status	status	NOUN
chd-117	115	30	.	.	PUNCT
chd-117	116	1	the	the	DET
chd-117	116	2	average	average	ADJ
chd-117	116	3	raw	raw	ADJ
chd-117	116	4	fpkm	fpkm	NOUN
chd-117	116	5	values	value	NOUN
chd-117	116	6	for	for	ADP
chd-117	116	7	ugt1a1	ugt1a1	NOUN
chd-117	116	8	were	be	AUX
chd-117	116	9	zero	zero	NUM
chd-117	116	10	or	or	CCONJ
chd-117	116	11	close	close	ADJ
chd-117	116	12	to	to	ADP
chd-117	116	13	zero	zero	NUM
chd-117	116	14	.	.	PUNCT
chd-117	117	1	discussion	discussion	NOUN
chd-117	117	2	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-117	117	3	e8	e8	PROPN
chd-117	117	4	cancer	cancer	NOUN
chd-117	117	5	health	health	NOUN
chd-117	117	6	disparities	disparity	NOUN
chd-117	117	7	research	research	NOUN
chd-117	117	8	in	in	ADP
chd-117	117	9	the	the	DET
chd-117	117	10	present	present	ADJ
chd-117	117	11	study	study	NOUN
chd-117	117	12	,	,	PUNCT
chd-117	117	13	we	we	PRON
chd-117	117	14	investigated	investigate	VERB
chd-117	117	15	the	the	DET
chd-117	117	16	associations	association	NOUN
chd-117	117	17	between	between	ADP
chd-117	117	18	the	the	DET
chd-117	117	19	ugt1a1	ugt1a1	NOUN
chd-117	117	20	*	*	PROPN
chd-117	117	21	28	28	NUM
chd-117	117	22	ta	ta	PART
chd-117	117	23	repeat	repeat	VERB
chd-117	117	24	polymorphism	polymorphism	NOUN
chd-117	117	25	located	locate	VERB
chd-117	117	26	in	in	ADP
chd-117	117	27	the	the	DET
chd-117	117	28	promoter	promoter	NOUN
chd-117	117	29	region	region	NOUN
chd-117	117	30	of	of	ADP
chd-117	117	31	ugt1a1	ugt1a1	NOUN
chd-117	117	32	among	among	ADP
chd-117	117	33	aa	aa	PROPN
chd-117	117	34	breast	breast	NOUN
chd-117	117	35	cancer	cancer	NOUN
chd-117	117	36	cases	case	NOUN
chd-117	117	37	and	and	CCONJ
chd-117	117	38	healthy	healthy	ADJ
chd-117	117	39	aa	aa	NOUN
chd-117	117	40	women	woman	NOUN
chd-117	117	41	volunteers	volunteer	NOUN
chd-117	117	42	.	.	PUNCT
chd-117	118	1	our	our	PRON
chd-117	118	2	study	study	NOUN
chd-117	118	3	is	be	AUX
chd-117	118	4	the	the	DET
chd-117	118	5	first	first	ADJ
chd-117	118	6	to	to	PART
chd-117	118	7	investigate	investigate	VERB
chd-117	118	8	the	the	DET
chd-117	118	9	association	association	NOUN
chd-117	118	10	between	between	ADP
chd-117	118	11	the	the	DET
chd-117	118	12	ugt1a1	ugt1a1	PROPN
chd-117	118	13	*	*	ADJ
chd-117	118	14	28	28	NUM
chd-117	118	15	polymorphism	polymorphism	NOUN
chd-117	118	16	and	and	CCONJ
chd-117	118	17	breast	breast	NOUN
chd-117	118	18	cancer	cancer	NOUN
chd-117	118	19	risk	risk	NOUN
chd-117	118	20	among	among	ADP
chd-117	118	21	women	woman	NOUN
chd-117	118	22	in	in	ADP
chd-117	118	23	memphis	memphis	PROPN
chd-117	118	24	,	,	PUNCT
chd-117	118	25	tn	tn	PROPN
chd-117	118	26	,	,	PUNCT
chd-117	118	27	a	a	DET
chd-117	118	28	city	city	NOUN
chd-117	118	29	with	with	ADP
chd-117	118	30	one	one	NUM
chd-117	118	31	of	of	ADP
chd-117	118	32	the	the	DET
chd-117	118	33	highest	high	ADJ
chd-117	118	34	breast	breast	NOUN
chd-117	118	35	cancer	cancer	NOUN
chd-117	118	36	mortality	mortality	NOUN
chd-117	118	37	disparity	disparity	NOUN
chd-117	118	38	rates	rate	NOUN
chd-117	118	39	among	among	ADP
chd-117	118	40	aa	aa	ADJ
chd-117	118	41	women	woman	NOUN
chd-117	118	42	compared	compare	VERB
chd-117	118	43	to	to	ADP
chd-117	118	44	non	non	ADJ
chd-117	118	45	-	-	ADJ
chd-117	118	46	hispanic	hispanic	ADJ
chd-117	118	47	white	white	ADJ
chd-117	118	48	women	woman	NOUN
chd-117	118	49	in	in	ADP
chd-117	118	50	the	the	DET
chd-117	118	51	us	us	PROPN
chd-117	118	52	.	.	PUNCT
chd-117	119	1	the	the	DET
chd-117	119	2	human	human	PROPN
chd-117	119	3	ugt1a1	ugt1a1	ADJ
chd-117	119	4	gene	gene	NOUN
chd-117	119	5	is	be	AUX
chd-117	119	6	a	a	DET
chd-117	119	7	member	member	NOUN
chd-117	119	8	of	of	ADP
chd-117	119	9	the	the	DET
chd-117	119	10	ugt1a	ugt1a	PROPN
chd-117	119	11	subfamily	subfamily	ADV
chd-117	119	12	of	of	ADP
chd-117	119	13	enzymes	enzyme	NOUN
chd-117	119	14	that	that	PRON
chd-117	119	15	are	be	AUX
chd-117	119	16	encoded	encode	VERB
chd-117	119	17	by	by	ADP
chd-117	119	18	the	the	DET
chd-117	119	19	ugt1a	ugt1a	PROPN
chd-117	119	20	gene	gene	NOUN
chd-117	119	21	locus	locus	NOUN
chd-117	119	22	on	on	ADP
chd-117	119	23	chromosome	chromosome	NOUN
chd-117	119	24	2q37.1	2q37.1	NUM
chd-117	119	25	.	.	PUNCT
chd-117	120	1	the	the	DET
chd-117	120	2	ugt1a	ugt1a	PROPN
chd-117	120	3	isoforms	isoform	NOUN
chd-117	120	4	share	share	VERB
chd-117	120	5	4	4	NUM
chd-117	120	6	common	common	ADJ
chd-117	120	7	exons	exon	NOUN
chd-117	120	8	from	from	ADP
chd-117	120	9	exon	exon	NOUN
chd-117	120	10	2	2	NUM
chd-117	120	11	to	to	PART
chd-117	120	12	exon	exon	VERB
chd-117	120	13	5	5	NUM
chd-117	120	14	and	and	CCONJ
chd-117	120	15	have	have	VERB
chd-117	120	16	a	a	DET
chd-117	120	17	unique	unique	ADJ
chd-117	120	18	exon	exon	NOUN
chd-117	120	19	1	1	NUM
chd-117	120	20	and	and	CCONJ
chd-117	120	21	individual	individual	ADJ
chd-117	120	22	promoter	promoter	NOUN
chd-117	120	23	pairs	pair	NOUN
chd-117	120	24	(	(	PUNCT
chd-117	120	25	tukey	tukey	NOUN
chd-117	120	26	and	and	CCONJ
chd-117	120	27	strassburg	strassburg	NOUN
chd-117	120	28	,	,	PUNCT
chd-117	120	29	2000	2000	NUM
chd-117	120	30	)	)	PUNCT
chd-117	120	31	.	.	PUNCT
chd-117	121	1	ugt1a1	ugt1a1	NOUN
chd-117	121	2	is	be	AUX
chd-117	121	3	the	the	DET
chd-117	121	4	most	most	ADV
chd-117	121	5	abundant	abundant	ADJ
chd-117	121	6	member	member	NOUN
chd-117	121	7	of	of	ADP
chd-117	121	8	the	the	DET
chd-117	121	9	ugt1a	ugt1a	PROPN
chd-117	121	10	family	family	NOUN
chd-117	121	11	in	in	ADP
chd-117	121	12	human	human	ADJ
chd-117	121	13	liver	liver	NOUN
chd-117	121	14	and	and	CCONJ
chd-117	121	15	is	be	AUX
chd-117	121	16	also	also	ADV
chd-117	121	17	the	the	DET
chd-117	121	18	major	major	ADJ
chd-117	121	19	isoform	isoform	NOUN
chd-117	121	20	responsible	responsible	ADJ
chd-117	121	21	for	for	ADP
chd-117	121	22	the	the	DET
chd-117	121	23	metabolism	metabolism	NOUN
chd-117	121	24	and	and	CCONJ
chd-117	121	25	clearance	clearance	NOUN
chd-117	121	26	of	of	ADP
chd-117	121	27	many	many	ADJ
chd-117	121	28	endogenous	endogenous	ADJ
chd-117	121	29	and	and	CCONJ
chd-117	121	30	exogenous	exogenous	ADJ
chd-117	121	31	compounds	compound	NOUN
chd-117	121	32	,	,	PUNCT
chd-117	121	33	including	include	VERB
chd-117	121	34	β	β	X
chd-117	121	35	-	-	NOUN
chd-117	121	36	estradiol	estradiol	PROPN
chd-117	121	37	and	and	CCONJ
chd-117	121	38	its	its	PRON
chd-117	121	39	metabolites	metabolite	NOUN
chd-117	121	40	(	(	PUNCT
chd-117	121	41	lepine	lepine	NOUN
chd-117	121	42	et	et	PROPN
chd-117	121	43	al	al	PROPN
chd-117	121	44	.	.	PROPN
chd-117	121	45	,	,	PUNCT
chd-117	121	46	2004	2004	NUM
chd-117	121	47	)	)	PUNCT
chd-117	121	48	.	.	PUNCT
chd-117	122	1	it	it	PRON
chd-117	122	2	is	be	AUX
chd-117	122	3	well	well	ADV
chd-117	122	4	known	know	VERB
chd-117	122	5	that	that	SCONJ
chd-117	122	6	prolonged	prolong	VERB
chd-117	122	7	exposure	exposure	NOUN
chd-117	122	8	to	to	ADP
chd-117	122	9	β	β	X
chd-117	122	10	-	-	NOUN
chd-117	122	11	estradiol	estradiol	PROPN
chd-117	122	12	is	be	AUX
chd-117	122	13	a	a	DET
chd-117	122	14	major	major	ADJ
chd-117	122	15	risk	risk	NOUN
chd-117	122	16	factor	factor	NOUN
chd-117	122	17	for	for	ADP
chd-117	122	18	breast	breast	NOUN
chd-117	122	19	cancer	cancer	NOUN
chd-117	122	20	development	development	NOUN
chd-117	122	21	in	in	ADP
chd-117	122	22	women	woman	NOUN
chd-117	122	23	.	.	PUNCT
chd-117	123	1	elevated	elevated	ADJ
chd-117	123	2	levels	level	NOUN
chd-117	123	3	of	of	ADP
chd-117	123	4	circulating	circulate	VERB
chd-117	123	5	estrogens	estrogen	NOUN
chd-117	123	6	are	be	AUX
chd-117	123	7	associated	associate	VERB
chd-117	123	8	with	with	ADP
chd-117	123	9	increased	increase	VERB
chd-117	123	10	breast	breast	NOUN
chd-117	123	11	cancer	cancer	NOUN
chd-117	123	12	risk	risk	NOUN
chd-117	123	13	in	in	ADP
chd-117	123	14	postmenopausal	postmenopausal	ADJ
chd-117	123	15	women	woman	NOUN
chd-117	123	16	.	.	PUNCT
chd-117	124	1	the	the	DET
chd-117	124	2	carcinogenic	carcinogenic	ADJ
chd-117	124	3	potential	potential	NOUN
chd-117	124	4	of	of	ADP
chd-117	124	5	estrogens	estrogen	NOUN
chd-117	124	6	is	be	AUX
chd-117	124	7	not	not	PART
chd-117	124	8	only	only	ADV
chd-117	124	9	mediated	mediate	VERB
chd-117	124	10	by	by	ADP
chd-117	124	11	estrogen	estrogen	NOUN
chd-117	124	12	receptor	receptor	NOUN
chd-117	124	13	signaling	signal	VERB
chd-117	124	14	but	but	CCONJ
chd-117	124	15	also	also	ADV
chd-117	124	16	mediated	mediate	VERB
chd-117	124	17	by	by	ADP
chd-117	124	18	increased	increase	VERB
chd-117	124	19	cellular	cellular	ADJ
chd-117	124	20	oxidative	oxidative	ADJ
chd-117	124	21	metabolism	metabolism	NOUN
chd-117	124	22	of	of	ADP
chd-117	124	23	estrogens	estrogen	NOUN
chd-117	124	24	to	to	ADP
chd-117	124	25	genotoxic	genotoxic	ADJ
chd-117	124	26	estrogen	estrogen	NOUN
chd-117	124	27	metabolites	metabolite	NOUN
chd-117	124	28	(	(	PUNCT
chd-117	124	29	cavalieri	cavalieri	PROPN
chd-117	124	30	et	et	PROPN
chd-117	124	31	al	al	PROPN
chd-117	124	32	.	.	PROPN
chd-117	124	33	,	,	PUNCT
chd-117	124	34	1997	1997	NUM
chd-117	124	35	)	)	PUNCT
chd-117	124	36	.	.	PUNCT
chd-117	125	1	several	several	ADJ
chd-117	125	2	studies	study	NOUN
chd-117	125	3	have	have	AUX
chd-117	125	4	investigated	investigate	VERB
chd-117	125	5	the	the	DET
chd-117	125	6	impact	impact	NOUN
chd-117	125	7	of	of	ADP
chd-117	125	8	inherited	inherit	VERB
chd-117	125	9	genetic	genetic	ADJ
chd-117	125	10	variations	variation	NOUN
chd-117	125	11	in	in	ADP
chd-117	125	12	ugt1a1	ugt1a1	NOUN
chd-117	125	13	on	on	ADP
chd-117	125	14	the	the	DET
chd-117	125	15	incidence	incidence	ADJ
chd-117	125	16	risk	risk	NOUN
chd-117	125	17	of	of	ADP
chd-117	125	18	various	various	ADJ
chd-117	125	19	cancers	cancer	NOUN
chd-117	125	20	including	include	VERB
chd-117	125	21	breast	breast	NOUN
chd-117	125	22	cancer	cancer	NOUN
chd-117	125	23	(	(	PUNCT
chd-117	125	24	adegoke	adegoke	VERB
chd-117	125	25	et	et	PROPN
chd-117	125	26	al	al	PROPN
chd-117	125	27	.	.	PROPN
chd-117	125	28	,	,	PUNCT
chd-117	125	29	2004	2004	NUM
chd-117	125	30	;	;	PUNCT
chd-117	125	31	guillemette	guillemette	NOUN
chd-117	125	32	et	et	PROPN
chd-117	125	33	al	al	PROPN
chd-117	125	34	.	.	PROPN
chd-117	125	35	,	,	PUNCT
chd-117	125	36	2000	2000	NUM
chd-117	125	37	;	;	PUNCT
chd-117	125	38	huo	huo	PROPN
chd-117	125	39	et	et	NOUN
chd-117	125	40	al	al	PROPN
chd-117	125	41	.	.	PROPN
chd-117	125	42	,	,	PUNCT
chd-117	125	43	2008	2008	NUM
chd-117	125	44	;	;	PUNCT
chd-117	125	45	shatalova	shatalova	VERB
chd-117	125	46	et	et	PROPN
chd-117	125	47	al	al	PROPN
chd-117	125	48	.	.	PROPN
chd-117	125	49	,	,	PUNCT
chd-117	125	50	2006	2006	NUM
chd-117	125	51	)	)	PUNCT
chd-117	125	52	.	.	PUNCT
chd-117	126	1	the	the	DET
chd-117	126	2	scientific	scientific	ADJ
chd-117	126	3	premise	premise	NOUN
chd-117	126	4	for	for	ADP
chd-117	126	5	the	the	DET
chd-117	126	6	association	association	NOUN
chd-117	126	7	of	of	ADP
chd-117	126	8	ugt1a1	ugt1a1	ADJ
chd-117	126	9	genetic	genetic	ADJ
chd-117	126	10	variants	variant	NOUN
chd-117	126	11	and	and	CCONJ
chd-117	126	12	breast	breast	NOUN
chd-117	126	13	cancer	cancer	NOUN
chd-117	126	14	risk	risk	NOUN
chd-117	126	15	stems	stem	VERB
chd-117	126	16	from	from	ADP
chd-117	126	17	the	the	DET
chd-117	126	18	hypothesis	hypothesis	NOUN
chd-117	126	19	that	that	PRON
chd-117	126	20	reduced	reduce	VERB
chd-117	126	21	ugt1a1	ugt1a1	ADJ
chd-117	126	22	estrogen	estrogen	NOUN
chd-117	126	23	conjugating	conjugate	VERB
chd-117	126	24	activity	activity	NOUN
chd-117	126	25	results	result	NOUN
chd-117	126	26	in	in	ADP
chd-117	126	27	decreased	decrease	VERB
chd-117	126	28	cellular	cellular	ADJ
chd-117	126	29	oxidative	oxidative	ADJ
chd-117	126	30	estrogen	estrogen	NOUN
chd-117	126	31	metabolism	metabolism	NOUN
chd-117	126	32	and	and	CCONJ
chd-117	126	33	increased	increase	VERB
chd-117	126	34	estrogen	estrogen	NOUN
chd-117	126	35	bioavailability	bioavailability	NOUN
chd-117	126	36	in	in	ADP
chd-117	126	37	circulation	circulation	NOUN
chd-117	126	38	.	.	PUNCT
chd-117	127	1	the	the	DET
chd-117	127	2	most	most	ADV
chd-117	127	3	studied	studied	ADJ
chd-117	127	4	ugt1a1	ugt1a1	ADJ
chd-117	127	5	polymorphism	polymorphism	NOUN
chd-117	127	6	is	be	AUX
chd-117	127	7	ugt1a1	ugt1a1	ADJ
chd-117	127	8	*	*	SYM
chd-117	127	9	28	28	NUM
chd-117	127	10	(	(	PUNCT
chd-117	127	11	rs8175347	rs8175347	ADJ
chd-117	127	12	)	)	PUNCT
chd-117	127	13	polymorphism	polymorphism	NOUN
chd-117	127	14	is	be	AUX
chd-117	127	15	characterized	characterize	VERB
chd-117	127	16	by	by	ADP
chd-117	127	17	an	an	DET
chd-117	127	18	extra	extra	ADJ
chd-117	127	19	ta	ta	PART
chd-117	127	20	repeat	repeat	VERB
chd-117	127	21	(	(	PUNCT
chd-117	127	22	ta-7	ta-7	NUM
chd-117	127	23	)	)	PUNCT
chd-117	127	24	in	in	ADP
chd-117	127	25	the	the	DET
chd-117	127	26	tata	tata	PROPN
chd-117	127	27	box	box	PROPN
chd-117	127	28	region	region	NOUN
chd-117	127	29	in	in	ADP
chd-117	127	30	the	the	DET
chd-117	127	31	ugt1a1	ugt1a1	ADJ
chd-117	127	32	promoter	promoter	NOUN
chd-117	127	33	resulting	result	VERB
chd-117	127	34	in	in	ADP
chd-117	127	35	decreased	decrease	VERB
chd-117	127	36	gene	gene	NOUN
chd-117	127	37	transcription	transcription	NOUN
chd-117	127	38	and	and	CCONJ
chd-117	127	39	glucuronidation	glucuronidation	NOUN
chd-117	127	40	activity	activity	NOUN
chd-117	127	41	(	(	PUNCT
chd-117	127	42	beutler	beutler	NOUN
chd-117	127	43	et	et	NOUN
chd-117	127	44	al	al	PROPN
chd-117	127	45	.	.	PROPN
chd-117	127	46	,	,	PUNCT
chd-117	127	47	1998	1998	NUM
chd-117	127	48	)	)	PUNCT
chd-117	127	49	.	.	PUNCT
chd-117	128	1	ugt1a1	ugt1a1	PROPN
chd-117	128	2	*	*	NOUN
chd-117	128	3	28	28	NUM
chd-117	128	4	has	have	AUX
chd-117	128	5	been	be	AUX
chd-117	128	6	previously	previously	ADV
chd-117	128	7	linked	link	VERB
chd-117	128	8	to	to	ADP
chd-117	128	9	increased	increase	VERB
chd-117	128	10	risk	risk	NOUN
chd-117	128	11	of	of	ADP
chd-117	128	12	breast	breast	NOUN
chd-117	128	13	cancer	cancer	NOUN
chd-117	128	14	.	.	PUNCT
chd-117	129	1	for	for	ADP
chd-117	129	2	instance	instance	NOUN
chd-117	129	3	,	,	PUNCT
chd-117	129	4	a	a	DET
chd-117	129	5	study	study	NOUN
chd-117	129	6	by	by	ADP
chd-117	129	7	guillemette	guillemette	PROPN
chd-117	129	8	et	et	PROPN
chd-117	129	9	al	al	PROPN
chd-117	129	10	showed	show	VERB
chd-117	129	11	for	for	ADP
chd-117	129	12	the	the	DET
chd-117	129	13	first	first	ADJ
chd-117	129	14	time	time	NOUN
chd-117	129	15	that	that	SCONJ
chd-117	129	16	200	200	NUM
chd-117	129	17	premenopausal	premenopausal	NOUN
chd-117	129	18	aa	aa	NOUN
chd-117	129	19	women	woman	NOUN
chd-117	129	20	with	with	ADP
chd-117	129	21	er	er	INTJ
chd-117	129	22	negative	negative	ADJ
chd-117	129	23	breast	breast	NOUN
chd-117	129	24	cancer	cancer	NOUN
chd-117	129	25	have	have	VERB
chd-117	129	26	a	a	DET
chd-117	129	27	higher	high	ADJ
chd-117	129	28	prevalence	prevalence	NOUN
chd-117	129	29	of	of	ADP
chd-117	129	30	low	low	ADJ
chd-117	129	31	ugt1a1	ugt1a1	ADJ
chd-117	129	32	activity	activity	NOUN
chd-117	129	33	allele	allele	NOUN
chd-117	129	34	-	-	PUNCT
chd-117	129	35	containing	contain	VERB
chd-117	129	36	genotypes	genotype	NOUN
chd-117	129	37	than	than	ADP
chd-117	129	38	200	200	NUM
chd-117	129	39	female	female	ADJ
chd-117	129	40	controls	control	NOUN
chd-117	129	41	of	of	ADP
chd-117	129	42	african	african	ADJ
chd-117	129	43	ancestry	ancestry	NOUN
chd-117	129	44	(	(	PUNCT
chd-117	129	45	guillemette	guillemette	NOUN
chd-117	129	46	et	et	PROPN
chd-117	129	47	al	al	PROPN
chd-117	129	48	.	.	PROPN
chd-117	129	49	,	,	PUNCT
chd-117	129	50	2000	2000	NUM
chd-117	129	51	)	)	PUNCT
chd-117	129	52	.	.	PUNCT
chd-117	130	1	although	although	SCONJ
chd-117	130	2	a	a	DET
chd-117	130	3	limitation	limitation	NOUN
chd-117	130	4	of	of	ADP
chd-117	130	5	our	our	PRON
chd-117	130	6	genetic	genetic	ADJ
chd-117	130	7	study	study	NOUN
chd-117	130	8	was	be	AUX
chd-117	130	9	the	the	DET
chd-117	130	10	small	small	ADJ
chd-117	130	11	population	population	NOUN
chd-117	130	12	sample	sample	NOUN
chd-117	130	13	size	size	NOUN
chd-117	130	14	and	and	CCONJ
chd-117	130	15	lack	lack	NOUN
chd-117	130	16	of	of	ADP
chd-117	130	17	information	information	NOUN
chd-117	130	18	regarding	regard	VERB
chd-117	130	19	hormone	hormone	NOUN
chd-117	130	20	receptor	receptor	NOUN
chd-117	130	21	breast	breast	NOUN
chd-117	130	22	tumor	tumor	NOUN
chd-117	130	23	status	status	NOUN
chd-117	130	24	among	among	ADP
chd-117	130	25	breast	breast	NOUN
chd-117	130	26	cancer	cancer	NOUN
chd-117	130	27	patients	patient	NOUN
chd-117	130	28	,	,	PUNCT
chd-117	130	29	we	we	PRON
chd-117	130	30	still	still	ADV
chd-117	130	31	observed	observe	VERB
chd-117	130	32	the	the	DET
chd-117	130	33	low	low	ADJ
chd-117	130	34	activity	activity	NOUN
chd-117	130	35	ugt1a1	ugt1a1	NOUN
chd-117	130	36	*	*	NOUN
chd-117	130	37	28	28	NUM
chd-117	130	38	polymorphism	polymorphism	NOUN
chd-117	130	39	among	among	ADP
chd-117	130	40	premenopausal	premenopausal	NOUN
chd-117	130	41	aa	aa	NOUN
chd-117	130	42	women	woman	NOUN
chd-117	130	43	with	with	ADP
chd-117	130	44	breast	breast	NOUN
chd-117	130	45	cancer	cancer	NOUN
chd-117	130	46	but	but	CCONJ
chd-117	130	47	not	not	PART
chd-117	130	48	in	in	ADP
chd-117	130	49	postmenopausal	postmenopausal	ADJ
chd-117	130	50	aa	aa	PROPN
chd-117	130	51	breast	breast	NOUN
chd-117	130	52	cancer	cancer	NOUN
chd-117	130	53	patients	patient	NOUN
chd-117	130	54	,	,	PUNCT
chd-117	130	55	which	which	PRON
chd-117	130	56	is	be	AUX
chd-117	130	57	in	in	ADP
chd-117	130	58	agreement	agreement	NOUN
chd-117	130	59	with	with	ADP
chd-117	130	60	findings	finding	NOUN
chd-117	130	61	previously	previously	ADV
chd-117	130	62	reported	report	VERB
chd-117	130	63	(	(	PUNCT
chd-117	130	64	guillemette	guillemette	NOUN
chd-117	130	65	et	et	PROPN
chd-117	130	66	al	al	PROPN
chd-117	130	67	.	.	PROPN
chd-117	130	68	,	,	PUNCT
chd-117	130	69	2000	2000	NUM
chd-117	130	70	)	)	PUNCT
chd-117	130	71	.	.	PUNCT
chd-117	131	1	additionally	additionally	ADV
chd-117	131	2	,	,	PUNCT
chd-117	131	3	in	in	ADP
chd-117	131	4	our	our	PRON
chd-117	131	5	study	study	NOUN
chd-117	131	6	,	,	PUNCT
chd-117	131	7	the	the	DET
chd-117	131	8	gene	gene	NOUN
chd-117	131	9	frequency	frequency	NOUN
chd-117	131	10	of	of	ADP
chd-117	131	11	all	all	DET
chd-117	131	12	ugt1a1	ugt1a1	ADJ
chd-117	131	13	alleles	allele	NOUN
chd-117	131	14	in	in	ADP
chd-117	131	15	african	african	ADJ
chd-117	131	16	american	american	ADJ
chd-117	131	17	women	woman	NOUN
chd-117	131	18	was	be	AUX
chd-117	131	19	similar	similar	ADJ
chd-117	131	20	to	to	ADP
chd-117	131	21	those	those	PRON
chd-117	131	22	reported	report	VERB
chd-117	131	23	previously	previously	ADV
chd-117	131	24	by	by	ADP
chd-117	131	25	guillemette	guillemette	PROPN
chd-117	131	26	et	et	PROPN
chd-117	131	27	al	al	PROPN
chd-117	131	28	(	(	PUNCT
chd-117	131	29	guillemette	guillemette	NOUN
chd-117	131	30	et	et	PROPN
chd-117	131	31	al	al	PROPN
chd-117	131	32	.	.	PROPN
chd-117	131	33	,	,	PUNCT
chd-117	131	34	2000	2000	NUM
chd-117	131	35	)	)	PUNCT
chd-117	131	36	.	.	PUNCT
chd-117	132	1	a	a	DET
chd-117	132	2	similar	similar	ADJ
chd-117	132	3	study	study	NOUN
chd-117	132	4	was	be	AUX
chd-117	132	5	conducted	conduct	VERB
chd-117	132	6	on	on	ADP
chd-117	132	7	women	woman	NOUN
chd-117	132	8	in	in	ADP
chd-117	132	9	the	the	DET
chd-117	132	10	shanghai	shanghai	PROPN
chd-117	132	11	breast	breast	PROPN
chd-117	132	12	cancer	cancer	NOUN
chd-117	132	13	study	study	NOUN
chd-117	132	14	,	,	PUNCT
chd-117	132	15	a	a	DET
chd-117	132	16	populationbased	populationbase	VERB
chd-117	132	17	case	case	NOUN
chd-117	132	18	-	-	PUNCT
chd-117	132	19	control	control	NOUN
chd-117	132	20	study	study	NOUN
chd-117	132	21	that	that	PRON
chd-117	132	22	found	find	VERB
chd-117	132	23	similar	similar	ADJ
chd-117	132	24	results	result	NOUN
chd-117	132	25	(	(	PUNCT
chd-117	132	26	adegoke	adegoke	VERB
chd-117	132	27	et	et	PROPN
chd-117	132	28	al	al	PROPN
chd-117	132	29	.	.	PROPN
chd-117	132	30	,	,	PUNCT
chd-117	132	31	2004	2004	NUM
chd-117	132	32	)	)	PUNCT
chd-117	132	33	.	.	PUNCT
chd-117	133	1	in	in	ADP
chd-117	133	2	that	that	DET
chd-117	133	3	study	study	NOUN
chd-117	133	4	,	,	PUNCT
chd-117	133	5	adegoke	adegoke	VERB
chd-117	133	6	et	et	NOUN
chd-117	133	7	al	al	PROPN
chd-117	133	8	also	also	ADV
chd-117	133	9	found	find	VERB
chd-117	133	10	that	that	SCONJ
chd-117	133	11	women	woman	NOUN
chd-117	133	12	under	under	ADP
chd-117	133	13	the	the	DET
chd-117	133	14	age	age	NOUN
chd-117	133	15	of	of	ADP
chd-117	133	16	40	40	NUM
chd-117	133	17	who	who	PRON
chd-117	133	18	carried	carry	VERB
chd-117	133	19	the	the	DET
chd-117	133	20	ugt1a1	ugt1a1	NOUN
chd-117	133	21	*	*	ADJ
chd-117	133	22	28	28	NUM
chd-117	133	23	risk	risk	NOUN
chd-117	133	24	allele	allele	NOUN
chd-117	133	25	had	have	VERB
chd-117	133	26	an	an	DET
chd-117	133	27	increased	increase	VERB
chd-117	133	28	risk	risk	NOUN
chd-117	133	29	of	of	ADP
chd-117	133	30	breast	breast	NOUN
chd-117	133	31	cancer	cancer	NOUN
chd-117	133	32	with	with	ADP
chd-117	133	33	an	an	PRON
chd-117	133	34	or	or	CCONJ
chd-117	133	35	=	=	SYM
chd-117	133	36	1.7	1.7	NUM
chd-117	133	37	;	;	PUNCT
chd-117	133	38	95	95	NUM
chd-117	133	39	%	%	NOUN
chd-117	133	40	ci	ci	NOUN
chd-117	134	1	=	=	NOUN
chd-117	135	1	1.0	1.0	NUM
chd-117	135	2	-	-	SYM
chd-117	135	3	2.7	2.7	NUM
chd-117	135	4	)	)	PUNCT
chd-117	135	5	but	but	CCONJ
chd-117	135	6	not	not	PART
chd-117	135	7	among	among	ADP
chd-117	135	8	women	woman	NOUN
chd-117	135	9	40	40	NUM
chd-117	135	10	years	year	NOUN
chd-117	135	11	old	old	ADJ
chd-117	135	12	and	and	CCONJ
chd-117	135	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-117	135	14	e9	e9	PROPN
chd-117	135	15	cancer	cancer	NOUN
chd-117	135	16	health	health	NOUN
chd-117	135	17	disparities	disparity	NOUN
chd-117	135	18	research	research	VERB
chd-117	135	19	over	over	ADP
chd-117	135	20	(	(	PUNCT
chd-117	135	21	or	or	CCONJ
chd-117	135	22	=	=	SYM
chd-117	135	23	0.8	0.8	NUM
chd-117	135	24	;	;	PUNCT
chd-117	135	25	0.7	0.7	NUM
chd-117	135	26	-	-	SYM
chd-117	135	27	1.1	1.1	NUM
chd-117	135	28	)	)	PUNCT
chd-117	135	29	(	(	PUNCT
chd-117	135	30	adegoke	adegoke	VERB
chd-117	135	31	et	et	PROPN
chd-117	135	32	al	al	PROPN
chd-117	135	33	.	.	PROPN
chd-117	135	34	,	,	PUNCT
chd-117	135	35	2004	2004	NUM
chd-117	135	36	)	)	PUNCT
chd-117	135	37	.	.	PUNCT
chd-117	136	1	likewise	likewise	ADV
chd-117	136	2	,	,	PUNCT
chd-117	136	3	similar	similar	ADJ
chd-117	136	4	findings	finding	NOUN
chd-117	136	5	have	have	AUX
chd-117	136	6	been	be	AUX
chd-117	136	7	found	find	VERB
chd-117	136	8	in	in	ADP
chd-117	136	9	russian	russian	ADJ
chd-117	136	10	women	woman	NOUN
chd-117	136	11	(	(	PUNCT
chd-117	136	12	shatalova	shatalova	VERB
chd-117	136	13	et	et	PROPN
chd-117	136	14	al	al	PROPN
chd-117	136	15	.	.	PROPN
chd-117	136	16	,	,	PUNCT
chd-117	136	17	2006	2006	NUM
chd-117	136	18	)	)	PUNCT
chd-117	136	19	.	.	PUNCT
chd-117	137	1	by	by	ADP
chd-117	137	2	contrast	contrast	NOUN
chd-117	137	3	,	,	PUNCT
chd-117	137	4	huo	huo	PROPN
chd-117	137	5	et	et	NOUN
chd-117	137	6	al	al	PROPN
chd-117	137	7	genotyped	genotype	VERB
chd-117	137	8	dna	dna	NOUN
chd-117	137	9	for	for	ADP
chd-117	137	10	the	the	DET
chd-117	137	11	ugt1a1	ugt1a1	ADJ
chd-117	137	12	*	*	ADJ
chd-117	137	13	28	28	NUM
chd-117	137	14	polymorphism	polymorphism	NOUN
chd-117	137	15	among	among	ADP
chd-117	137	16	512	512	NUM
chd-117	137	17	nigerian	nigerian	ADJ
chd-117	137	18	breast	breast	NOUN
chd-117	137	19	cancer	cancer	NOUN
chd-117	137	20	cases	case	NOUN
chd-117	137	21	and	and	CCONJ
chd-117	137	22	226	226	NUM
chd-117	137	23	community	community	NOUN
chd-117	137	24	controls	control	NOUN
chd-117	137	25	and	and	CCONJ
chd-117	137	26	found	find	VERB
chd-117	137	27	that	that	PRON
chd-117	137	28	premenopausal	premenopausal	NOUN
chd-117	137	29	indigenous	indigenous	ADJ
chd-117	137	30	nigerian	nigerian	ADJ
chd-117	137	31	african	african	ADJ
chd-117	137	32	women	woman	NOUN
chd-117	137	33	with	with	ADP
chd-117	137	34	the	the	DET
chd-117	137	35	low	low	ADJ
chd-117	137	36	-	-	PUNCT
chd-117	137	37	activity	activity	NOUN
chd-117	137	38	ugt1a1	ugt1a1	NOUN
chd-117	137	39	ta	ta	AUX
chd-117	137	40	repeat	repeat	VERB
chd-117	137	41	alleles	allele	NOUN
chd-117	137	42	were	be	AUX
chd-117	137	43	protected	protect	VERB
chd-117	137	44	against	against	ADP
chd-117	137	45	breast	breast	NOUN
chd-117	137	46	cancer	cancer	NOUN
chd-117	137	47	(	(	PUNCT
chd-117	137	48	huo	huo	NOUN
chd-117	137	49	et	et	NOUN
chd-117	137	50	al	al	PROPN
chd-117	137	51	.	.	PROPN
chd-117	137	52	,	,	PUNCT
chd-117	137	53	2008	2008	NUM
chd-117	137	54	)	)	PUNCT
chd-117	137	55	.	.	PUNCT
chd-117	138	1	these	these	DET
chd-117	138	2	findings	finding	NOUN
chd-117	138	3	show	show	VERB
chd-117	138	4	that	that	SCONJ
chd-117	138	5	the	the	DET
chd-117	138	6	frequency	frequency	NOUN
chd-117	138	7	of	of	ADP
chd-117	138	8	the	the	DET
chd-117	138	9	ugt1a1	ugt1a1	PROPN
chd-117	138	10	*	*	ADJ
chd-117	138	11	28	28	NUM
chd-117	138	12	polymorphism	polymorphism	NOUN
chd-117	138	13	varies	vary	VERB
chd-117	138	14	between	between	ADP
chd-117	138	15	populations	population	NOUN
chd-117	138	16	by	by	ADP
chd-117	138	17	race	race	NOUN
chd-117	138	18	and	and	CCONJ
chd-117	138	19	ethnicity	ethnicity	NOUN
chd-117	138	20	.	.	PUNCT
chd-117	139	1	in	in	ADP
chd-117	139	2	our	our	PRON
chd-117	139	3	previous	previous	ADJ
chd-117	139	4	published	publish	VERB
chd-117	139	5	study	study	NOUN
chd-117	139	6	,	,	PUNCT
chd-117	139	7	we	we	PRON
chd-117	139	8	showed	show	VERB
chd-117	139	9	that	that	SCONJ
chd-117	139	10	the	the	DET
chd-117	139	11	ugt1a1	ugt1a1	ADJ
chd-117	139	12	*	*	ADJ
chd-117	139	13	28	28	NUM
chd-117	139	14	promoter	promoter	NOUN
chd-117	139	15	polymorphism	polymorphism	NOUN
chd-117	139	16	was	be	AUX
chd-117	139	17	associated	associate	VERB
chd-117	139	18	with	with	ADP
chd-117	139	19	decreased	decrease	VERB
chd-117	139	20	ugt1a1	ugt1a1	ADJ
chd-117	139	21	gene	gene	NOUN
chd-117	139	22	expression	expression	NOUN
chd-117	139	23	in	in	ADP
chd-117	139	24	aa	aa	PROPN
chd-117	139	25	and	and	CCONJ
chd-117	139	26	non	non	ADJ
chd-117	139	27	-	-	ADJ
chd-117	139	28	hispanic	hispanic	ADJ
chd-117	139	29	white	white	ADJ
chd-117	139	30	women	woman	NOUN
chd-117	139	31	with	with	ADP
chd-117	139	32	breast	breast	NOUN
chd-117	139	33	cancer	cancer	NOUN
chd-117	139	34	(	(	PUNCT
chd-117	139	35	starlard	starlard	NOUN
chd-117	139	36	-	-	PUNCT
chd-117	139	37	davenport	davenport	NOUN
chd-117	139	38	et	et	PROPN
chd-117	139	39	al	al	PROPN
chd-117	139	40	.	.	PROPN
chd-117	139	41	,	,	PUNCT
chd-117	139	42	2012	2012	NUM
chd-117	139	43	)	)	PUNCT
chd-117	139	44	.	.	PUNCT
chd-117	140	1	in	in	ADP
chd-117	140	2	that	that	DET
chd-117	140	3	study	study	NOUN
chd-117	140	4	,	,	PUNCT
chd-117	140	5	we	we	PRON
chd-117	140	6	observed	observe	VERB
chd-117	140	7	a	a	DET
chd-117	140	8	significant	significant	ADJ
chd-117	140	9	decrease	decrease	NOUN
chd-117	140	10	in	in	ADP
chd-117	140	11	ugt1a1	ugt1a1	ADJ
chd-117	140	12	mrna	mrna	PROPN
chd-117	140	13	expression	expression	NOUN
chd-117	140	14	levels	level	NOUN
chd-117	140	15	among	among	ADP
chd-117	140	16	breast	breast	NOUN
chd-117	140	17	tissues	tissue	NOUN
chd-117	140	18	isolated	isolate	VERB
chd-117	140	19	from	from	ADP
chd-117	140	20	aa	aa	NOUN
chd-117	140	21	and	and	CCONJ
chd-117	140	22	nonhispanic	nonhispanic	ADJ
chd-117	140	23	white	white	ADJ
chd-117	140	24	women	woman	NOUN
chd-117	140	25	with	with	ADP
chd-117	140	26	breast	breast	NOUN
chd-117	140	27	cancer	cancer	NOUN
chd-117	140	28	(	(	PUNCT
chd-117	140	29	n	n	NOUN
chd-117	140	30	=	=	SYM
chd-117	140	31	17	17	NUM
chd-117	140	32	)	)	PUNCT
chd-117	140	33	and	and	CCONJ
chd-117	140	34	normal	normal	ADJ
chd-117	140	35	healthy	healthy	ADJ
chd-117	140	36	controls	control	NOUN
chd-117	140	37	(	(	PUNCT
chd-117	140	38	n	n	NOUN
chd-117	140	39	=	=	SYM
chd-117	140	40	30	30	NUM
chd-117	140	41	)	)	PUNCT
chd-117	140	42	(	(	PUNCT
chd-117	140	43	p	p	X
chd-117	140	44	=	=	NOUN
chd-117	140	45	0.02	0.02	NUM
chd-117	140	46	)	)	PUNCT
chd-117	140	47	.	.	PUNCT
chd-117	141	1	based	base	VERB
chd-117	141	2	on	on	ADP
chd-117	141	3	these	these	DET
chd-117	141	4	findings	finding	NOUN
chd-117	141	5	and	and	CCONJ
chd-117	141	6	those	those	PRON
chd-117	141	7	of	of	ADP
chd-117	141	8	guillemette	guillemette	NOUN
chd-117	141	9	et	et	PROPN
chd-117	141	10	al	al	PROPN
chd-117	141	11	(	(	PUNCT
chd-117	141	12	guillemette	guillemette	NOUN
chd-117	141	13	et	et	PROPN
chd-117	141	14	al	al	PROPN
chd-117	141	15	.	.	PROPN
chd-117	141	16	,	,	PUNCT
chd-117	141	17	2000	2000	NUM
chd-117	141	18	)	)	PUNCT
chd-117	141	19	who	who	PRON
chd-117	141	20	found	find	VERB
chd-117	141	21	an	an	DET
chd-117	141	22	association	association	NOUN
chd-117	141	23	between	between	ADP
chd-117	141	24	the	the	DET
chd-117	141	25	ugt1a1	ugt1a1	PROPN
chd-117	141	26	*	*	ADJ
chd-117	141	27	28	28	NUM
chd-117	141	28	polymorphism	polymorphism	NOUN
chd-117	141	29	and	and	CCONJ
chd-117	141	30	er	er	INTJ
chd-117	141	31	negative	negative	ADJ
chd-117	141	32	breast	breast	NOUN
chd-117	141	33	cancer	cancer	NOUN
chd-117	141	34	risk	risk	NOUN
chd-117	141	35	in	in	ADP
chd-117	141	36	aa	aa	PROPN
chd-117	141	37	women	woman	NOUN
chd-117	141	38	,	,	PUNCT
chd-117	141	39	we	we	PRON
chd-117	141	40	interrogated	interrogate	VERB
chd-117	141	41	existing	exist	VERB
chd-117	141	42	tcga	tcga	PROPN
chd-117	141	43	rna	rna	NOUN
chd-117	141	44	sequencing	sequencing	NOUN
chd-117	141	45	datasets	dataset	NOUN
chd-117	141	46	to	to	PART
chd-117	141	47	determine	determine	VERB
chd-117	141	48	whether	whether	SCONJ
chd-117	141	49	ugt1a1	ugt1a1	ADJ
chd-117	141	50	gene	gene	NOUN
chd-117	141	51	expression	expression	NOUN
chd-117	141	52	was	be	AUX
chd-117	141	53	differentially	differentially	ADV
chd-117	141	54	expressed	express	VERB
chd-117	141	55	among	among	ADP
chd-117	141	56	aa	aa	NOUN
chd-117	141	57	and	and	CCONJ
chd-117	141	58	non	non	ADJ
chd-117	141	59	-	-	ADJ
chd-117	141	60	hispanic	hispanic	ADJ
chd-117	141	61	white	white	ADJ
chd-117	141	62	breast	breast	NOUN
chd-117	141	63	cancer	cancer	NOUN
chd-117	141	64	patients	patient	NOUN
chd-117	141	65	by	by	ADP
chd-117	141	66	er	er	INTJ
chd-117	141	67	status	status	NOUN
chd-117	141	68	.	.	PUNCT
chd-117	142	1	in	in	ADP
chd-117	142	2	our	our	PRON
chd-117	142	3	analysis	analysis	NOUN
chd-117	142	4	,	,	PUNCT
chd-117	142	5	we	we	PRON
chd-117	142	6	were	be	AUX
chd-117	142	7	unable	unable	ADJ
chd-117	142	8	to	to	PART
chd-117	142	9	compare	compare	VERB
chd-117	142	10	ugt1a1	ugt1a1	ADJ
chd-117	142	11	mrna	mrna	NOUN
chd-117	142	12	expression	expression	NOUN
chd-117	142	13	between	between	ADP
chd-117	142	14	aa	aa	PROPN
chd-117	142	15	breast	breast	NOUN
chd-117	142	16	cancer	cancer	NOUN
chd-117	142	17	cases	case	NOUN
chd-117	142	18	and	and	CCONJ
chd-117	142	19	aa	aa	ADJ
chd-117	142	20	healthy	healthy	ADJ
chd-117	142	21	controls	control	NOUN
chd-117	142	22	since	since	SCONJ
chd-117	142	23	there	there	PRON
chd-117	142	24	was	be	VERB
chd-117	142	25	only	only	ADV
chd-117	142	26	one	one	NUM
chd-117	142	27	healthy	healthy	ADJ
chd-117	142	28	control	control	NOUN
chd-117	142	29	available	available	ADJ
chd-117	142	30	for	for	ADP
chd-117	142	31	comparison	comparison	NOUN
chd-117	142	32	.	.	PUNCT
chd-117	143	1	thus	thus	ADV
chd-117	143	2	,	,	PUNCT
chd-117	143	3	it	it	PRON
chd-117	143	4	was	be	AUX
chd-117	143	5	impossible	impossible	ADJ
chd-117	143	6	to	to	PART
chd-117	143	7	conduct	conduct	VERB
chd-117	143	8	statistical	statistical	ADJ
chd-117	143	9	analysis	analysis	NOUN
chd-117	143	10	of	of	ADP
chd-117	143	11	ugt1a1	ugt1a1	ADJ
chd-117	143	12	mrna	mrna	PROPN
chd-117	143	13	between	between	ADP
chd-117	143	14	normal	normal	ADJ
chd-117	143	15	and	and	CCONJ
chd-117	143	16	breast	breast	NOUN
chd-117	143	17	cancer	cancer	NOUN
chd-117	143	18	aa	aa	NOUN
chd-117	143	19	patients	patient	NOUN
chd-117	143	20	in	in	ADP
chd-117	143	21	the	the	DET
chd-117	143	22	tcga	tcga	NOUN
chd-117	143	23	.	.	PUNCT
chd-117	144	1	however	however	ADV
chd-117	144	2	,	,	PUNCT
chd-117	144	3	further	further	ADJ
chd-117	144	4	analysis	analysis	NOUN
chd-117	144	5	of	of	ADP
chd-117	144	6	ugt1a1	ugt1a1	ADJ
chd-117	144	7	mrna	mrna	NOUN
chd-117	144	8	expression	expression	NOUN
chd-117	144	9	in	in	ADP
chd-117	144	10	the	the	DET
chd-117	144	11	tcga	tcga	ADJ
chd-117	144	12	database	database	NOUN
chd-117	144	13	between	between	ADP
chd-117	144	14	aa	aa	NOUN
chd-117	144	15	breast	breast	NOUN
chd-117	144	16	cancers	cancer	NOUN
chd-117	144	17	and	and	CCONJ
chd-117	144	18	non	non	ADJ
chd-117	144	19	-	-	ADJ
chd-117	144	20	hispanic	hispanic	ADJ
chd-117	144	21	white	white	ADJ
chd-117	144	22	breast	breast	NOUN
chd-117	144	23	cancer	cancer	NOUN
chd-117	144	24	cases	case	NOUN
chd-117	144	25	showed	show	VERB
chd-117	144	26	that	that	SCONJ
chd-117	144	27	ugt1a1	ugt1a1	ADJ
chd-117	144	28	expression	expression	NOUN
chd-117	144	29	was	be	AUX
chd-117	144	30	downregulated	downregulate	VERB
chd-117	144	31	in	in	ADP
chd-117	144	32	breast	breast	NOUN
chd-117	144	33	cancers	cancer	NOUN
chd-117	144	34	and	and	CCONJ
chd-117	144	35	was	be	AUX
chd-117	144	36	lower	low	ADJ
chd-117	144	37	among	among	ADP
chd-117	144	38	aa	aa	ADJ
chd-117	144	39	breast	breast	NOUN
chd-117	144	40	cancers	cancer	NOUN
chd-117	144	41	compared	compare	VERB
chd-117	144	42	to	to	ADP
chd-117	144	43	nonhispanic	nonhispanic	ADJ
chd-117	144	44	white	white	ADJ
chd-117	144	45	breast	breast	NOUN
chd-117	144	46	cancer	cancer	NOUN
chd-117	144	47	cases	case	NOUN
chd-117	144	48	,	,	PUNCT
chd-117	144	49	especially	especially	ADV
chd-117	144	50	among	among	ADP
chd-117	144	51	er	er	INTJ
chd-117	144	52	negative	negative	ADJ
chd-117	144	53	breast	breast	NOUN
chd-117	144	54	tumors	tumor	NOUN
chd-117	144	55	from	from	ADP
chd-117	144	56	aa	aa	PROPN
chd-117	144	57	women	woman	NOUN
chd-117	144	58	.	.	PUNCT
chd-117	145	1	in	in	ADP
chd-117	145	2	conclusion	conclusion	NOUN
chd-117	145	3	,	,	PUNCT
chd-117	145	4	this	this	DET
chd-117	145	5	genetic	genetic	ADJ
chd-117	145	6	study	study	NOUN
chd-117	145	7	supports	support	VERB
chd-117	145	8	previous	previous	ADJ
chd-117	145	9	findings	finding	NOUN
chd-117	145	10	highlighting	highlight	VERB
chd-117	145	11	the	the	DET
chd-117	145	12	association	association	NOUN
chd-117	145	13	between	between	ADP
chd-117	145	14	the	the	DET
chd-117	145	15	ugt1a1	ugt1a1	PROPN
chd-117	145	16	*	*	ADJ
chd-117	145	17	28	28	NUM
chd-117	145	18	polymorphism	polymorphism	NOUN
chd-117	145	19	and	and	CCONJ
chd-117	145	20	premenopausal	premenopausal	NOUN
chd-117	145	21	breast	breast	NOUN
chd-117	145	22	cancer	cancer	NOUN
chd-117	145	23	risk	risk	NOUN
chd-117	145	24	among	among	ADP
chd-117	145	25	aa	aa	ADJ
chd-117	145	26	women	woman	NOUN
chd-117	145	27	.	.	PUNCT
chd-117	146	1	this	this	DET
chd-117	146	2	study	study	NOUN
chd-117	146	3	also	also	ADV
chd-117	146	4	highlights	highlight	VERB
chd-117	146	5	the	the	DET
chd-117	146	6	importance	importance	NOUN
chd-117	146	7	of	of	ADP
chd-117	146	8	investigating	investigate	VERB
chd-117	146	9	genetic	genetic	ADJ
chd-117	146	10	studies	study	NOUN
chd-117	146	11	in	in	ADP
chd-117	146	12	an	an	DET
chd-117	146	13	underserved	underserved	ADJ
chd-117	146	14	minority	minority	NOUN
chd-117	146	15	aa	aa	NOUN
chd-117	146	16	population	population	NOUN
chd-117	146	17	such	such	ADJ
chd-117	146	18	as	as	ADP
chd-117	146	19	memphis	memphis	PROPN
chd-117	146	20	,	,	PUNCT
chd-117	146	21	tn	tn	ADP
chd-117	146	22	where	where	SCONJ
chd-117	146	23	the	the	DET
chd-117	146	24	breast	breast	NOUN
chd-117	146	25	cancer	cancer	NOUN
chd-117	146	26	mortality	mortality	NOUN
chd-117	146	27	rates	rate	NOUN
chd-117	146	28	is	be	AUX
chd-117	146	29	significantly	significantly	ADV
chd-117	146	30	higher	high	ADJ
chd-117	146	31	among	among	ADP
chd-117	146	32	aa	aa	ADJ
chd-117	146	33	women	woman	NOUN
chd-117	146	34	compared	compare	VERB
chd-117	146	35	to	to	ADP
chd-117	146	36	non	non	ADJ
chd-117	146	37	-	-	ADJ
chd-117	146	38	hispanic	hispanic	ADJ
chd-117	146	39	white	white	ADJ
chd-117	146	40	women	woman	NOUN
chd-117	146	41	.	.	PUNCT
chd-117	147	1	larger	large	ADJ
chd-117	147	2	epidemiological	epidemiological	ADJ
chd-117	147	3	studies	study	NOUN
chd-117	147	4	are	be	AUX
chd-117	147	5	required	require	VERB
chd-117	147	6	to	to	PART
chd-117	147	7	replicate	replicate	VERB
chd-117	147	8	these	these	DET
chd-117	147	9	findings	finding	NOUN
chd-117	147	10	in	in	ADP
chd-117	147	11	other	other	ADJ
chd-117	147	12	populations	population	NOUN
chd-117	147	13	of	of	ADP
chd-117	147	14	african	african	ADJ
chd-117	147	15	ancestry	ancestry	NOUN
chd-117	147	16	and	and	CCONJ
chd-117	147	17	to	to	PART
chd-117	147	18	delineate	delineate	VERB
chd-117	147	19	the	the	DET
chd-117	147	20	exact	exact	ADJ
chd-117	147	21	biological	biological	ADJ
chd-117	147	22	mechanisms	mechanism	NOUN
chd-117	147	23	underlying	underlie	VERB
chd-117	147	24	the	the	DET
chd-117	147	25	effects	effect	NOUN
chd-117	147	26	of	of	ADP
chd-117	147	27	the	the	DET
chd-117	147	28	ugt1a1	ugt1a1	ADJ
chd-117	147	29	*	*	ADJ
chd-117	147	30	28	28	NUM
chd-117	147	31	promoter	promoter	NOUN
chd-117	147	32	polymorphism	polymorphism	NOUN
chd-117	147	33	in	in	ADP
chd-117	147	34	aa	aa	PROPN
chd-117	147	35	women	woman	NOUN
chd-117	147	36	.	.	PUNCT
chd-117	148	1	acknowledgements	acknowledgement	NOUN
chd-117	148	2	the	the	DET
chd-117	148	3	authors	author	NOUN
chd-117	148	4	wish	wish	VERB
chd-117	148	5	to	to	PART
chd-117	148	6	thank	thank	VERB
chd-117	148	7	all	all	DET
chd-117	148	8	participants	participant	NOUN
chd-117	148	9	in	in	ADP
chd-117	148	10	this	this	DET
chd-117	148	11	study	study	NOUN
chd-117	148	12	and	and	CCONJ
chd-117	148	13	volunteers	volunteer	NOUN
chd-117	148	14	who	who	PRON
chd-117	148	15	assisted	assist	VERB
chd-117	148	16	in	in	ADP
chd-117	148	17	consenting	consent	VERB
chd-117	148	18	and	and	CCONJ
chd-117	148	19	collecting	collect	VERB
chd-117	148	20	biospecimens	biospecimen	NOUN
chd-117	148	21	.	.	PUNCT
chd-117	149	1	special	special	ADJ
chd-117	149	2	thanks	thank	NOUN
chd-117	149	3	to	to	ADP
chd-117	149	4	mrs	mrs	PROPN
chd-117	149	5	.	.	PROPN
chd-117	149	6	gwendolyn	gwendolyn	PROPN
chd-117	149	7	brown	brown	PROPN
chd-117	149	8	with	with	ADP
chd-117	149	9	the	the	DET
chd-117	149	10	carin	carin	NOUN
chd-117	149	11	and	and	CCONJ
chd-117	149	12	sharin	sharin	NOUN
chd-117	149	13	breast	breast	NOUN
chd-117	149	14	cancer	cancer	NOUN
chd-117	149	15	support	support	NOUN
chd-117	149	16	group	group	NOUN
chd-117	149	17	and	and	CCONJ
chd-117	149	18	dr	dr	PROPN
chd-117	149	19	.	.	PROPN
chd-117	149	20	osborne	osborne	PROPN
chd-117	149	21	burks	burks	PROPN
chd-117	149	22	at	at	ADP
chd-117	149	23	southwest	southwest	PROPN
chd-117	149	24	tennessee	tennessee	PROPN
chd-117	149	25	community	community	PROPN
chd-117	149	26	college	college	PROPN
chd-117	149	27	.	.	PUNCT
chd-117	150	1	the	the	DET
chd-117	150	2	authors	author	NOUN
chd-117	150	3	wish	wish	VERB
chd-117	150	4	to	to	PART
chd-117	150	5	acknowledge	acknowledge	VERB
chd-117	150	6	support	support	NOUN
chd-117	150	7	from	from	ADP
chd-117	150	8	the	the	DET
chd-117	150	9	university	university	PROPN
chd-117	150	10	of	of	ADP
chd-117	150	11	tennessee	tennessee	PROPN
chd-117	150	12	health	health	PROPN
chd-117	150	13	science	science	PROPN
chd-117	150	14	center	center	PROPN
chd-117	150	15	(	(	PUNCT
chd-117	150	16	uthsc	uthsc	NOUN
chd-117	150	17	)	)	PUNCT
chd-117	150	18	molecular	molecular	ADJ
chd-117	150	19	resource	resource	NOUN
chd-117	150	20	center	center	NOUN
chd-117	150	21	and	and	CCONJ
chd-117	150	22	the	the	DET
chd-117	150	23	west	west	PROPN
chd-117	150	24	cancer	cancer	NOUN
chd-117	150	25	center	center	NOUN
chd-117	150	26	.	.	PUNCT
chd-117	151	1	funding	funding	NOUN
chd-117	151	2	sources	source	NOUN
chd-117	151	3	this	this	DET
chd-117	151	4	work	work	NOUN
chd-117	151	5	was	be	AUX
chd-117	151	6	supported	support	VERB
chd-117	151	7	by	by	ADP
chd-117	151	8	generous	generous	ADJ
chd-117	151	9	funds	fund	NOUN
chd-117	151	10	from	from	ADP
chd-117	151	11	the	the	DET
chd-117	151	12	uthsc	uthsc	ADJ
chd-117	151	13	center	center	NOUN
chd-117	151	14	for	for	ADP
chd-117	151	15	integrative	integrative	ADJ
chd-117	151	16	genetics	genetic	NOUN
chd-117	151	17	(	(	PUNCT
chd-117	151	18	citg	citg	VERB
chd-117	151	19	)	)	PUNCT
chd-117	151	20	and	and	CCONJ
chd-117	151	21	methodist	methodist	NOUN
chd-117	151	22	mission	mission	NOUN
chd-117	151	23	to	to	ADP
chd-117	151	24	as	as	ADP
chd-117	151	25	-	-	PUNCT
chd-117	151	26	d	d	NOUN
chd-117	151	27	)	)	PUNCT
chd-117	151	28	.	.	PUNCT
chd-117	152	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-117	152	2	e10	e10	NUM
chd-117	152	3	cancer	cancer	NOUN
chd-117	152	4	health	health	NOUN
chd-117	152	5	disparities	disparity	NOUN
chd-117	152	6	research	research	VERB
chd-117	152	7	conflict	conflict	NOUN
chd-117	152	8	of	of	ADP
chd-117	152	9	interest	interest	NOUN
chd-117	152	10	the	the	DET
chd-117	152	11	authors	author	NOUN
chd-117	152	12	declare	declare	VERB
chd-117	152	13	that	that	SCONJ
chd-117	152	14	no	no	DET
chd-117	152	15	competing	compete	VERB
chd-117	152	16	or	or	CCONJ
chd-117	152	17	conflict	conflict	NOUN
chd-117	152	18	of	of	ADP
chd-117	152	19	interests	interest	NOUN
chd-117	152	20	exists	exist	VERB
chd-117	152	21	.	.	PUNCT
chd-117	153	1	the	the	DET
chd-117	153	2	funders	funder	NOUN
chd-117	153	3	had	have	VERB
chd-117	153	4	no	no	DET
chd-117	153	5	role	role	NOUN
chd-117	153	6	in	in	ADP
chd-117	153	7	study	study	NOUN
chd-117	153	8	design	design	NOUN
chd-117	153	9	,	,	PUNCT
chd-117	153	10	writing	writing	NOUN
chd-117	153	11	of	of	ADP
chd-117	153	12	the	the	DET
chd-117	153	13	manuscript	manuscript	NOUN
chd-117	153	14	,	,	PUNCT
chd-117	153	15	or	or	CCONJ
chd-117	153	16	decision	decision	NOUN
chd-117	153	17	to	to	PART
chd-117	153	18	publish	publish	VERB
chd-117	153	19	.	.	PUNCT
chd-117	154	1	authors	author	NOUN
chd-117	154	2	’	’	PART
chd-117	154	3	contributions	contribution	NOUN
chd-117	154	4	conceptualization	conceptualization	NOUN
chd-117	154	5	:	:	PUNCT
chd-117	154	6	as	as	ADP
chd-117	154	7	-	-	PUNCT
chd-117	154	8	d	d	NOUN
chd-117	154	9	,	,	PUNCT
chd-117	154	10	formal	formal	ADJ
chd-117	154	11	analysis	analysis	NOUN
chd-117	154	12	:	:	PUNCT
chd-117	154	13	as	as	ADP
chd-117	154	14	-	-	PUNCT
chd-117	154	15	d	d	PROPN
chd-117	154	16	,	,	PUNCT
chd-117	154	17	cdc	cdc	PROPN
chd-117	154	18	,	,	PUNCT
chd-117	154	19	cs	cs	PROPN
chd-117	154	20	.	.	PROPN
chd-117	154	21	methodology	methodology	PROPN
chd-117	154	22	:	:	PUNCT
chd-117	154	23	as	as	ADP
chd-117	154	24	,	,	PUNCT
chd-117	154	25	jc	jc	PROPN
chd-117	154	26	,	,	PUNCT
chd-117	154	27	gv	gv	ADP
chd-117	154	28	,	,	PUNCT
chd-117	154	29	ep	ep	PROPN
chd-117	154	30	.	.	PROPN
chd-117	154	31	supervision	supervision	PROPN
chd-117	154	32	:	:	PUNCT
chd-117	154	33	as	as	SCONJ
chd-117	154	34	-	-	PUNCT
chd-117	154	35	d.	d.	NOUN
chd-117	154	36	writing	write	VERB
chd-117	154	37	±	±	NUM
chd-117	154	38	original	original	ADJ
chd-117	154	39	draft	draft	NOUN
chd-117	154	40	:	:	PUNCT
chd-117	154	41	as	as	ADP
chd-117	154	42	-	-	PUNCT
chd-117	154	43	d	d	NOUN
chd-117	154	44	,	,	PUNCT
chd-117	154	45	as	as	ADP
chd-117	154	46	,	,	PUNCT
chd-117	154	47	cdc	cdc	PROPN
chd-117	154	48	,	,	PUNCT
chd-117	154	49	gv	gv	PROPN
chd-117	154	50	.	.	PUNCT
chd-117	154	51	writing	write	VERB
chd-117	154	52	±	±	NUM
chd-117	154	53	review	review	NOUN
chd-117	154	54	&	&	CCONJ
chd-117	154	55	editing	editing	NOUN
chd-117	154	56	:	:	PUNCT
chd-117	154	57	as	as	ADP
chd-117	154	58	-	-	PUNCT
chd-117	154	59	d	d	NOUN
chd-117	154	60	,	,	PUNCT
chd-117	154	61	as	as	ADP
chd-117	154	62	,	,	PUNCT
chd-117	154	63	cdc	cdc	PROPN
chd-117	154	64	,	,	PUNCT
chd-117	154	65	gv	gv	ADP
chd-117	154	66	,	,	PUNCT
chd-117	154	67	cs	cs	ADJ
chd-117	154	68	references	reference	NOUN
chd-117	154	69	adegoke	adegoke	VERB
chd-117	154	70	,	,	PUNCT
chd-117	154	71	o.j	o.j	PROPN
chd-117	154	72	.	.	PROPN
chd-117	154	73	,	,	PUNCT
chd-117	154	74	shu	shu	PROPN
chd-117	154	75	,	,	PUNCT
chd-117	154	76	x.o	x.o	PROPN
chd-117	154	77	.	.	PROPN
chd-117	154	78	,	,	PUNCT
chd-117	154	79	gao	gao	PROPN
chd-117	154	80	,	,	PUNCT
chd-117	154	81	y.t	y.t	PROPN
chd-117	154	82	.	.	PROPN
chd-117	154	83	,	,	PUNCT
chd-117	154	84	cai	cai	PROPN
chd-117	154	85	,	,	PUNCT
chd-117	154	86	q.	q.	PROPN
chd-117	154	87	,	,	PUNCT
chd-117	154	88	breyer	breyer	NOUN
chd-117	154	89	,	,	PUNCT
chd-117	154	90	j.	j.	PROPN
chd-117	154	91	,	,	PUNCT
chd-117	154	92	smith	smith	PROPN
chd-117	154	93	,	,	PUNCT
chd-117	154	94	j.	j.	PROPN
chd-117	154	95	,	,	PUNCT
chd-117	154	96	and	and	CCONJ
chd-117	154	97	zheng	zheng	PROPN
chd-117	154	98	,	,	PUNCT
chd-117	154	99	w.	w.	PROPN
chd-117	154	100	(	(	PUNCT
chd-117	154	101	2004	2004	NUM
chd-117	154	102	)	)	PUNCT
chd-117	154	103	.	.	PUNCT
chd-117	155	1	genetic	genetic	ADJ
chd-117	155	2	polymorphisms	polymorphism	NOUN
chd-117	155	3	in	in	ADP
chd-117	155	4	uridine	uridine	NOUN
chd-117	155	5	diphospho	diphospho	NOUN
chd-117	155	6	-	-	PUNCT
chd-117	155	7	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	155	8	1a1	1a1	NUM
chd-117	155	9	(	(	PUNCT
chd-117	155	10	ugt1a1	ugt1a1	NOUN
chd-117	155	11	)	)	PUNCT
chd-117	155	12	and	and	CCONJ
chd-117	155	13	risk	risk	NOUN
chd-117	155	14	of	of	ADP
chd-117	155	15	breast	breast	NOUN
chd-117	155	16	cancer	cancer	NOUN
chd-117	155	17	.	.	PUNCT
chd-117	156	1	breast	breast	NOUN
chd-117	156	2	cancer	cancer	NOUN
chd-117	156	3	research	research	NOUN
chd-117	156	4	and	and	CCONJ
chd-117	156	5	treatment	treatment	NOUN
chd-117	156	6	85	85	NUM
chd-117	156	7	,	,	PUNCT
chd-117	156	8	239	239	NUM
chd-117	156	9	-	-	SYM
chd-117	156	10	245	245	NUM
chd-117	156	11	.	.	PUNCT
chd-117	157	1	ambrosone	ambrosone	NOUN
chd-117	157	2	,	,	PUNCT
chd-117	157	3	c.b	c.b	PROPN
chd-117	157	4	.	.	PROPN
chd-117	157	5	,	,	PUNCT
chd-117	157	6	zirpoli	zirpoli	PROPN
chd-117	157	7	,	,	PUNCT
chd-117	157	8	g.	g.	PROPN
chd-117	157	9	,	,	PUNCT
chd-117	157	10	hong	hong	PROPN
chd-117	157	11	,	,	PUNCT
chd-117	157	12	c.c	c.c	PROPN
chd-117	157	13	.	.	PROPN
chd-117	157	14	,	,	PUNCT
chd-117	157	15	yao	yao	PROPN
chd-117	157	16	,	,	PUNCT
chd-117	157	17	s.	s.	PROPN
chd-117	157	18	,	,	PUNCT
chd-117	157	19	troester	troester	PROPN
chd-117	157	20	,	,	PUNCT
chd-117	157	21	m.a	m.a	PROPN
chd-117	157	22	.	.	PROPN
chd-117	157	23	,	,	PUNCT
chd-117	157	24	bandera	bandera	PROPN
chd-117	157	25	,	,	PUNCT
chd-117	157	26	e.v	e.v	PROPN
chd-117	157	27	.	.	PROPN
chd-117	157	28	,	,	PUNCT
chd-117	157	29	schedin	schedin	NOUN
chd-117	157	30	,	,	PUNCT
chd-117	157	31	p.	p.	PROPN
chd-117	157	32	,	,	PUNCT
chd-117	157	33	bethea	bethea	PROPN
chd-117	157	34	,	,	PUNCT
chd-117	157	35	t.n	t.n	PROPN
chd-117	157	36	.	.	PROPN
chd-117	157	37	,	,	PUNCT
chd-117	157	38	borges	borge	NOUN
chd-117	157	39	,	,	PUNCT
chd-117	157	40	v.	v.	ADV
chd-117	157	41	,	,	PUNCT
chd-117	157	42	park	park	NOUN
chd-117	157	43	,	,	PUNCT
chd-117	157	44	s.y	s.y	PROPN
chd-117	157	45	.	.	PROPN
chd-117	157	46	,	,	PUNCT
chd-117	157	47	et	et	PROPN
chd-117	157	48	al	al	PROPN
chd-117	157	49	.	.	PUNCT
chd-117	157	50	(	(	PUNCT
chd-117	157	51	2015	2015	NUM
chd-117	157	52	)	)	PUNCT
chd-117	157	53	.	.	PUNCT
chd-117	158	1	important	important	ADJ
chd-117	158	2	role	role	NOUN
chd-117	158	3	of	of	ADP
chd-117	158	4	menarche	menarche	NOUN
chd-117	158	5	in	in	ADP
chd-117	158	6	development	development	NOUN
chd-117	158	7	of	of	ADP
chd-117	158	8	estrogen	estrogen	NOUN
chd-117	158	9	receptor	receptor	NOUN
chd-117	158	10	-	-	PUNCT
chd-117	158	11	negative	negative	ADJ
chd-117	158	12	breast	breast	NOUN
chd-117	158	13	cancer	cancer	NOUN
chd-117	158	14	in	in	ADP
chd-117	158	15	african	african	ADJ
chd-117	158	16	american	american	ADJ
chd-117	158	17	women	woman	NOUN
chd-117	158	18	.	.	PUNCT
chd-117	159	1	journal	journal	PROPN
chd-117	159	2	of	of	ADP
chd-117	159	3	the	the	DET
chd-117	159	4	national	national	PROPN
chd-117	159	5	cancer	cancer	PROPN
chd-117	159	6	institute	institute	PROPN
chd-117	159	7	107	107	NUM
chd-117	159	8	.	.	PUNCT
chd-117	160	1	beutler	beutler	PROPN
chd-117	160	2	,	,	PUNCT
chd-117	160	3	e.	e.	PROPN
chd-117	160	4	,	,	PUNCT
chd-117	160	5	gelbart	gelbart	NOUN
chd-117	160	6	,	,	PUNCT
chd-117	160	7	t.	t.	PROPN
chd-117	160	8	,	,	PUNCT
chd-117	160	9	and	and	CCONJ
chd-117	160	10	demina	demina	PROPN
chd-117	160	11	,	,	PUNCT
chd-117	160	12	a.	a.	PROPN
chd-117	160	13	(	(	PUNCT
chd-117	160	14	1998	1998	NUM
chd-117	160	15	)	)	PUNCT
chd-117	160	16	.	.	PUNCT
chd-117	161	1	racial	racial	ADJ
chd-117	161	2	variability	variability	NOUN
chd-117	161	3	in	in	ADP
chd-117	161	4	the	the	DET
chd-117	161	5	udp	udp	NOUN
chd-117	161	6	-	-	NOUN
chd-117	161	7	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	161	8	1	1	NUM
chd-117	161	9	(	(	PUNCT
chd-117	161	10	ugt1a1	ugt1a1	NOUN
chd-117	161	11	)	)	PUNCT
chd-117	161	12	promoter	promoter	NOUN
chd-117	161	13	:	:	PUNCT
chd-117	161	14	a	a	DET
chd-117	161	15	balanced	balanced	ADJ
chd-117	161	16	polymorphism	polymorphism	NOUN
chd-117	161	17	for	for	ADP
chd-117	161	18	regulation	regulation	NOUN
chd-117	161	19	of	of	ADP
chd-117	161	20	bilirubin	bilirubin	ADJ
chd-117	161	21	metabolism	metabolism	NOUN
chd-117	161	22	?	?	PUNCT
chd-117	162	1	proceedings	proceeding	NOUN
chd-117	162	2	of	of	ADP
chd-117	162	3	the	the	DET
chd-117	162	4	national	national	PROPN
chd-117	162	5	academy	academy	PROPN
chd-117	162	6	of	of	ADP
chd-117	162	7	sciences	sciences	PROPN
chd-117	162	8	of	of	ADP
chd-117	162	9	the	the	DET
chd-117	162	10	united	united	PROPN
chd-117	162	11	states	states	PROPN
chd-117	162	12	of	of	ADP
chd-117	162	13	america	america	PROPN
chd-117	162	14	95	95	NUM
chd-117	162	15	,	,	PUNCT
chd-117	162	16	8170	8170	NUM
chd-117	162	17	-	-	SYM
chd-117	162	18	8174	8174	NUM
chd-117	162	19	.	.	PUNCT
chd-117	163	1	bock	bock	NOUN
chd-117	163	2	,	,	PUNCT
chd-117	163	3	k.w	k.w	PROPN
chd-117	163	4	.	.	PROPN
chd-117	163	5	,	,	PUNCT
chd-117	163	6	lilienblum	lilienblum	PROPN
chd-117	163	7	,	,	PUNCT
chd-117	163	8	w.	w.	PROPN
chd-117	163	9	,	,	PUNCT
chd-117	163	10	fischer	fischer	PROPN
chd-117	163	11	,	,	PUNCT
chd-117	163	12	g.	g.	PROPN
chd-117	163	13	,	,	PUNCT
chd-117	163	14	schirmer	schirmer	PROPN
chd-117	163	15	,	,	PUNCT
chd-117	163	16	g.	g.	PROPN
chd-117	163	17	,	,	PUNCT
chd-117	163	18	and	and	CCONJ
chd-117	163	19	bockhenning	bockhenning	NOUN
chd-117	163	20	,	,	PUNCT
chd-117	163	21	b.s	b.s	PROPN
chd-117	163	22	.	.	PROPN
chd-117	163	23	(	(	PUNCT
chd-117	163	24	1987	1987	NUM
chd-117	163	25	)	)	PUNCT
chd-117	163	26	.	.	PUNCT
chd-117	164	1	the	the	DET
chd-117	164	2	role	role	NOUN
chd-117	164	3	of	of	ADP
chd-117	164	4	conjugation	conjugation	NOUN
chd-117	164	5	reactions	reaction	NOUN
chd-117	164	6	in	in	ADP
chd-117	164	7	detoxication	detoxication	NOUN
chd-117	164	8	.	.	PUNCT
chd-117	165	1	archives	archive	NOUN
chd-117	165	2	of	of	ADP
chd-117	165	3	toxicology	toxicology	NOUN
chd-117	165	4	60	60	NUM
chd-117	165	5	,	,	PUNCT
chd-117	165	6	22	22	NUM
chd-117	165	7	-	-	SYM
chd-117	165	8	29	29	NUM
chd-117	165	9	.	.	PUNCT
chd-117	166	1	boyd	boyd	PROPN
chd-117	166	2	,	,	PUNCT
chd-117	166	3	m.a	m.a	PROPN
chd-117	166	4	.	.	PROPN
chd-117	166	5	,	,	PUNCT
chd-117	166	6	srasuebkul	srasuebkul	NOUN
chd-117	166	7	,	,	PUNCT
chd-117	166	8	p.	p.	PROPN
chd-117	166	9	,	,	PUNCT
chd-117	166	10	ruxrungtham	ruxrungtham	PROPN
chd-117	166	11	,	,	PUNCT
chd-117	166	12	k.	k.	PROPN
chd-117	166	13	,	,	PUNCT
chd-117	166	14	mackenzie	mackenzie	PROPN
chd-117	166	15	,	,	PUNCT
chd-117	166	16	p.i	p.i	PROPN
chd-117	166	17	.	.	PROPN
chd-117	166	18	,	,	PUNCT
chd-117	166	19	uchaipichat	uchaipichat	PROPN
chd-117	166	20	,	,	PUNCT
chd-117	166	21	v.	v.	PROPN
chd-117	166	22	,	,	PUNCT
chd-117	166	23	stek	stek	PROPN
chd-117	166	24	,	,	PUNCT
chd-117	166	25	m.	m.	NOUN
chd-117	166	26	,	,	PUNCT
chd-117	166	27	jr	jr	PROPN
chd-117	166	28	.	.	PROPN
chd-117	166	29	,	,	PUNCT
chd-117	166	30	lange	lange	PROPN
chd-117	166	31	,	,	PUNCT
chd-117	166	32	j.m	j.m	PROPN
chd-117	166	33	.	.	PROPN
chd-117	166	34	,	,	PUNCT
chd-117	166	35	phanuphak	phanuphak	PROPN
chd-117	166	36	,	,	PUNCT
chd-117	166	37	p.	p.	PROPN
chd-117	166	38	,	,	PUNCT
chd-117	166	39	cooper	cooper	PROPN
chd-117	166	40	,	,	PUNCT
chd-117	166	41	d.a	d.a	PROPN
chd-117	166	42	.	.	PROPN
chd-117	166	43	,	,	PUNCT
chd-117	166	44	udomuksorn	udomuksorn	ADJ
chd-117	166	45	,	,	PUNCT
chd-117	166	46	w.	w.	PROPN
chd-117	166	47	,	,	PUNCT
chd-117	166	48	et	et	PROPN
chd-117	166	49	al	al	PROPN
chd-117	166	50	.	.	PUNCT
chd-117	166	51	(	(	PUNCT
chd-117	166	52	2006	2006	NUM
chd-117	166	53	)	)	PUNCT
chd-117	166	54	.	.	PUNCT
chd-117	167	1	relationship	relationship	NOUN
chd-117	167	2	between	between	ADP
chd-117	167	3	hyperbilirubinaemia	hyperbilirubinaemia	NOUN
chd-117	167	4	and	and	CCONJ
chd-117	167	5	udpglucuronosyltransferase	udpglucuronosyltransferase	PROPN
chd-117	167	6	1a1	1a1	NUM
chd-117	167	7	(	(	PUNCT
chd-117	167	8	ugt1a1	ugt1a1	ADJ
chd-117	167	9	)	)	PUNCT
chd-117	167	10	polymorphism	polymorphism	NOUN
chd-117	167	11	in	in	ADP
chd-117	167	12	adult	adult	PROPN
chd-117	167	13	hiv	hiv	PROPN
chd-117	167	14	-	-	PUNCT
chd-117	167	15	infected	infect	VERB
chd-117	167	16	thai	thai	ADJ
chd-117	167	17	patients	patient	NOUN
chd-117	167	18	treated	treat	VERB
chd-117	167	19	with	with	ADP
chd-117	167	20	indinavir	indinavir	NOUN
chd-117	167	21	.	.	PUNCT
chd-117	168	1	pharmacogenetics	pharmacogenetic	NOUN
chd-117	168	2	and	and	CCONJ
chd-117	168	3	genomics	genomic	NOUN
chd-117	168	4	16	16	NUM
chd-117	168	5	,	,	PUNCT
chd-117	168	6	321	321	NUM
chd-117	168	7	-	-	SYM
chd-117	168	8	329	329	NUM
chd-117	168	9	.	.	PUNCT
chd-117	169	1	cavalieri	cavalieri	PROPN
chd-117	169	2	,	,	PUNCT
chd-117	169	3	e.l	e.l	PROPN
chd-117	169	4	.	.	PROPN
chd-117	169	5	,	,	PUNCT
chd-117	169	6	stack	stack	NOUN
chd-117	169	7	,	,	PUNCT
chd-117	169	8	d.e	d.e	PROPN
chd-117	169	9	.	.	PROPN
chd-117	169	10	,	,	PUNCT
chd-117	169	11	devanesan	devanesan	PROPN
chd-117	169	12	,	,	PUNCT
chd-117	169	13	p.d	p.d	PROPN
chd-117	169	14	.	.	PROPN
chd-117	169	15	,	,	PUNCT
chd-117	169	16	todorovic	todorovic	PROPN
chd-117	169	17	,	,	PUNCT
chd-117	169	18	r.	r.	PROPN
chd-117	169	19	,	,	PUNCT
chd-117	169	20	dwivedy	dwivedy	PROPN
chd-117	169	21	,	,	PUNCT
chd-117	169	22	i.	i.	PROPN
chd-117	169	23	,	,	PUNCT
chd-117	169	24	higginbotham	higginbotham	PROPN
chd-117	169	25	,	,	PUNCT
chd-117	169	26	s.	s.	PROPN
chd-117	169	27	,	,	PUNCT
chd-117	169	28	johansson	johansson	PROPN
chd-117	169	29	,	,	PUNCT
chd-117	169	30	s.l	s.l	PROPN
chd-117	169	31	.	.	PROPN
chd-117	169	32	,	,	PUNCT
chd-117	169	33	patil	patil	PROPN
chd-117	169	34	,	,	PUNCT
chd-117	169	35	k.d	k.d	PROPN
chd-117	169	36	.	.	PROPN
chd-117	169	37	,	,	PUNCT
chd-117	169	38	gross	gross	PROPN
chd-117	169	39	,	,	PUNCT
chd-117	169	40	m.l	m.l	PROPN
chd-117	169	41	.	.	PROPN
chd-117	169	42	,	,	PUNCT
chd-117	169	43	gooden	gooden	PROPN
chd-117	169	44	,	,	PUNCT
chd-117	169	45	j.k	j.k	PROPN
chd-117	169	46	.	.	PROPN
chd-117	169	47	,	,	PUNCT
chd-117	169	48	et	et	PROPN
chd-117	169	49	al	al	PROPN
chd-117	169	50	.	.	PROPN
chd-117	169	51	(	(	PUNCT
chd-117	169	52	1997	1997	NUM
chd-117	169	53	)	)	PUNCT
chd-117	169	54	.	.	PUNCT
chd-117	170	1	molecular	molecular	ADJ
chd-117	170	2	origin	origin	NOUN
chd-117	170	3	of	of	ADP
chd-117	170	4	cancer	cancer	NOUN
chd-117	170	5	:	:	PUNCT
chd-117	170	6	catechol	catechol	NOUN
chd-117	170	7	estrogen-3,4	estrogen-3,4	ADJ
chd-117	170	8	-	-	NOUN
chd-117	170	9	quinones	quinone	NOUN
chd-117	170	10	as	as	ADP
chd-117	170	11	endogenous	endogenous	ADJ
chd-117	170	12	tumor	tumor	NOUN
chd-117	170	13	initiators	initiator	NOUN
chd-117	170	14	.	.	PUNCT
chd-117	171	1	proceedings	proceeding	NOUN
chd-117	171	2	of	of	ADP
chd-117	171	3	the	the	DET
chd-117	171	4	national	national	PROPN
chd-117	171	5	academy	academy	PROPN
chd-117	171	6	of	of	ADP
chd-117	171	7	sciences	sciences	PROPN
chd-117	171	8	of	of	ADP
chd-117	171	9	the	the	DET
chd-117	171	10	united	united	PROPN
chd-117	171	11	states	states	PROPN
chd-117	171	12	of	of	ADP
chd-117	171	13	america	america	PROPN
chd-117	171	14	94	94	NUM
chd-117	171	15	,	,	PUNCT
chd-117	171	16	1093710942	1093710942	NUM
chd-117	171	17	.	.	PUNCT
chd-117	172	1	corsini	corsini	PROPN
chd-117	172	2	,	,	PUNCT
chd-117	172	3	c.	c.	PROPN
chd-117	172	4	,	,	PUNCT
chd-117	172	5	henouda	henouda	NOUN
chd-117	172	6	,	,	PUNCT
chd-117	172	7	s.	s.	PROPN
chd-117	172	8	,	,	PUNCT
chd-117	172	9	nejima	nejima	PROPN
chd-117	172	10	,	,	PUNCT
chd-117	172	11	d.b	d.b	PROPN
chd-117	172	12	.	.	PROPN
chd-117	172	13	,	,	PUNCT
chd-117	172	14	bertet	bertet	PROPN
chd-117	172	15	,	,	PUNCT
chd-117	172	16	h.	h.	PROPN
chd-117	172	17	,	,	PUNCT
chd-117	172	18	toledano	toledano	PROPN
chd-117	172	19	,	,	PUNCT
chd-117	172	20	a.	a.	NOUN
chd-117	172	21	,	,	PUNCT
chd-117	172	22	boussen	boussen	VERB
chd-117	172	23	,	,	PUNCT
chd-117	172	24	h.	h.	PROPN
chd-117	172	25	,	,	PUNCT
chd-117	172	26	habib	habib	PROPN
chd-117	172	27	,	,	PUNCT
chd-117	172	28	f.	f.	PROPN
chd-117	172	29	,	,	PUNCT
chd-117	172	30	mouhout	mouhout	PROPN
chd-117	172	31	,	,	PUNCT
chd-117	172	32	a.	a.	NOUN
chd-117	172	33	,	,	PUNCT
chd-117	172	34	gaballah	gaballah	PROPN
chd-117	172	35	,	,	PUNCT
chd-117	172	36	a.	a.	NOUN
chd-117	172	37	,	,	PUNCT
chd-117	172	38	ghazaly	ghazaly	NOUN
chd-117	172	39	,	,	PUNCT
chd-117	172	40	h.e	h.e	PROPN
chd-117	172	41	.	.	PROPN
chd-117	172	42	,	,	PUNCT
chd-117	172	43	et	et	PROPN
chd-117	172	44	al	al	PROPN
chd-117	172	45	.	.	PUNCT
chd-117	172	46	(	(	PUNCT
chd-117	172	47	2017	2017	NUM
chd-117	172	48	)	)	PUNCT
chd-117	172	49	.	.	PUNCT
chd-117	173	1	early	early	ADJ
chd-117	173	2	onset	onset	VERB
chd-117	173	3	breast	breast	NOUN
chd-117	173	4	cancer	cancer	NOUN
chd-117	173	5	:	:	PUNCT
chd-117	173	6	differences	difference	NOUN
chd-117	173	7	in	in	ADP
chd-117	173	8	risk	risk	NOUN
chd-117	173	9	factors	factor	NOUN
chd-117	173	10	,	,	PUNCT
chd-117	173	11	tumor	tumor	NOUN
chd-117	173	12	phenotype	phenotype	NOUN
chd-117	173	13	,	,	PUNCT
chd-117	173	14	and	and	CCONJ
chd-117	173	15	genotype	genotype	NOUN
chd-117	173	16	between	between	ADP
chd-117	173	17	north	north	NOUN
chd-117	173	18	african	african	ADJ
chd-117	173	19	and	and	CCONJ
chd-117	173	20	south	south	ADJ
chd-117	173	21	european	european	ADJ
chd-117	173	22	women	woman	NOUN
chd-117	173	23	.	.	PUNCT
chd-117	174	1	breast	breast	NOUN
chd-117	174	2	cancer	cancer	NOUN
chd-117	174	3	research	research	NOUN
chd-117	174	4	and	and	CCONJ
chd-117	174	5	treatment	treatment	NOUN
chd-117	174	6	166	166	NUM
chd-117	174	7	,	,	PUNCT
chd-117	174	8	631639	631639	NUM
chd-117	174	9	.	.	PUNCT
chd-117	175	1	desantis	desantis	PROPN
chd-117	175	2	,	,	PUNCT
chd-117	175	3	c.e	c.e	PROPN
chd-117	175	4	.	.	PROPN
chd-117	175	5	,	,	PUNCT
chd-117	175	6	ma	ma	PROPN
chd-117	175	7	,	,	PUNCT
chd-117	175	8	j.	j.	PROPN
chd-117	175	9	,	,	PUNCT
chd-117	175	10	goding	gode	VERB
chd-117	175	11	sauer	sauer	NOUN
chd-117	175	12	,	,	PUNCT
chd-117	175	13	a.	a.	PROPN
chd-117	175	14	,	,	PUNCT
chd-117	175	15	newman	newman	PROPN
chd-117	175	16	,	,	PUNCT
chd-117	175	17	l.a	l.a	PROPN
chd-117	175	18	.	.	PROPN
chd-117	175	19	,	,	PUNCT
chd-117	175	20	and	and	CCONJ
chd-117	175	21	jemal	jemal	ADJ
chd-117	175	22	,	,	PUNCT
chd-117	175	23	a.	a.	NOUN
chd-117	175	24	(	(	PUNCT
chd-117	175	25	2017	2017	NUM
chd-117	175	26	)	)	PUNCT
chd-117	175	27	.	.	PUNCT
chd-117	176	1	breast	breast	NOUN
chd-117	176	2	cancer	cancer	NOUN
chd-117	176	3	statistics	statistic	NOUN
chd-117	176	4	,	,	PUNCT
chd-117	176	5	2017	2017	NUM
chd-117	176	6	,	,	PUNCT
chd-117	176	7	racial	racial	ADJ
chd-117	176	8	disparity	disparity	NOUN
chd-117	176	9	in	in	ADP
chd-117	176	10	mortality	mortality	NOUN
chd-117	176	11	by	by	ADP
chd-117	176	12	state	state	NOUN
chd-117	176	13	.	.	PUNCT
chd-117	177	1	ca	can	AUX
chd-117	177	2	:	:	PUNCT
chd-117	177	3	a	a	DET
chd-117	177	4	cancer	cancer	NOUN
chd-117	177	5	journal	journal	NOUN
chd-117	177	6	for	for	ADP
chd-117	177	7	clinicians	clinician	NOUN
chd-117	177	8	67	67	NUM
chd-117	177	9	,	,	PUNCT
chd-117	177	10	439	439	NUM
chd-117	177	11	-	-	SYM
chd-117	177	12	448	448	NUM
chd-117	177	13	.	.	PUNCT
chd-117	178	1	dietze	dietze	PROPN
chd-117	178	2	,	,	PUNCT
chd-117	178	3	e.c	e.c	PROPN
chd-117	178	4	.	.	PROPN
chd-117	178	5	,	,	PUNCT
chd-117	178	6	chavez	chavez	PROPN
chd-117	178	7	,	,	PUNCT
chd-117	178	8	t.a	t.a	PROPN
chd-117	178	9	.	.	PROPN
chd-117	178	10	,	,	PUNCT
chd-117	178	11	and	and	CCONJ
chd-117	178	12	seewaldt	seewaldt	ADJ
chd-117	178	13	,	,	PUNCT
chd-117	178	14	v.l	v.l	PROPN
chd-117	178	15	.	.	PROPN
chd-117	178	16	(	(	PUNCT
chd-117	178	17	2018	2018	NUM
chd-117	178	18	)	)	PUNCT
chd-117	178	19	.	.	PUNCT
chd-117	179	1	obesity	obesity	NOUN
chd-117	179	2	and	and	CCONJ
chd-117	179	3	triple	triple	ADJ
chd-117	179	4	-	-	PUNCT
chd-117	179	5	negative	negative	ADJ
chd-117	179	6	breast	breast	NOUN
chd-117	179	7	cancer	cancer	NOUN
chd-117	179	8	:	:	PUNCT
chd-117	179	9	disparities	disparity	NOUN
chd-117	179	10	,	,	PUNCT
chd-117	179	11	controversies	controversy	NOUN
chd-117	179	12	,	,	PUNCT
chd-117	179	13	and	and	CCONJ
chd-117	179	14	biology	biology	NOUN
chd-117	179	15	.	.	PUNCT
chd-117	180	1	the	the	DET
chd-117	180	2	american	american	PROPN
chd-117	180	3	journal	journal	PROPN
chd-117	180	4	of	of	ADP
chd-117	180	5	pathology	pathology	NOUN
chd-117	180	6	188	188	NUM
chd-117	180	7	,	,	PUNCT
chd-117	180	8	280	280	NUM
chd-117	180	9	-	-	SYM
chd-117	180	10	290	290	NUM
chd-117	180	11	.	.	PUNCT
chd-117	181	1	gerard	gerard	PROPN
chd-117	181	2	,	,	PUNCT
chd-117	181	3	c.	c.	PROPN
chd-117	181	4	,	,	PUNCT
chd-117	181	5	and	and	CCONJ
chd-117	181	6	brown	brown	PROPN
chd-117	181	7	,	,	PUNCT
chd-117	181	8	k.a	k.a	PROPN
chd-117	181	9	.	.	PROPN
chd-117	181	10	(	(	PUNCT
chd-117	181	11	2018	2018	NUM
chd-117	181	12	)	)	PUNCT
chd-117	181	13	.	.	PUNCT
chd-117	182	1	obesity	obesity	NOUN
chd-117	182	2	and	and	CCONJ
chd-117	182	3	breast	breast	NOUN
chd-117	182	4	cancer	cancer	NOUN
chd-117	182	5	role	role	NOUN
chd-117	182	6	of	of	ADP
chd-117	182	7	estrogens	estrogen	NOUN
chd-117	182	8	and	and	CCONJ
chd-117	182	9	the	the	DET
chd-117	182	10	molecular	molecular	ADJ
chd-117	182	11	underpinnings	underpinning	NOUN
chd-117	182	12	of	of	ADP
chd-117	182	13	aromatase	aromatase	ADJ
chd-117	182	14	regulation	regulation	NOUN
chd-117	182	15	in	in	ADP
chd-117	182	16	breast	breast	NOUN
chd-117	182	17	adipose	adipose	NOUN
chd-117	182	18	tissue	tissue	NOUN
chd-117	182	19	.	.	PUNCT
chd-117	183	1	molecular	molecular	ADJ
chd-117	183	2	and	and	CCONJ
chd-117	183	3	cellular	cellular	ADJ
chd-117	183	4	endocrinology	endocrinology	NOUN
chd-117	183	5	466	466	NUM
chd-117	183	6	,	,	PUNCT
chd-117	183	7	15	15	NUM
chd-117	183	8	-	-	SYM
chd-117	183	9	30	30	NUM
chd-117	183	10	.	.	PUNCT
chd-117	184	1	guillemette	guillemette	PROPN
chd-117	184	2	,	,	PUNCT
chd-117	184	3	c.	c.	PROPN
chd-117	184	4	,	,	PUNCT
chd-117	184	5	de	de	X
chd-117	184	6	vivo	vivo	NOUN
chd-117	184	7	,	,	PUNCT
chd-117	184	8	i.	i.	PROPN
chd-117	184	9	,	,	PUNCT
chd-117	184	10	hankinson	hankinson	PROPN
chd-117	184	11	,	,	PUNCT
chd-117	184	12	s.e	s.e	PROPN
chd-117	184	13	.	.	PROPN
chd-117	184	14	,	,	PUNCT
chd-117	184	15	haiman	haiman	PROPN
chd-117	184	16	,	,	PUNCT
chd-117	184	17	c.a	c.a	PROPN
chd-117	184	18	.	.	PROPN
chd-117	184	19	,	,	PUNCT
chd-117	184	20	spiegelman	spiegelman	PROPN
chd-117	184	21	,	,	PUNCT
chd-117	184	22	d.	d.	PROPN
chd-117	184	23	,	,	PUNCT
chd-117	184	24	housman	housman	PROPN
chd-117	184	25	,	,	PUNCT
chd-117	184	26	d.e	d.e	PROPN
chd-117	184	27	.	.	PROPN
chd-117	184	28	,	,	PUNCT
chd-117	184	29	and	and	CCONJ
chd-117	184	30	hunter	hunter	NOUN
chd-117	184	31	,	,	PUNCT
chd-117	184	32	d.j	d.j	PROPN
chd-117	184	33	.	.	PROPN
chd-117	184	34	(	(	PUNCT
chd-117	184	35	2001	2001	NUM
chd-117	184	36	)	)	PUNCT
chd-117	184	37	.	.	PUNCT
chd-117	185	1	association	association	NOUN
chd-117	185	2	of	of	ADP
chd-117	185	3	genetic	genetic	ADJ
chd-117	185	4	polymorphisms	polymorphism	NOUN
chd-117	185	5	in	in	ADP
chd-117	185	6	ugt1a1	ugt1a1	NOUN
chd-117	185	7	with	with	ADP
chd-117	185	8	breast	breast	NOUN
chd-117	185	9	cancer	cancer	NOUN
chd-117	185	10	and	and	CCONJ
chd-117	185	11	plasma	plasma	NOUN
chd-117	185	12	hormone	hormone	NOUN
chd-117	185	13	levels	level	NOUN
chd-117	185	14	.	.	PUNCT
chd-117	186	1	cancer	cancer	NOUN
chd-117	186	2	epidemiology	epidemiology	NOUN
chd-117	186	3	,	,	PUNCT
chd-117	186	4	biomarkers	biomarker	NOUN
chd-117	186	5	&	&	CCONJ
chd-117	186	6	prevention	prevention	NOUN
chd-117	186	7	:	:	PUNCT
chd-117	186	8	a	a	DET
chd-117	186	9	publication	publication	NOUN
chd-117	186	10	of	of	ADP
chd-117	186	11	the	the	DET
chd-117	186	12	american	american	PROPN
chd-117	186	13	association	association	PROPN
chd-117	186	14	for	for	ADP
chd-117	186	15	cancer	cancer	NOUN
chd-117	186	16	research	research	NOUN
chd-117	186	17	,	,	PUNCT
chd-117	186	18	cosponsored	cosponsor	VERB
chd-117	186	19	by	by	ADP
chd-117	186	20	the	the	DET
chd-117	186	21	american	american	ADJ
chd-117	186	22	society	society	NOUN
chd-117	186	23	of	of	ADP
chd-117	186	24	preventive	preventive	ADJ
chd-117	186	25	oncology	oncology	NOUN
chd-117	186	26	10	10	NUM
chd-117	186	27	,	,	PUNCT
chd-117	186	28	711	711	NUM
chd-117	186	29	-	-	SYM
chd-117	186	30	714	714	NUM
chd-117	186	31	.	.	PUNCT
chd-117	187	1	guillemette	guillemette	NOUN
chd-117	187	2	,	,	PUNCT
chd-117	187	3	c.	c.	PROPN
chd-117	187	4	,	,	PUNCT
chd-117	187	5	millikan	millikan	PROPN
chd-117	187	6	,	,	PUNCT
chd-117	187	7	r.c	r.c	PROPN
chd-117	187	8	.	.	PROPN
chd-117	187	9	,	,	PUNCT
chd-117	187	10	newman	newman	PROPN
chd-117	187	11	,	,	PUNCT
chd-117	187	12	b.	b.	PROPN
chd-117	187	13	,	,	PUNCT
chd-117	187	14	and	and	CCONJ
chd-117	187	15	housman	housman	PROPN
chd-117	187	16	,	,	PUNCT
chd-117	187	17	d.e	d.e	PROPN
chd-117	187	18	.	.	PROPN
chd-117	187	19	(	(	PUNCT
chd-117	187	20	2000	2000	NUM
chd-117	187	21	)	)	PUNCT
chd-117	187	22	.	.	PUNCT
chd-117	188	1	genetic	genetic	ADJ
chd-117	188	2	polymorphisms	polymorphism	NOUN
chd-117	188	3	in	in	ADP
chd-117	188	4	uridine	uridine	ADJ
chd-117	188	5	diphosphoglucuronosyltransferase	diphosphoglucuronosyltransferase	NOUN
chd-117	188	6	1a1	1a1	NUM
chd-117	188	7	and	and	CCONJ
chd-117	188	8	association	association	NOUN
chd-117	188	9	with	with	ADP
chd-117	188	10	breast	breast	NOUN
chd-117	188	11	cancer	cancer	NOUN
chd-117	188	12	among	among	ADP
chd-117	188	13	african	african	ADJ
chd-117	188	14	americans	americans	PROPN
chd-117	188	15	.	.	PUNCT
chd-117	189	1	cancer	cancer	NOUN
chd-117	189	2	research	research	NOUN
chd-117	189	3	60	60	NUM
chd-117	189	4	,	,	PUNCT
chd-117	189	5	950	950	NUM
chd-117	189	6	-	-	SYM
chd-117	189	7	956	956	NUM
chd-117	189	8	.	.	PUNCT
chd-117	190	1	hunt	hunt	PROPN
chd-117	190	2	,	,	PUNCT
chd-117	190	3	b.r	b.r	PROPN
chd-117	190	4	.	.	PROPN
chd-117	190	5	,	,	PUNCT
chd-117	190	6	whitman	whitman	PROPN
chd-117	190	7	,	,	PUNCT
chd-117	190	8	s.	s.	PROPN
chd-117	190	9	,	,	PUNCT
chd-117	190	10	and	and	CCONJ
chd-117	190	11	hurlbert	hurlbert	PROPN
chd-117	190	12	,	,	PUNCT
chd-117	190	13	m.s	m.s	PROPN
chd-117	190	14	.	.	PROPN
chd-117	190	15	(	(	PUNCT
chd-117	190	16	2014	2014	NUM
chd-117	190	17	)	)	PUNCT
chd-117	190	18	.	.	PUNCT
chd-117	191	1	increasing	increase	VERB
chd-117	191	2	black	black	ADJ
chd-117	191	3	:	:	PUNCT
chd-117	191	4	white	white	ADJ
chd-117	191	5	disparities	disparity	NOUN
chd-117	191	6	in	in	ADP
chd-117	191	7	breast	breast	NOUN
chd-117	191	8	cancer	cancer	NOUN
chd-117	191	9	mortality	mortality	NOUN
chd-117	191	10	in	in	ADP
chd-117	191	11	the	the	DET
chd-117	191	12	50	50	NUM
chd-117	191	13	largest	large	ADJ
chd-117	191	14	cities	city	NOUN
chd-117	191	15	in	in	ADP
chd-117	191	16	the	the	DET
chd-117	191	17	united	united	PROPN
chd-117	191	18	states	states	PROPN
chd-117	191	19	.	.	PUNCT
chd-117	192	1	cancer	cancer	NOUN
chd-117	192	2	epidemiology	epidemiology	NOUN
chd-117	192	3	38	38	NUM
chd-117	192	4	,	,	PUNCT
chd-117	192	5	118	118	NUM
chd-117	192	6	-	-	SYM
chd-117	192	7	123	123	NUM
chd-117	192	8	.	.	PUNCT
chd-117	193	1	huo	huo	NOUN
chd-117	193	2	,	,	PUNCT
chd-117	193	3	d.	d.	PROPN
chd-117	193	4	,	,	PUNCT
chd-117	193	5	kim	kim	PROPN
chd-117	193	6	,	,	PUNCT
chd-117	193	7	h.j	h.j	PROPN
chd-117	193	8	.	.	PROPN
chd-117	193	9	,	,	PUNCT
chd-117	193	10	adebamowo	adebamowo	PROPN
chd-117	193	11	,	,	PUNCT
chd-117	193	12	c.a	c.a	PROPN
chd-117	193	13	.	.	PROPN
chd-117	193	14	,	,	PUNCT
chd-117	193	15	ogundiran	ogundiran	PROPN
chd-117	193	16	,	,	PUNCT
chd-117	193	17	t.o	t.o	PROPN
chd-117	193	18	.	.	PROPN
chd-117	193	19	,	,	PUNCT
chd-117	193	20	akang	akang	PROPN
chd-117	193	21	,	,	PUNCT
chd-117	193	22	e.e	e.e	PROPN
chd-117	193	23	.	.	PROPN
chd-117	193	24	,	,	PUNCT
chd-117	193	25	campbell	campbell	PROPN
chd-117	193	26	,	,	PUNCT
chd-117	193	27	o.	o.	NOUN
chd-117	193	28	,	,	PUNCT
chd-117	193	29	adenipekun	adenipekun	NOUN
chd-117	193	30	,	,	PUNCT
chd-117	193	31	a.	a.	NOUN
chd-117	193	32	,	,	PUNCT
chd-117	193	33	niu	niu	PROPN
chd-117	193	34	,	,	PUNCT
chd-117	193	35	q.	q.	PROPN
chd-117	193	36	,	,	PUNCT
chd-117	193	37	sveen	sveen	PROPN
chd-117	193	38	,	,	PUNCT
chd-117	193	39	l.	l.	PROPN
chd-117	193	40	,	,	PUNCT
chd-117	193	41	fackenthal	fackenthal	ADJ
chd-117	193	42	,	,	PUNCT
chd-117	193	43	j.d	j.d	PROPN
chd-117	193	44	.	.	PROPN
chd-117	193	45	,	,	PUNCT
chd-117	193	46	et	et	PROPN
chd-117	193	47	al	al	PROPN
chd-117	193	48	.	.	PUNCT
chd-117	194	1	(	(	PUNCT
chd-117	194	2	2008	2008	NUM
chd-117	194	3	)	)	PUNCT
chd-117	194	4	.	.	PUNCT
chd-117	195	1	genetic	genetic	ADJ
chd-117	195	2	polymorphisms	polymorphism	NOUN
chd-117	195	3	in	in	ADP
chd-117	195	4	uridine	uridine	NOUN
chd-117	195	5	diphospho	diphospho	NOUN
chd-117	195	6	-	-	PUNCT
chd-117	195	7	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	195	8	1a1	1a1	NUM
chd-117	195	9	and	and	CCONJ
chd-117	195	10	breast	breast	NOUN
chd-117	195	11	cancer	cancer	NOUN
chd-117	195	12	risk	risk	NOUN
chd-117	195	13	in	in	ADP
chd-117	195	14	africans	africans	PROPN
chd-117	195	15	.	.	PUNCT
chd-117	196	1	breast	breast	NOUN
chd-117	196	2	cancer	cancer	NOUN
chd-117	196	3	research	research	NOUN
chd-117	196	4	and	and	CCONJ
chd-117	196	5	treatment	treatment	NOUN
chd-117	196	6	110	110	NUM
chd-117	196	7	,	,	PUNCT
chd-117	196	8	367	367	NUM
chd-117	196	9	-	-	SYM
chd-117	196	10	376	376	NUM
chd-117	196	11	.	.	PUNCT
chd-117	197	1	iyer	iyer	PROPN
chd-117	197	2	,	,	PUNCT
chd-117	197	3	l.	l.	PROPN
chd-117	197	4	,	,	PUNCT
chd-117	197	5	hall	hall	PROPN
chd-117	197	6	,	,	PUNCT
chd-117	197	7	d.	d.	PROPN
chd-117	197	8	,	,	PUNCT
chd-117	197	9	das	das	PROPN
chd-117	197	10	,	,	PUNCT
chd-117	197	11	s.	s.	PROPN
chd-117	197	12	,	,	PUNCT
chd-117	197	13	mortell	mortell	PROPN
chd-117	197	14	,	,	PUNCT
chd-117	197	15	m.a	m.a	PROPN
chd-117	197	16	.	.	PROPN
chd-117	197	17	,	,	PUNCT
chd-117	197	18	ramirez	ramirez	PROPN
chd-117	197	19	,	,	PUNCT
chd-117	197	20	j.	j.	PROPN
chd-117	197	21	,	,	PUNCT
chd-117	197	22	kim	kim	PROPN
chd-117	197	23	,	,	PUNCT
chd-117	197	24	s.	s.	PROPN
chd-117	197	25	,	,	PUNCT
chd-117	197	26	di	di	NOUN
chd-117	197	27	rienzo	rienzo	PROPN
chd-117	197	28	,	,	PUNCT
chd-117	197	29	a.	a.	NOUN
chd-117	197	30	,	,	PUNCT
chd-117	197	31	and	and	CCONJ
chd-117	197	32	ratain	ratain	NOUN
chd-117	197	33	,	,	PUNCT
chd-117	197	34	m.j	m.j	PROPN
chd-117	197	35	.	.	PROPN
chd-117	197	36	(	(	PUNCT
chd-117	197	37	1999	1999	NUM
chd-117	197	38	)	)	PUNCT
chd-117	197	39	.	.	PUNCT
chd-117	198	1	phenotype	phenotype	NOUN
chd-117	198	2	-	-	PUNCT
chd-117	198	3	genotype	genotype	NOUN
chd-117	198	4	correlation	correlation	NOUN
chd-117	198	5	of	of	ADP
chd-117	198	6	in	in	ADP
chd-117	198	7	vitro	vitro	X
chd-117	198	8	sn-38	sn-38	X
chd-117	199	1	(	(	PUNCT
chd-117	199	2	active	active	ADJ
chd-117	199	3	metabolite	metabolite	NOUN
chd-117	199	4	of	of	ADP
chd-117	199	5	irinotecan	irinotecan	NOUN
chd-117	199	6	)	)	PUNCT
chd-117	199	7	and	and	CCONJ
chd-117	199	8	bilirubin	bilirubin	NOUN
chd-117	199	9	glucuronidation	glucuronidation	NOUN
chd-117	199	10	in	in	ADP
chd-117	199	11	human	human	ADJ
chd-117	199	12	liver	liver	NOUN
chd-117	199	13	tissue	tissue	NOUN
chd-117	199	14	with	with	ADP
chd-117	199	15	ugt1a1	ugt1a1	ADJ
chd-117	199	16	promoter	promoter	NOUN
chd-117	199	17	polymorphism	polymorphism	NOUN
chd-117	199	18	.	.	PUNCT
chd-117	200	1	clinical	clinical	ADJ
chd-117	200	2	pharmacology	pharmacology	NOUN
chd-117	200	3	and	and	CCONJ
chd-117	200	4	therapeutics	therapeutic	NOUN
chd-117	200	5	65	65	NUM
chd-117	200	6	,	,	PUNCT
chd-117	200	7	576	576	NUM
chd-117	200	8	-	-	SYM
chd-117	200	9	582	582	NUM
chd-117	200	10	.	.	PUNCT
chd-117	200	11	lepine	lepine	PROPN
chd-117	200	12	,	,	PUNCT
chd-117	200	13	j.	j.	PROPN
chd-117	200	14	,	,	PUNCT
chd-117	200	15	bernard	bernard	PROPN
chd-117	200	16	,	,	PUNCT
chd-117	200	17	o.	o.	PROPN
chd-117	200	18	,	,	PUNCT
chd-117	200	19	plante	plante	NOUN
chd-117	200	20	,	,	PUNCT
chd-117	200	21	m.	m.	NOUN
chd-117	200	22	,	,	PUNCT
chd-117	200	23	tetu	tetu	PROPN
chd-117	200	24	,	,	PUNCT
chd-117	200	25	b.	b.	PROPN
chd-117	200	26	,	,	PUNCT
chd-117	200	27	pelletier	pelletier	PROPN
chd-117	200	28	,	,	PUNCT
chd-117	200	29	g.	g.	PROPN
chd-117	200	30	,	,	PUNCT
chd-117	200	31	labrie	labrie	PROPN
chd-117	200	32	,	,	PUNCT
chd-117	200	33	f.	f.	PROPN
chd-117	200	34	,	,	PUNCT
chd-117	200	35	belanger	belanger	PROPN
chd-117	200	36	,	,	PUNCT
chd-117	200	37	a.	a.	NOUN
chd-117	200	38	,	,	PUNCT
chd-117	200	39	and	and	CCONJ
chd-117	200	40	guillemette	guillemette	NOUN
chd-117	200	41	,	,	PUNCT
chd-117	200	42	c.	c.	PROPN
chd-117	200	43	(	(	PUNCT
chd-117	200	44	2004	2004	NUM
chd-117	200	45	)	)	PUNCT
chd-117	200	46	.	.	PUNCT
chd-117	201	1	specificity	specificity	NOUN
chd-117	201	2	and	and	CCONJ
chd-117	201	3	regioselectivity	regioselectivity	NOUN
chd-117	201	4	of	of	ADP
chd-117	201	5	the	the	DET
chd-117	201	6	conjugation	conjugation	NOUN
chd-117	201	7	of	of	ADP
chd-117	201	8	estradiol	estradiol	PROPN
chd-117	201	9	,	,	PUNCT
chd-117	201	10	estrone	estrone	NOUN
chd-117	201	11	,	,	PUNCT
chd-117	201	12	and	and	CCONJ
chd-117	201	13	their	their	PRON
chd-117	201	14	catecholestrogen	catecholestrogen	NOUN
chd-117	201	15	and	and	CCONJ
chd-117	201	16	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-117	201	17	e11	e11	ADJ
chd-117	201	18	cancer	cancer	NOUN
chd-117	201	19	health	health	NOUN
chd-117	201	20	disparities	disparity	NOUN
chd-117	201	21	research	research	NOUN
chd-117	201	22	methoxyestrogen	methoxyestrogen	NOUN
chd-117	201	23	metabolites	metabolite	NOUN
chd-117	201	24	by	by	ADP
chd-117	201	25	human	human	ADJ
chd-117	201	26	uridine	uridine	NOUN
chd-117	201	27	diphospho	diphospho	NOUN
chd-117	201	28	-	-	PUNCT
chd-117	201	29	glucuronosyltransferases	glucuronosyltransferase	NOUN
chd-117	201	30	expressed	express	VERB
chd-117	201	31	in	in	ADP
chd-117	201	32	endometrium	endometrium	NOUN
chd-117	201	33	.	.	PUNCT
chd-117	202	1	the	the	DET
chd-117	202	2	journal	journal	NOUN
chd-117	202	3	of	of	ADP
chd-117	202	4	clinical	clinical	ADJ
chd-117	202	5	endocrinology	endocrinology	NOUN
chd-117	202	6	and	and	CCONJ
chd-117	202	7	metabolism	metabolism	NOUN
chd-117	202	8	89	89	NUM
chd-117	202	9	,	,	PUNCT
chd-117	202	10	5222	5222	NUM
chd-117	202	11	-	-	SYM
chd-117	202	12	5232	5232	NUM
chd-117	202	13	.	.	PUNCT
chd-117	203	1	massacesi	massacesi	PROPN
chd-117	203	2	,	,	PUNCT
chd-117	203	3	c.	c.	PROPN
chd-117	203	4	,	,	PUNCT
chd-117	203	5	terrazzino	terrazzino	PROPN
chd-117	203	6	,	,	PUNCT
chd-117	203	7	s.	s.	PROPN
chd-117	203	8	,	,	PUNCT
chd-117	203	9	marcucci	marcucci	PROPN
chd-117	203	10	,	,	PUNCT
chd-117	203	11	f.	f.	PROPN
chd-117	203	12	,	,	PUNCT
chd-117	203	13	rocchi	rocchi	PROPN
chd-117	203	14	,	,	PUNCT
chd-117	203	15	m.b	m.b	PROPN
chd-117	203	16	.	.	PROPN
chd-117	203	17	,	,	PUNCT
chd-117	203	18	lippe	lippe	PROPN
chd-117	203	19	,	,	PUNCT
chd-117	203	20	p.	p.	PROPN
chd-117	203	21	,	,	PUNCT
chd-117	203	22	bisonni	bisonni	PROPN
chd-117	203	23	,	,	PUNCT
chd-117	203	24	r.	r.	PROPN
chd-117	203	25	,	,	PUNCT
chd-117	203	26	lombardo	lombardo	PROPN
chd-117	203	27	,	,	PUNCT
chd-117	203	28	m.	m.	NOUN
chd-117	203	29	,	,	PUNCT
chd-117	203	30	pilone	pilone	PROPN
chd-117	203	31	,	,	PUNCT
chd-117	203	32	a.	a.	NOUN
chd-117	203	33	,	,	PUNCT
chd-117	203	34	mattioli	mattioli	PROPN
chd-117	203	35	,	,	PUNCT
chd-117	203	36	r.	r.	PROPN
chd-117	203	37	,	,	PUNCT
chd-117	203	38	and	and	CCONJ
chd-117	203	39	leon	leon	PROPN
chd-117	203	40	,	,	PUNCT
chd-117	203	41	a.	a.	NOUN
chd-117	203	42	(	(	PUNCT
chd-117	203	43	2006	2006	NUM
chd-117	203	44	)	)	PUNCT
chd-117	203	45	.	.	PUNCT
chd-117	204	1	uridine	uridine	NOUN
chd-117	204	2	diphosphate	diphosphate	PROPN
chd-117	204	3	glucuronosyl	glucuronosyl	NOUN
chd-117	204	4	transferase	transferase	NOUN
chd-117	204	5	1a1	1a1	NUM
chd-117	204	6	promoter	promoter	NOUN
chd-117	204	7	polymorphism	polymorphism	NOUN
chd-117	204	8	predicts	predict	VERB
chd-117	204	9	the	the	DET
chd-117	204	10	risk	risk	NOUN
chd-117	204	11	of	of	ADP
chd-117	204	12	gastrointestinal	gastrointestinal	ADJ
chd-117	204	13	toxicity	toxicity	NOUN
chd-117	204	14	and	and	CCONJ
chd-117	204	15	fatigue	fatigue	NOUN
chd-117	204	16	induced	induce	VERB
chd-117	204	17	by	by	ADP
chd-117	204	18	irinotecan	irinotecan	NOUN
chd-117	204	19	-	-	PUNCT
chd-117	204	20	based	base	VERB
chd-117	204	21	chemotherapy	chemotherapy	NOUN
chd-117	204	22	.	.	PUNCT
chd-117	205	1	cancer	cancer	NOUN
chd-117	205	2	106	106	NUM
chd-117	205	3	,	,	PUNCT
chd-117	205	4	1007	1007	NUM
chd-117	205	5	-	-	SYM
chd-117	205	6	1016	1016	NUM
chd-117	205	7	.	.	PUNCT
chd-117	206	1	shatalova	shatalova	PROPN
chd-117	206	2	,	,	PUNCT
chd-117	206	3	e.g.	e.g.	ADV
chd-117	206	4	,	,	PUNCT
chd-117	206	5	loginov	loginov	NOUN
chd-117	206	6	,	,	PUNCT
chd-117	206	7	v.i	v.i	PROPN
chd-117	206	8	.	.	PROPN
chd-117	206	9	,	,	PUNCT
chd-117	206	10	braga	braga	PROPN
chd-117	206	11	,	,	PUNCT
chd-117	206	12	e.a	e.a	PROPN
chd-117	206	13	.	.	PROPN
chd-117	206	14	,	,	PUNCT
chd-117	206	15	kazubskaia	kazubskaia	PROPN
chd-117	206	16	,	,	PUNCT
chd-117	206	17	t.p	t.p	PROPN
chd-117	206	18	.	.	PROPN
chd-117	206	19	,	,	PUNCT
chd-117	206	20	sudomoina	sudomoina	PROPN
chd-117	206	21	,	,	PUNCT
chd-117	206	22	m.a	m.a	PROPN
chd-117	206	23	.	.	PROPN
chd-117	206	24	,	,	PUNCT
chd-117	206	25	blanchard	blanchard	PROPN
chd-117	206	26	,	,	PUNCT
chd-117	206	27	r.l	r.l	PROPN
chd-117	206	28	.	.	PROPN
chd-117	206	29	,	,	PUNCT
chd-117	206	30	and	and	CCONJ
chd-117	206	31	favorova	favorova	VERB
chd-117	206	32	,	,	PUNCT
chd-117	206	33	o.o	o.o	PROPN
chd-117	206	34	.	.	PROPN
chd-117	206	35	(	(	PUNCT
chd-117	206	36	2006	2006	NUM
chd-117	206	37	)	)	PUNCT
chd-117	206	38	.	.	PUNCT
chd-117	207	1	[	[	X
chd-117	207	2	association	association	NOUN
chd-117	207	3	of	of	ADP
chd-117	207	4	polymorphisms	polymorphism	NOUN
chd-117	207	5	in	in	ADP
chd-117	207	6	sult1a1	sult1a1	ADJ
chd-117	207	7	and	and	CCONJ
chd-117	207	8	ugt1a1	ugt1a1	ADJ
chd-117	207	9	genes	gene	NOUN
chd-117	207	10	with	with	ADP
chd-117	207	11	breast	breast	NOUN
chd-117	207	12	cancer	cancer	NOUN
chd-117	207	13	risk	risk	NOUN
chd-117	207	14	and	and	CCONJ
chd-117	207	15	phenotypes	phenotype	NOUN
chd-117	207	16	in	in	ADP
chd-117	207	17	russian	russian	ADJ
chd-117	207	18	women	woman	NOUN
chd-117	207	19	]	]	PUNCT
chd-117	207	20	.	.	PUNCT
chd-117	208	1	molekuliarnaia	molekuliarnaia	PROPN
chd-117	208	2	biologiia	biologiia	VERB
chd-117	208	3	40	40	NUM
chd-117	208	4	,	,	PUNCT
chd-117	208	5	263	263	NUM
chd-117	208	6	-	-	SYM
chd-117	208	7	270	270	NUM
chd-117	208	8	.	.	PUNCT
chd-117	209	1	starlard	starlard	NOUN
chd-117	209	2	-	-	PUNCT
chd-117	209	3	davenport	davenport	NOUN
chd-117	209	4	,	,	PUNCT
chd-117	209	5	a.	a.	NOUN
chd-117	209	6	,	,	PUNCT
chd-117	209	7	word	word	NOUN
chd-117	209	8	,	,	PUNCT
chd-117	209	9	b.	b.	PROPN
chd-117	209	10	,	,	PUNCT
chd-117	209	11	and	and	CCONJ
chd-117	209	12	lyn	lyn	PROPN
chd-117	209	13	-	-	PUNCT
chd-117	209	14	cook	cook	PROPN
chd-117	209	15	,	,	PUNCT
chd-117	209	16	b.	b.	PROPN
chd-117	209	17	(	(	PUNCT
chd-117	209	18	2012	2012	NUM
chd-117	209	19	)	)	PUNCT
chd-117	209	20	.	.	PUNCT
chd-117	210	1	characterization	characterization	NOUN
chd-117	210	2	of	of	ADP
chd-117	210	3	udp	udp	NOUN
chd-117	210	4	-	-	NOUN
chd-117	210	5	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	210	6	(	(	PUNCT
chd-117	210	7	ugt1a1	ugt1a1	NOUN
chd-117	210	8	)	)	PUNCT
chd-117	210	9	promoter	promoter	NOUN
chd-117	210	10	polymorphisms	polymorphism	NOUN
chd-117	210	11	and	and	CCONJ
chd-117	210	12	gene	gene	NOUN
chd-117	210	13	expression	expression	NOUN
chd-117	210	14	on	on	ADP
chd-117	210	15	ethnicity	ethnicity	NOUN
chd-117	210	16	,	,	PUNCT
chd-117	210	17	stage	stage	NOUN
chd-117	210	18	of	of	ADP
chd-117	210	19	disease	disease	NOUN
chd-117	210	20	,	,	PUNCT
chd-117	210	21	and	and	CCONJ
chd-117	210	22	menopausal	menopausal	ADJ
chd-117	210	23	status	status	NOUN
chd-117	210	24	in	in	ADP
chd-117	210	25	breast	breast	NOUN
chd-117	210	26	cancer	cancer	NOUN
chd-117	210	27	.	.	PUNCT
chd-117	211	1	drug	drug	NOUN
chd-117	211	2	metabolism	metabolism	NOUN
chd-117	211	3	and	and	CCONJ
chd-117	211	4	toxicology	toxicology	NOUN
chd-117	211	5	s4	s4	NOUN
chd-117	211	6	,	,	PUNCT
chd-117	211	7	1	1	NUM
chd-117	211	8	-	-	SYM
chd-117	211	9	5	5	NUM
chd-117	211	10	.	.	PUNCT
chd-117	211	11	starlard	starlard	NOUN
chd-117	211	12	-	-	PUNCT
chd-117	211	13	davenport	davenport	NOUN
chd-117	211	14	,	,	PUNCT
chd-117	211	15	a.	a.	PROPN
chd-117	211	16	,	,	PUNCT
chd-117	211	17	xiong	xiong	PROPN
chd-117	211	18	,	,	PUNCT
chd-117	211	19	y.	y.	PROPN
chd-117	211	20	,	,	PUNCT
chd-117	211	21	bratton	bratton	PROPN
chd-117	211	22	,	,	PUNCT
chd-117	211	23	s.	s.	PROPN
chd-117	211	24	,	,	PUNCT
chd-117	211	25	gallus	gallus	NOUN
chd-117	211	26	-	-	PUNCT
chd-117	211	27	zawada	zawada	PROPN
chd-117	211	28	,	,	PUNCT
chd-117	211	29	a.	a.	PROPN
chd-117	211	30	,	,	PUNCT
chd-117	211	31	finel	finel	NOUN
chd-117	211	32	,	,	PUNCT
chd-117	211	33	m.	m.	NOUN
chd-117	211	34	,	,	PUNCT
chd-117	211	35	and	and	CCONJ
chd-117	211	36	radominska	radominska	NOUN
chd-117	211	37	-	-	PUNCT
chd-117	211	38	pandya	pandya	PROPN
chd-117	211	39	,	,	PUNCT
chd-117	211	40	a.	a.	NOUN
chd-117	211	41	(	(	PUNCT
chd-117	211	42	2007	2007	NUM
chd-117	211	43	)	)	PUNCT
chd-117	211	44	.	.	PUNCT
chd-117	212	1	phenylalanine(90	phenylalanine(90	PROPN
chd-117	212	2	)	)	PUNCT
chd-117	212	3	and	and	CCONJ
chd-117	212	4	phenylalanine(93	phenylalanine(93	NOUN
chd-117	212	5	)	)	PUNCT
chd-117	212	6	are	be	AUX
chd-117	212	7	crucial	crucial	ADJ
chd-117	212	8	amino	amino	NOUN
chd-117	212	9	acids	acid	NOUN
chd-117	212	10	within	within	ADP
chd-117	212	11	the	the	DET
chd-117	212	12	estrogen	estrogen	NOUN
chd-117	212	13	binding	bind	VERB
chd-117	212	14	site	site	NOUN
chd-117	212	15	of	of	ADP
chd-117	212	16	the	the	DET
chd-117	212	17	human	human	PROPN
chd-117	212	18	udp	udp	PROPN
chd-117	212	19	-	-	NOUN
chd-117	212	20	glucuronosyltransferase	glucuronosyltransferase	NOUN
chd-117	212	21	1a10	1a10	NOUN
chd-117	212	22	.	.	PUNCT
chd-117	213	1	steroids	steroid	NOUN
chd-117	213	2	72	72	NUM
chd-117	213	3	,	,	PUNCT
chd-117	213	4	85	85	NUM
chd-117	213	5	-	-	SYM
chd-117	213	6	94	94	NUM
chd-117	213	7	.	.	PUNCT
chd-117	214	1	tan	tan	PROPN
chd-117	214	2	,	,	PUNCT
chd-117	214	3	m.	m.	NOUN
chd-117	214	4	,	,	PUNCT
chd-117	214	5	mamun	mamun	PROPN
chd-117	214	6	,	,	PUNCT
chd-117	214	7	a.	a.	PROPN
chd-117	214	8	,	,	PUNCT
chd-117	214	9	kitzman	kitzman	NOUN
chd-117	214	10	,	,	PUNCT
chd-117	214	11	h.	h.	PROPN
chd-117	214	12	,	,	PUNCT
chd-117	214	13	mandapati	mandapati	PROPN
chd-117	214	14	,	,	PUNCT
chd-117	214	15	s.r	s.r	PROPN
chd-117	214	16	.	.	PROPN
chd-117	214	17	,	,	PUNCT
chd-117	214	18	and	and	CCONJ
chd-117	214	19	dodgen	dodgen	PROPN
chd-117	214	20	,	,	PUNCT
chd-117	214	21	l.	l.	PROPN
chd-117	214	22	(	(	PUNCT
chd-117	214	23	2017	2017	NUM
chd-117	214	24	)	)	PUNCT
chd-117	214	25	.	.	PUNCT
chd-117	215	1	neighborhood	neighborhood	NOUN
chd-117	215	2	disadvantage	disadvantage	NOUN
chd-117	215	3	and	and	CCONJ
chd-117	215	4	allostatic	allostatic	ADJ
chd-117	215	5	load	load	NOUN
chd-117	215	6	in	in	ADP
chd-117	215	7	african	african	ADJ
chd-117	215	8	american	american	ADJ
chd-117	215	9	women	woman	NOUN
chd-117	215	10	at	at	ADP
chd-117	215	11	risk	risk	NOUN
chd-117	215	12	for	for	ADP
chd-117	215	13	obesity	obesity	NOUN
chd-117	215	14	-	-	PUNCT
chd-117	215	15	related	relate	VERB
chd-117	215	16	diseases	disease	NOUN
chd-117	215	17	.	.	PUNCT
chd-117	216	1	preventing	prevent	VERB
chd-117	216	2	chronic	chronic	ADJ
chd-117	216	3	disease	disease	NOUN
chd-117	216	4	14	14	NUM
chd-117	216	5	,	,	PUNCT
chd-117	216	6	e119	e119	PROPN
chd-117	216	7	.	.	PUNCT
chd-117	217	1	trapnell	trapnell	PROPN
chd-117	217	2	,	,	PUNCT
chd-117	217	3	c.	c.	PROPN
chd-117	217	4	,	,	PUNCT
chd-117	217	5	hendrickson	hendrickson	PROPN
chd-117	217	6	,	,	PUNCT
chd-117	217	7	d.g	d.g	PROPN
chd-117	217	8	.	.	PROPN
chd-117	217	9	,	,	PUNCT
chd-117	217	10	sauvageau	sauvageau	PROPN
chd-117	217	11	,	,	PUNCT
chd-117	217	12	m.	m.	NOUN
chd-117	217	13	,	,	PUNCT
chd-117	217	14	goff	goff	PROPN
chd-117	217	15	,	,	PUNCT
chd-117	217	16	l.	l.	PROPN
chd-117	217	17	,	,	PUNCT
chd-117	217	18	rinn	rinn	PROPN
chd-117	217	19	,	,	PUNCT
chd-117	217	20	j.l	j.l	PROPN
chd-117	217	21	.	.	PROPN
chd-117	217	22	,	,	PUNCT
chd-117	217	23	and	and	CCONJ
chd-117	217	24	pachter	pachter	PROPN
chd-117	217	25	,	,	PUNCT
chd-117	217	26	l.	l.	PROPN
chd-117	217	27	(	(	PUNCT
chd-117	217	28	2013	2013	NUM
chd-117	217	29	)	)	PUNCT
chd-117	217	30	.	.	PUNCT
chd-117	218	1	differential	differential	ADJ
chd-117	218	2	analysis	analysis	NOUN
chd-117	218	3	of	of	ADP
chd-117	218	4	gene	gene	NOUN
chd-117	218	5	regulation	regulation	NOUN
chd-117	218	6	at	at	ADP
chd-117	218	7	transcript	transcript	NOUN
chd-117	218	8	resolution	resolution	NOUN
chd-117	218	9	with	with	ADP
chd-117	218	10	rna	rna	PROPN
chd-117	218	11	-	-	PUNCT
chd-117	218	12	seq	seq	NOUN
chd-117	218	13	.	.	PUNCT
chd-117	219	1	nature	nature	PROPN
chd-117	219	2	biotechnology	biotechnology	PROPN
chd-117	219	3	31	31	NUM
chd-117	219	4	,	,	PUNCT
chd-117	219	5	46	46	NUM
chd-117	219	6	-	-	SYM
chd-117	219	7	53	53	NUM
chd-117	219	8	.	.	PUNCT
chd-117	220	1	tukey	tukey	PROPN
chd-117	220	2	,	,	PUNCT
chd-117	220	3	r.h	r.h	PROPN
chd-117	220	4	.	.	PROPN
chd-117	220	5	,	,	PUNCT
chd-117	220	6	and	and	CCONJ
chd-117	220	7	strassburg	strassburg	NOUN
chd-117	220	8	,	,	PUNCT
chd-117	220	9	c.p	c.p	PROPN
chd-117	220	10	.	.	PROPN
chd-117	220	11	(	(	PUNCT
chd-117	220	12	2000	2000	NUM
chd-117	220	13	)	)	PUNCT
chd-117	220	14	.	.	PUNCT
chd-117	221	1	human	human	ADJ
chd-117	221	2	udpglucuronosyltransferases	udpglucuronosyltransferase	NOUN
chd-117	221	3	:	:	PUNCT
chd-117	221	4	metabolism	metabolism	NOUN
chd-117	221	5	,	,	PUNCT
chd-117	221	6	expression	expression	NOUN
chd-117	221	7	,	,	PUNCT
chd-117	221	8	and	and	CCONJ
chd-117	221	9	disease	disease	NOUN
chd-117	221	10	.	.	PUNCT
chd-117	222	1	annual	annual	ADJ
chd-117	222	2	review	review	NOUN
chd-117	222	3	of	of	ADP
chd-117	222	4	pharmacology	pharmacology	NOUN
chd-117	222	5	and	and	CCONJ
chd-117	222	6	toxicology	toxicology	NOUN
chd-117	222	7	40	40	NUM
chd-117	222	8	,	,	PUNCT
chd-117	222	9	581	581	NUM
chd-117	222	10	-	-	SYM
chd-117	222	11	616	616	NUM
chd-117	222	12	.	.	PUNCT
chd-117	223	1	vidal	vidal	NOUN
chd-117	223	2	,	,	PUNCT
chd-117	223	3	g.	g.	PROPN
chd-117	223	4	,	,	PUNCT
chd-117	223	5	bursac	bursac	NOUN
chd-117	223	6	,	,	PUNCT
chd-117	223	7	z.	z.	PROPN
chd-117	223	8	,	,	PUNCT
chd-117	223	9	miranda	miranda	PROPN
chd-117	223	10	-	-	PUNCT
chd-117	223	11	carboni	carboni	PROPN
chd-117	223	12	,	,	PUNCT
chd-117	223	13	g.	g.	PROPN
chd-117	223	14	,	,	PUNCT
chd-117	223	15	white	white	ADJ
chd-117	223	16	-	-	PUNCT
chd-117	223	17	means	mean	NOUN
chd-117	223	18	,	,	PUNCT
chd-117	223	19	s.	s.	PROPN
chd-117	223	20	,	,	PUNCT
chd-117	223	21	and	and	CCONJ
chd-117	223	22	starlard	starlard	NOUN
chd-117	223	23	-	-	PUNCT
chd-117	223	24	davenport	davenport	NOUN
chd-117	223	25	,	,	PUNCT
chd-117	223	26	a.	a.	NOUN
chd-117	223	27	(	(	PUNCT
chd-117	223	28	2017	2017	NUM
chd-117	223	29	)	)	PUNCT
chd-117	223	30	.	.	PUNCT
chd-117	224	1	racial	racial	ADJ
chd-117	224	2	disparities	disparity	NOUN
chd-117	224	3	in	in	ADP
chd-117	224	4	survival	survival	NOUN
chd-117	224	5	outcomes	outcome	NOUN
chd-117	224	6	by	by	ADP
chd-117	224	7	breast	breast	NOUN
chd-117	224	8	tumor	tumor	NOUN
chd-117	224	9	subtype	subtype	NOUN
chd-117	224	10	among	among	ADP
chd-117	224	11	african	african	ADJ
chd-117	224	12	american	american	ADJ
chd-117	224	13	women	woman	NOUN
chd-117	224	14	in	in	ADP
chd-117	224	15	memphis	memphis	PROPN
chd-117	224	16	,	,	PUNCT
chd-117	224	17	tennessee	tennessee	PROPN
chd-117	224	18	.	.	PUNCT
chd-117	225	1	cancer	cancer	NOUN
chd-117	225	2	medicine	medicine	NOUN
chd-117	225	3	6	6	NUM
chd-117	225	4	,	,	PUNCT
chd-117	225	5	1776	1776	NUM
chd-117	225	6	-	-	SYM
chd-117	225	7	1786	1786	NUM
chd-117	225	8	.	.	PUNCT
chd-117	226	1	whitman	whitman	PROPN
chd-117	226	2	,	,	PUNCT
chd-117	226	3	s.	s.	PROPN
chd-117	226	4	,	,	PUNCT
chd-117	226	5	orsi	orsi	PROPN
chd-117	226	6	,	,	PUNCT
chd-117	226	7	j.	j.	PROPN
chd-117	226	8	,	,	PUNCT
chd-117	226	9	and	and	CCONJ
chd-117	226	10	hurlbert	hurlbert	NOUN
chd-117	226	11	,	,	PUNCT
chd-117	226	12	m.	m.	NOUN
chd-117	226	13	(	(	PUNCT
chd-117	226	14	2012	2012	NUM
chd-117	226	15	)	)	PUNCT
chd-117	226	16	.	.	PUNCT
chd-117	227	1	the	the	DET
chd-117	227	2	racial	racial	ADJ
chd-117	227	3	disparity	disparity	NOUN
chd-117	227	4	in	in	ADP
chd-117	227	5	breast	breast	NOUN
chd-117	227	6	cancer	cancer	NOUN
chd-117	227	7	mortality	mortality	NOUN
chd-117	227	8	in	in	ADP
chd-117	227	9	the	the	DET
chd-117	227	10	25	25	NUM
chd-117	227	11	largest	large	ADJ
chd-117	227	12	cities	city	NOUN
chd-117	227	13	in	in	ADP
chd-117	227	14	the	the	DET
chd-117	227	15	united	united	PROPN
chd-117	227	16	states	states	PROPN
chd-117	227	17	.	.	PUNCT
chd-117	228	1	cancer	cancer	NOUN
chd-117	228	2	epidemiology	epidemiology	NOUN
chd-117	228	3	36	36	NUM
chd-117	228	4	,	,	PUNCT
chd-117	228	5	e147	e147	PROPN
chd-117	228	6	-	-	PUNCT
chd-117	228	7	151	151	NUM
chd-117	228	8	.	.	PUNCT
chd-117	229	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-117	229	2	e12	e12	NOUN
chd-117	229	3	cancer	cancer	NOUN
chd-117	229	4	health	health	NOUN
chd-117	229	5	disparities	disparity	NOUN
chd-117	229	6	research	research	VERB
chd-117	229	7	supplemental	supplemental	ADJ
chd-117	229	8	figure	figure	NOUN
chd-117	229	9	1	1	NUM